James E. Crowe, Jr., M.D.

11415F MRB IV
2213 Garland Ave
Nashville, TN 37232-0417

Our laboratory studies focus on the molecular and structural basis for the development of effective B cell responses to viruses in humans. We also have active programs in biodefense research, vaccine and monoclonal antibody development, and biotechnology. Our group uses a very broad array of techniques including molecular and cellular biology, state-of-the-art imaging and flow cytometry, bioinformatics, next generation sequencing, EM and crystallography, computational modeling, and bioengineering approaches to attack the scientific problems that are of interest to us. Our philosophy is to work on major human pathogens, not model systems. Current studies center on Ebola and Marburg, chikungunya, Zika, influenza, dengue viruses, HIV, respiratory syncytial virus, human metapneumovirus, rotavirus and noroviruses, rabies, Rift Valley Fever virus, West Nile virus, and vaccinia virus/monkeypox/smallpox. We also have new studies of the human antibody response to bacterial toxins including those of pertussis and Staph aureus.

Many vaccine candidates and human monoclonal antibodies developed during our team’s research have been tested in Phase I-III clinical trials in humans, including tixagevimab + cilgavimab (Evusheld) that obtained EUA or full approval from the US FDA and European EMA for preventing COVID-19 with over 3 million treatments given to patients in the US, Europe, Middle East, Africa and Australia.

Our basic science studies focus on the genetic origins and structural determinants of virus neutralizing antibodies. To study this area, we have developed unique B cell and antibody engineering techniques including novel methods for generation of human B cell hybridomas, direct cloning of antibody variable genes from virus-specific B cells, high throughput sequence analysis, and full-length expression of recombinant antibodies including high throughput expression techniques. This work has allowed us to understand better structure/function characteristics of antiviral antibodies. Several of the recombinant human antibodies that we have generated are being developed commercially for testing in humans.

Dr. Crowe is board certified in Pediatric Infectious Diseases, but is no longer practicing medicine except for conducing research studies of immunology in humans.

Monoclonal antibodies, Immunology, Infectious disease, Microbiology, Viruses, B cells, influenza virus, dengue virus, HIV, RSV, MPV, rotavirus, smallpox, monkeypox virus vaccinia virus, Ebola virus, Marburg virus, chikungunya virus, Zika virus, respiratory syncytial virus, human metapneumovirus, norovirus, rabies virus, Rift Valley Fever virus, West Nile virus. Pertussis. Staphylococcus aureus, COVID-19, SARS-CoV-2, SARS-CoV. MERS-CoV. Host-Pathogen Interaction. Immunology. Microbiology. Microbiology and Immunology. Structural Biology. Virology.

McMillen CM, Chapman NS, Hoehl RM, Skvarca LB, Schwarz MM, Handal LS, Crowe JE, Hartman AL. A highly potent human neutralizing antibody prevents vertical transmission of Rift Valley fever virus in a rat model. Nat Commun. 2023 Jul 7/26/2023; 14(1): 4507. PMID: 37495594, PMCID: PMC10372071, PII: 10.1038/s41467-023-40187-z, DOI: 10.1038/s41467-023-40187-z, ISSN: 2041-1723.

Wen X, Suryadevara N, Kose N, Liu J, Zhan X, Handal LS, Williamson LE, Trivette A, Carnahan RH, Jardetzky TS, Crowe JE. Potent cross-neutralization of respiratory syncytial virus and human metapneumovirus through a structurally conserved antibody recognition mode. Cell Host Microbe [print-electronic]. 2023 Jul 7/26/2023; PMID: 37516111, PII: S1931-3128(23)00298-6, DOI: 10.1016/j.chom.2023.07.002, ISSN: 1934-6069.

Stass R, Engdahl TB, Chapman NS, Wolters RM, Handal LS, Diaz SM, Crowe JE, Bowden TA. Mechanistic basis for potent neutralization of Sin Nombre hantavirus by a human monoclonal antibody. Nat Microbiol [print-electronic]. 2023 Jul; 8(7): 1293-303. PMID: 37322112, PMCID: PMC10322703, PII: 10.1038/s41564-023-01413-y, DOI: 10.1038/s41564-023-01413-y, ISSN: 2058-5276.

Rolsma SL, Yoder SM, Nargi RS, Brady E, Jimenez-Truque N, Thomsen I, Kontos M, Carnahan RH, Sutton RE, Armstrong E, Dally L, Crowe JE, Edwards KM, Creech CB. Development of a Kinetic ELISA and Reactive B Cell Frequency Assay to Detect Respiratory Syncytial Virus Pre-Fusion F Protein-Specific Immune Responses in Infants. J Pediatric Infect Dis Soc. 2023 May 5/31/2023; 12(5): 298-305. PMID: 37029694, PMCID: PMC10231354, PII: 7111176, DOI: 10.1093/jpids/piad019, ISSN: 2048-7207.

Raju S, Adams LJ, Earnest JT, Warfield K, Vang L, Crowe JE, Fremont DH, Diamond MS. A chikungunya virus-like particle vaccine induces broadly neutralizing and protective antibodies against alphaviruses in humans. Sci Transl Med [print-electronic]. 2023 May 5/17/2023; 15(696): eade8273. PMID: 37196061, DOI: 10.1126/scitranslmed.ade8273, ISSN: 1946-6242.

Parrington HM, Kose N, Armstrong E, Handal L, Diaz S, Reidy J, Dong J, Stewart-Jones GB, Shrivastava-Ranjan P, Jain S, Albariño CG, Carnahan RH, Crowe JE. Potently neutralizing human mAbs against the zoonotic pararubulavirus Sosuga virus. JCI Insight. 2023 Apr 4/24/2023; 8(8): PMID: 36853802, PMCID: PMC10243738, PII: 166811, DOI: 10.1172/jci.insight.166811, ISSN: 2379-3708.

Chen EC, Gilchuk P, Zost SJ, Ilinykh PA, Binshtein E, Huang K, Myers L, Bonissone S, Day S, Kona CR, Trivette A, Reidy JX, Sutton RE, Gainza C, Diaz S, Williams JK, Selverian CN, Davidson E, Saphire EO, Doranz BJ, Castellana N, Bukreyev A, Carnahan RH, Crowe JE. Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypes. Cell Rep [print-electronic]. 2023 Apr 4/6/2023; 42(4): 112370. PMID: 37029928, PII: S2211-1247(23)00381-9, DOI: 10.1016/j.celrep.2023.112370, ISSN: 2211-1247.

Williamson LE, Bandyopadhyay A, Bailey K, Sirohi D, Klose T, Julander JG, Kuhn RJ, Crowe JE. Structural constraints link differences in neutralization potency of human anti-Eastern equine encephalitis virus monoclonal antibodies. Proc Natl Acad Sci U S A [print-electronic]. 2023 Mar 3/28/2023; 120(13): e2213690120. PMID: 36961925, PMCID: PMC10068833, DOI: 10.1073/pnas.2213690120, ISSN: 1091-6490.

Engdahl TB, Binshtein E, Brocato RL, Kuzmina NA, Principe LM, Kwilas SA, Kim RK, Chapman NS, Porter MS, Guardado-Calvo P, Rey FA, Handal LS, Diaz SM, Zagol-Ikapitte IA, Tran MH, McDonald WH, Meiler J, Reidy JX, Trivette A, Bukreyev A, Hooper JW, Crowe JE. Antigenic mapping and functional characterization of human New World hantavirus neutralizing antibodies. Elife. 2023 Mar 3/27/2023; 12: PMID: 36971354, PMCID: PMC10115451, PII: 81743, DOI: 10.7554/eLife.81743, ISSN: 2050-084X.

Rghei AD, Yates JGE, Lopes JA, Zhan X, Guilleman MM, Pei Y, van Lieshout LP, Santry LA, Bridle BW, Karimi K, Thompson B, Susta L, Crowe JE, Wootton SK. Antibody-based protection against respiratory syncytial virus in mice and their offspring through vectored immunoprophylaxis. Gene Ther [print-electronic]. 2023 Feb 2/2/2023; PMID: 36732618, PII: 10.1038/s41434-023-00385-2, DOI: 10.1038/s41434-023-00385-2, ISSN: 1476-5462.

Pilewski KA, Wall S, Richardson SI, Manamela NP, Clark K, Hermanus T, Binshtein E, Venkat R, Sautto GA, Kramer KJ, Shiakolas AR, Setliff I, Salas J, Mapengo RE, Suryadevara N, Brannon JR, Beebout CJ, Parks R, Raju N, Frumento N, Walker LM, Fechter EF, Qin JS, Murji AA, Janowska K, Thakur B, Lindenberger J, May AJ, Huang X, Sammour S, Acharya P, Carnahan RH, Ross TM, Haynes BF, Hadjifrangiskou M, Crowe JE, Bailey JR, Kalams S, Morris L, Georgiev IS. Functional HIV-1/HCV cross-reactive antibodies isolated from a chronically co-infected donor. Cell Rep [print-electronic]. 2023 Jan 1/27/2023; 42(2): 112044. PMID: 36708513, PMCID: PMC10372200, PII: S2211-1247(23)00055-4, DOI: 10.1016/j.celrep.2023.112044, ISSN: 2211-1247.

Mazur NI, Terstappen J, Baral R, Bardají A, Beutels P, Buchholz UJ, Cohen C, Crowe JE, Cutland CL, Eckert L, Feikin D, Fitzpatrick T, Fong Y, Graham BS, Heikkinen T, Higgins D, Hirve S, Klugman KP, Kragten-Tabatabaie L, Lemey P, Libster R, Löwensteyn Y, Mejias A, Munoz FM, Munywoki PK, Mwananyanda L, Nair H, Nunes MC, Ramilo O, Richmond P, Ruckwardt TJ, Sande C, Srikantiah P, Thacker N, Waldstein KA, Weinberger D, Wildenbeest J, Wiseman D, Zar HJ, Zambon M, Bont L. Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape. Lancet Infect Dis [print-electronic]. 2023 Jan; 23(1): e2-e21-e21. PMID: 35952703, PMCID: PMC9896921, PII: S1473-3099(22)00291-2, DOI: 10.1016/S1473-3099(22)00291-2, ISSN: 1474-4457.

Skinner NE, Ogega CO, Frumento N, Clark KE, Yegnasubramanian S, Schuebel K, Meyers J, Gupta A, Wheelan S, Cox AL, Crowe JE, Ray SC, Bailey JR. Convergent antibody responses are associated with broad neutralization of hepatitis C virus. Front Immunol. 2023; 14: 1135841. PMID: 37033983, PMCID: PMC10080129, DOI: 10.3389/fimmu.2023.1135841, ISSN: 1664-3224.

Martina CE, Crowe JE, Meiler J. Glycan masking in vaccine design: Targets, immunogens and applications. Front Immunol. 2023; 14: 1126034. PMID: 37033915, PMCID: PMC10076883, DOI: 10.3389/fimmu.2023.1126034, ISSN: 1664-3224.

Skinner NE, Ogega CO, Frumento N, Clark KE, Paul H, Yegnasubramanian S, Schuebel K, Meyers J, Gupta A, Wheelan S, Cox AL, Crowe JE, Ray SC, Bailey JR. Corrigendum: Convergent antibody responses are associated with broad neutralization of hepatitis C virus. Front Immunol. 2023; 14: 1201033. PMID: 37180140, PMCID: PMC10167485, DOI: 10.3389/fimmu.2023.1201033, ISSN: 1664-3224.

Raju N, Zhan X, Das S, Karwal L, Dean HJ, Crowe JE, Carnahan RH, Georgiev IS. Neutralization fingerprinting technology for characterizing polyclonal antibody responses to dengue vaccines. Cell Rep. 2022 Dec 12/13/2022; 41(11): 111807. PMID: 36516766, PII: S2211-1247(22)01695-3, DOI: 10.1016/j.celrep.2022.111807, ISSN: 2211-1247.

Vanover D, Zurla C, Peck HE, Orr-Burks N, Joo JY, Murray J, Holladay N, Hobbs RA, Jung Y, Chaves LCS, Rotolo L, Lifland AW, Olivier AK, Li D, Saunders KO, Sempowski GD, Crowe JE, Haynes BF, Lafontaine ER, Hogan RJ, Santangelo PJ. Nebulized mRNA-Encoded Antibodies Protect Hamsters from SARS-CoV-2 Infection. Adv Sci (Weinh) [print-electronic]. 2022 Dec; 9(34): e2202771. PMID: 36316224, PMCID: PMC9731714, DOI: 10.1002/advs.202202771, ISSN: 2198-3844.

Fischer MFS, Crowe JE, Meiler J. Computational epitope mapping of class I fusion proteins using low complexity supervised learning methods. PLoS Comput Biol. 2022 Dec; 18(12): e1010230. PMID: 36477260, PMCID: PMC9762601, PII: PCOMPBIOL-D-22-00778, DOI: 10.1371/journal.pcbi.1010230, ISSN: 1553-7358.

Self WH, Wheeler AP, Stewart TG, Schrager H, Mallada J, Thomas CB, Cataldo VD, O'Neal HR, Shapiro NI, Higgins C, Ginde AA, Chauhan L, Johnson NJ, Henning DJ, Jaiswal SJ, Mammen MJ, Harris ES, Pannu SR, Laguio-Vila M, El Atrouni W, de Wit M, Hoda D, Cohn CS, McWilliams C, Shanholtz C, Jones AE, Raval JS, Mucha S, Ipe TS, Qiao X, Schrantz SJ, Shenoy A, Fremont RD, Brady EJ, Carnahan RH, Chappell JD, Crowe JE, Denison MR, Gilchuk P, Stevens LJ, Sutton RE, Thomsen I, Yoder SM, Bistran-Hall AJ, Casey JD, Lindsell CJ, Wang L, Pulley JM, Rhoads JP, Bernard GR, Rice TW, . Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19: A Blinded, Randomized, Placebo-Controlled Trial. Chest [print-electronic]. 2022 Nov; 162(5): 982-94. PMID: 35780813, PMCID: PMC9247217, PII: S0012-3692(22)01201-6, DOI: 10.1016/j.chest.2022.06.029, ISSN: 1931-3543.

Nkolola JP, Yu J, Wan H, Chang A, McMahan K, Anioke T, Jacob-Dolan C, Powers O, Ye T, Chandrashekar A, Sellers D, Barrett J, Loo YM, Esser MT, Carnahan RH, Crowe JE, Barouch DH. A bivalent SARS-CoV-2 monoclonal antibody combination does not affect the immunogenicity of a vector-based COVID-19 vaccine in macaques. Sci Transl Med [print-electronic]. 2022 Oct 10/5/2022; 14(665): eabo6160. PMID: 35857623, PMCID: PMC9348747, DOI: 10.1126/scitranslmed.abo6160, ISSN: 1946-6242.

Chastain CA, Jenkins CA, Rose M, Moore D, Parker D, Cave B, Crowe J, Adams S, Rubio MG, Potter R, Quedado K, Jones ID, Han JH, Self WH. Non-targeted hepatitis C virus screening in acute care healthcare settings in the Southern Appalachian region. J Am Coll Emerg Physicians Open. 2022 Oct; 3(5): e12819. PMID: 36172306, PMCID: PMC9467969, PII: EMP212819, DOI: 10.1002/emp2.12819, ISSN: 2688-1152.

Shiakolas AR, Kramer KJ, Johnson NV, Wall SC, Suryadevara N, Wrapp D, Periasamy S, Pilewski KA, Raju N, Nargi R, Sutton RE, Walker LM, Setliff I, Crowe JE, Bukreyev A, Carnahan RH, McLellan JS, Georgiev IS. Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blocking. Nat Biotechnol [print-electronic]. 2022 Aug; 40(8): 1270-5. PMID: 35241839, PMCID: PMC9378442, PII: 10.1038/s41587-022-01232-2, DOI: 10.1038/s41587-022-01232-2, ISSN: 1546-1696.

Frumento N, Figueroa A, Wang T, Zahid MN, Wang S, Massaccesi G, Stavrakis G, Crowe JE, Flyak AI, Ji H, Ray SC, Shaw GM, Cox AL, Bailey JR. Repeated exposure to heterologous hepatitis C viruses associates with enhanced neutralizing antibody breadth and potency. J Clin Invest. 2022 Aug 8/1/2022; 132(15): PMID: 35588376, PMCID: PMC9337827, PII: 160058, DOI: 10.1172/JCI160058, ISSN: 1558-8238.

Case JB, Mackin S, Errico JM, Chong Z, Madden EA, Whitener B, Guarino B, Schmid MA, Rosenthal K, Ren K, Dang HV, Snell G, Jung A, Droit L, Handley SA, Halfmann PJ, Kawaoka Y, Crowe JE, Fremont DH, Virgin HW, Loo YM, Esser MT, Purcell LA, Corti D, Diamond MS. Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains. Nat Commun. 2022 Jul 7/2/2022; 13(1): 3824. PMID: 35780162, PMCID: PMC9250508, PII: 10.1038/s41467-022-31615-7, DOI: 10.1038/s41467-022-31615-7, ISSN: 2041-1723.

Doyle MP, Genualdi JR, Bailey AL, Kose N, Gainza C, Rodriguez J, Reeder KM, Nelson CA, Jethva PN, Sutton RE, Bombardi RG, Gross ML, Julander JG, Fremont DH, Diamond MS, Crowe JE. Isolation of a Potently Neutralizing and Protective Human Monoclonal Antibody Targeting Yellow Fever Virus. MBio [print-electronic]. 2022 Jun 6/28/2022; 13(3): e0051222. PMID: 35420472, PMCID: PMC9239089, DOI: 10.1128/mbio.00512-22, ISSN: 2150-7511.

Suryadevara N, Gilchuk P, Zost SJ, Mittal N, Zhao LL, Crowe JE, Carnahan RH. Real-time cell analysis: A high-throughput approach for testing SARS-CoV-2 antibody neutralization and escape. STAR Protoc. 2022 Jun 6/17/2022; 3(2): 101387. PMID: 35578733, PMCID: PMC9023333, PII: S2666-1667(22)00267-2, DOI: 10.1016/j.xpro.2022.101387, ISSN: 2666-1667.

Fowler BD, Kose N, Reidy JX, Handal LS, Skaar EP, Crowe JE. Human Monoclonal Antibodies to Escherichia coli Outer Membrane Protein A Porin Domain Cause Aggregation but Do Not Alter In Vivo Bacterial Burdens in a Murine Sepsis Model. Infect Immun [print-electronic]. 2022 Jun 6/16/2022; 90(6): e0017622. PMID: 35583347, PMCID: PMC9202393, DOI: 10.1128/iai.00176-22, ISSN: 1098-5522.

Kramer KJ, Wilfong EM, Voss K, Barone SM, Shiakolas AR, Raju N, Roe CE, Suryadevara N, Walker LM, Wall SC, Paulo A, Schaefer S, Dahunsi D, Westlake CS, Crowe JE, Carnahan RH, Rathmell JC, Bonami RH, Georgiev IS, Irish JM. Single-cell profiling of the antigen-specific response to BNT162b2 SARS-CoV-2 RNA vaccine. Nat Commun. 2022 Jun 6/16/2022; 13(1): 3466. PMID: 35710908, PMCID: PMC9201272, PII: 10.1038/s41467-022-31142-5, DOI: 10.1038/s41467-022-31142-5, ISSN: 2041-1723.

Bozhanova NG, Flyak AI, Brown BP, Ruiz SE, Salas J, Rho S, Bombardi RG, Myers L, Soto C, Bailey JR, Crowe JE, Bjorkman PJ, Meiler J. Computational identification of HCV neutralizing antibodies with a common HCDR3 disulfide bond motif in the antibody repertoires of infected individuals. Nat Commun. 2022 Jun 6/8/2022; 13(1): 3178. PMID: 35676279, PMCID: PMC9177688, PII: 10.1038/s41467-022-30865-9, DOI: 10.1038/s41467-022-30865-9, ISSN: 2041-1723.

Suryadevara N, Shiakolas AR, VanBlargan LA, Binshtein E, Chen RE, Case JB, Kramer KJ, Armstrong EC, Myers L, Trivette A, Gainza C, Nargi RS, Selverian CN, Davidson E, Doranz BJ, Diaz SM, Handal LS, Carnahan RH, Diamond MS, Georgiev IS, Crowe JE. An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer. J Clin Invest. 2022 Jun 6/1/2022; 132(11): PMID: 35472136, PMCID: PMC9151704, PII: 159062, DOI: 10.1172/JCI159062, ISSN: 1558-8238.

Vogt MR, Wright PF, Hickey WF, De Buysscher T, Boyd KL, Crowe JE. Enterovirus D68 in the Anterior Horn Cells of a Child with Acute Flaccid Myelitis [letter]. N Engl J Med. 2022 May 5/26/2022; 386(21): 2059-60. PMID: 35613028, PMCID: PMC9321432, DOI: 10.1056/NEJMc2118155, ISSN: 1533-4406.

Pfaff-Kilgore JM, Davidson E, Kadash-Edmondson K, Hernandez M, Rosenberg E, Chambers R, Castelli M, Clementi N, Mancini N, Bailey JR, Crowe JE, Law M, Doranz BJ. Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening. Cell Rep. 2022 May 5/24/2022; 39(8): 110859. PMID: 35613596, PMCID: PMC9281441, PII: S2211-1247(22)00632-5, DOI: 10.1016/j.celrep.2022.110859, ISSN: 2211-1247.

Bangaru S, Antanasijevic A, Kose N, Sewall LM, Jackson AM, Suryadevara N, Zhan X, Torres JL, Copps J, de la Peña AT, Crowe JE, Ward AB. Structural mapping of antibody landscapes to human betacoronavirus spike proteins. Sci Adv [print-electronic]. 2022 May 5/6/2022; 8(18): eabn2911. PMID: 35507649, PMCID: PMC9067923, DOI: 10.1126/sciadv.abn2911, ISSN: 2375-2548.

August A, Attarwala HZ, Himansu S, Kalidindi S, Lu S, Pajon R, Han S, Lecerf JM, Tomassini JE, Hard M, Ptaszek LM, Crowe JE, Zaks T. Author Correction: A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus. Nat Med. 2022 May; 28(5): 1095-6. PMID: 35449420, PMCID: PMC9117134, PII: 10.1038/s41591-022-01817-z, DOI: 10.1038/s41591-022-01817-z, ISSN: 1546-170X.

Schoeder CT, Gilchuk P, Sangha AK, Ledwitch KV, Malherbe DC, Zhang X, Binshtein E, Williamson LE, Martina CE, Dong J, Armstrong E, Sutton R, Nargi R, Rodriguez J, Kuzmina N, Fiala B, King NP, Bukreyev A, Crowe JE, Meiler J. Epitope-focused immunogen design based on the ebolavirus glycoprotein HR2-MPER region. PLoS Pathog. 2022 May; 18(5): e1010518. PMID: 35584193, PMCID: PMC9170092, PII: PPATHOGENS-D-21-02476, DOI: 10.1371/journal.ppat.1010518, ISSN: 1553-7374.

Crowe JE. Human Antibodies for Viral Infections. Annu Rev Immunol [print-electronic]. 2022 Apr 4/26/2022; 40: 349-86. PMID: 35113730, DOI: 10.1146/annurev-immunol-042718-041309, ISSN: 1545-3278.

Kafai NM, Williamson LE, Binshtein E, Sukupolvi-Petty S, Gardner CL, Liu J, Mackin S, Kim AS, Kose N, Carnahan RH, Jung A, Droit L, Reed DS, Handley SA, Klimstra WB, Crowe JE, Diamond MS. Neutralizing antibodies protect mice against Venezuelan equine encephalitis virus aerosol challenge. J Exp Med [print-electronic]. 2022 Apr 4/4/2022; 219(4): PMID: 35297953, PMCID: PMC9195047, PII: 213072, DOI: 10.1084/jem.20212532, ISSN: 1540-9538.

Cobb RR, Nkolola J, Gilchuk P, Chandrashekar A, Yu J, House RV, Earnhart CG, Dorsey NM, Hopkins SA, Snow DM, Chen RE, VanBlargan LA, Hechenblaickner M, Hoppe B, Collins L, Tomic MT, Nonet GH, Hackett K, Slaughter JC, Lewis MG, Andersen H, Cook A, Diamond MS, Carnahan RH, Barouch DH, Crowe JE. A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in cynomolgus macaques. Med [print-electronic]. 2022 Mar 3/11/2022; 3(3): 188-203.e4-203.e4. PMID: 35132398, PMCID: PMC8810411, PII: S2666-6340(22)00039-3, DOI: 10.1016/j.medj.2022.01.004, ISSN: 2666-6340.

Hu L, Salmen W, Chen R, Zhou Y, Neill F, Crowe JE, Atmar RL, Estes MK, Prasad BVV. Atomic structure of the predominant GII.4 human norovirus capsid reveals novel stability and plasticity. Nat Commun. 2022 Mar 3/10/2022; 13(1): 1241. PMID: 35273142, PMCID: PMC8913647, PII: 10.1038/s41467-022-28757-z, DOI: 10.1038/s41467-022-28757-z, ISSN: 2041-1723.

Loo YM, McTamney PM, Arends RH, Abram ME, Aksyuk AA, Diallo S, Flores DJ, Kelly EJ, Ren K, Roque R, Rosenthal K, Streicher K, Tuffy KM, Bond NJ, Cornwell O, Bouquet J, Cheng LI, Dunyak J, Huang Y, Rosenbaum AI, Pilla Reddy V, Andersen H, Carnahan RH, Crowe JE, Kuehne AI, Herbert AS, Dye JM, Bright H, Kallewaard NL, Pangalos MN, Esser MT. The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in nonhuman primates and has an extended half-life in humans. Sci Transl Med [print-electronic]. 2022 Mar 3/9/2022; 14(635): eabl8124. PMID: 35076282, PMCID: PMC8939769, DOI: 10.1126/scitranslmed.abl8124, ISSN: 1946-6242.

VanBlargan LA, Errico JM, Halfmann PJ, Zost SJ, Crowe JE, Purcell LA, Kawaoka Y, Corti D, Fremont DH, Diamond MS. An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies. Nat Med [print-electronic]. 2022 Mar; 28(3): 490-5. PMID: 35046573, PMCID: PMC8767531, PII: 10.1038/s41591-021-01678-y, DOI: 10.1038/s41591-021-01678-y, ISSN: 1546-170X.

Crowe JE. Bispecific antiviral neutralizing antibodies are twice as nice. Nat Immunol. 2022 Mar; 23(3): 346-7. PMID: 35228693, PII: 10.1038/s41590-022-01147-9, DOI: 10.1038/s41590-022-01147-9, ISSN: 1529-2916.

Crowe JE, Carnahan RH. Even old foes can learn sweet new tricks. Cell Host Microbe. 2022 Feb 2/9/2022; 30(2): 151-3. PMID: 35143767, PII: S1931-3128(22)00047-6, DOI: 10.1016/j.chom.2022.01.011, ISSN: 1934-6069.

Gilchuk P, Thomsen I, Yoder S, Brady E, Chappell JD, Stevens LJ, Denison MR, Sutton RE, Chen RE, VanBlargan LA, Suryadevara N, Zost SJ, Schmitz J, Pulley JM, Diamond MS, Rhoads JP, Bernard GR, Self WH, Rice TW, Wheeler AP, Crowe JE, Carnahan RH. Standardized two-step testing of antibody activity in COVID-19 convalescent plasma. IScience [print-electronic]. 2022 Jan 1/21/2022; 25(1): 103602. PMID: 34901783, PMCID: PMC8653399, PII: S2589-0042(21)01572-8, DOI: 10.1016/j.isci.2021.103602, ISSN: 2589-0042.

Yuan TZ, Garg P, Wang L, Willis JR, Kwan E, Hernandez AGL, Tuscano E, Sever EN, Keane E, Soto C, Mucker EM, Fouch ME, Davidson E, Doranz BJ, Kailasan S, Aman MJ, Li H, Hooper JW, Saphire EO, Crowe JE, Liu Q, Axelrod F, Sato AK. Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage libraries. MAbs. 2022; 14(1): 2002236. PMID: 34967699, PMCID: PMC8726723, DOI: 10.1080/19420862.2021.2002236, ISSN: 1942-0870.

Ogega CO, Skinner NE, Flyak AI, Clark KE, Board NL, Bjorkman PJ, Crowe JE, Cox AL, Ray SC, Bailey JR. B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infection. PLoS Pathog. 2022 Jan; 18(1): e1010179. PMID: 34990486, PMCID: PMC8769295, PII: PPATHOGENS-D-21-02023, DOI: 10.1371/journal.ppat.1010179, ISSN: 1553-7374.

Schmitz S, Schmitz EA, Crowe JE, Meiler J. The human antibody sequence space and structural design of the V, J regions, and CDRH3 with Rosetta. MAbs. 2022; 14(1): 2068212. PMID: 35544469, PMCID: PMC9103704, DOI: 10.1080/19420862.2022.2068212, ISSN: 1942-0870.

Ford-Siltz LA, Tohma K, Alvarado GS, Kendra JA, Pilewski KA, Crowe JE, Parra GI. Cross-reactive neutralizing human monoclonal antibodies mapping to variable antigenic sites on the norovirus major capsid protein. Front Immunol. 2022; 13: 1040836. PMID: 36389818, PMCID: PMC9641292, DOI: 10.3389/fimmu.2022.1040836, ISSN: 1664-3224.

VanBlargan L, Errico J, Halfmann P, Zost S, Crowe J, Purcell L, Kawaoka Y, Corti D, Fremont D, Diamond M. An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies. Res Sq. 2021 Dec 12/27/2021; PMID: 34981042, PMCID: PMC8722605, PII: rs.3.rs-1175516, DOI: 10.21203/rs.3.rs-1175516/v1.

August A, Attarwala HZ, Himansu S, Kalidindi S, Lu S, Pajon R, Han S, Lecerf JM, Tomassini JE, Hard M, Ptaszek LM, Crowe JE, Zaks T. A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus. Nat Med [print-electronic]. 2021 Dec; 27(12): 2224-33. PMID: 34887572, PMCID: PMC8674127, PII: 10.1038/s41591-021-01573-6, DOI: 10.1038/s41591-021-01573-6, ISSN: 1546-170X.

Drury SL, Miller AR, Laut CL, Walter AB, Bennett MR, Su M, Bai M, Jing B, Joseph SB, Metzger EJ, Bane CE, Black CC, Macdonald MT, Dutter BF, Romaine IM, Waterson AG, Sulikowski GA, Jansen ED, Crowe JE, Sciotti RJ, Skaar EP. Simultaneous Exposure to Intracellular and Extracellular Photosensitizers for the Treatment of Staphylococcus aureus Infections. Antimicrob Agents Chemother [print-electronic]. 2021 Nov 11/17/2021; 65(12): e0091921. PMID: 34516248, PMCID: PMC8597735, DOI: 10.1128/AAC.00919-21, ISSN: 1098-6596.

Kodali P, Schoeder CT, Schmitz S, Crowe JE, Meiler J. RosettaCM for antibodies with very long HCDR3s and low template availability. Proteins [print-electronic]. 2021 Nov; 89(11): 1458-72. PMID: 34176159, PMCID: PMC8492515, DOI: 10.1002/prot.26166, ISSN: 1097-0134.

Gilchuk P, Murin CD, Cross RW, Ilinykh PA, Huang K, Kuzmina N, Borisevich V, Agans KN, Geisbert JB, Zost SJ, Nargi RS, Sutton RE, Suryadevara N, Bombardi RG, Carnahan RH, Bukreyev A, Geisbert TW, Ward AB, Crowe JE. Pan-ebolavirus protective therapy by two multifunctional human antibodies. Cell. 2021 Oct 10/28/2021; 184(22): 5593-5607.e18-5607.e18. PMID: 34715022, PMCID: PMC8716180, PII: S0092-8674(21)01165-X, DOI: 10.1016/j.cell.2021.09.035, ISSN: 1097-4172.

Wessel AW, Doyle MP, Engdahl TB, Rodriguez J, Crowe JE, Diamond MS. Human Monoclonal Antibodies against NS1 Protein Protect against Lethal West Nile Virus Infection. MBio [print-electronic]. 2021 Oct 10/26/2021; 12(5): e0244021. PMID: 34634945, PMCID: PMC8510529, DOI: 10.1128/mBio.02440-21, ISSN: 2150-7511.

Alvarado G, Salmen W, Ettayebi K, Hu L, Sankaran B, Estes MK, Venkataram Prasad BV, Crowe JE. Author Correction: Broadly cross-reactive human antibodies that inhibit genogroup I and II noroviruses. Nat Commun. 2021 Oct 10/14/2021; 12(1): 6090. PMID: 34650069, PMCID: PMC8516901, PII: 10.1038/s41467-021-26418-1, DOI: 10.1038/s41467-021-26418-1, ISSN: 2041-1723.

VanBlargan LA, Adams LJ, Liu Z, Chen RE, Gilchuk P, Raju S, Smith BK, Zhao H, Case JB, Winkler ES, Whitener BM, Droit L, Aziati ID, Bricker TL, Joshi A, Shi PY, Creanga A, Pegu A, Handley SA, Wang D, Boon ACM, Crowe JE, Whelan SPJ, Fremont DH, Diamond MS. A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope. Immunity [print-electronic]. 2021 Oct 10/12/2021; 54(10): 2399-2416.e6-2416.e6. PMID: 34481543, PMCID: PMC8373659, PII: S1074-7613(21)00348-4, DOI: 10.1016/j.immuni.2021.08.016, ISSN: 1097-4180.

Gilchuk IM, Bangaru S, Kose N, Bombardi RG, Trivette A, Li S, Turner HL, Carnahan RH, Ward AB, Crowe JE. Human antibody recognition of H7N9 influenza virus HA following natural infection. JCI Insight. 2021 Oct 10/8/2021; 6(19): PMID: 34437301, PMCID: PMC8525637, PII: e152403, DOI: 10.1172/jci.insight.152403, ISSN: 2379-3708.

Kramer KJ, Johnson NV, Shiakolas AR, Suryadevara N, Periasamy S, Raju N, Williams JK, Wrapp D, Zost SJ, Walker LM, Wall SC, Holt CM, Hsieh CL, Sutton RE, Paulo A, Nargi RS, Davidson E, Doranz BJ, Crowe JE, Bukreyev A, Carnahan RH, McLellan JS, Georgiev IS. Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition. Cell Rep [print-electronic]. 2021 Oct 10/5/2021; 37(1): 109784. PMID: 34592170, PMCID: PMC8443366, PII: S2211-1247(21)01243-2, DOI: 10.1016/j.celrep.2021.109784, ISSN: 2211-1247.

Dong J, Zost SJ, Greaney AJ, Starr TN, Dingens AS, Chen EC, Chen RE, Case JB, Sutton RE, Gilchuk P, Rodriguez J, Armstrong E, Gainza C, Nargi RS, Binshtein E, Xie X, Zhang X, Shi PY, Logue J, Weston S, McGrath ME, Frieman MB, Brady T, Tuffy KM, Bright H, Loo YM, McTamney PM, Esser MT, Carnahan RH, Diamond MS, Bloom JD, Crowe JE. Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail. Nat Microbiol [print-electronic]. 2021 Oct; 6(10): 1233-44. PMID: 34548634, PMCID: PMC8543371, PII: 10.1038/s41564-021-00972-2, DOI: 10.1038/s41564-021-00972-2, ISSN: 2058-5276.

Doyle MP, Kose N, Borisevich V, Binshtein E, Amaya M, Nagel M, Annand EJ, Armstrong E, Bombardi R, Dong J, Schey KL, Broder CC, Zeitlin L, Kuang EA, Bornholdt ZA, West BR, Geisbert TW, Cross RW, Crowe JE. Cooperativity mediated by rationally selected combinations of human monoclonal antibodies targeting the henipavirus receptor binding protein. Cell Rep. 2021 Aug 8/31/2021; 36(9): 109628. PMID: 34469726, PMCID: PMC8527959, PII: S2211-1247(21)01066-4, DOI: 10.1016/j.celrep.2021.109628, ISSN: 2211-1247.

Chen EC, Gilchuk P, Zost SJ, Suryadevara N, Winkler ES, Cabel CR, Binshtein E, Chen RE, Sutton RE, Rodriguez J, Day S, Myers L, Trivette A, Williams JK, Davidson E, Li S, Doranz BJ, Campos SK, Carnahan RH, Thorne CA, Diamond MS, Crowe JE. Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals. Cell Rep [print-electronic]. 2021 Aug 8/24/2021; 36(8): 109604. PMID: 34411541, PMCID: PMC8352653, PII: S2211-1247(21)01042-1, DOI: 10.1016/j.celrep.2021.109604, ISSN: 2211-1247.

Williamson LE, Reeder KM, Bailey K, Tran MH, Roy V, Fouch ME, Kose N, Trivette A, Nargi RS, Winkler ES, Kim AS, Gainza C, Rodriguez J, Armstrong E, Sutton RE, Reidy J, Carnahan RH, McDonald WH, Schoeder CT, Klimstra WB, Davidson E, Doranz BJ, Alter G, Meiler J, Schey KL, Julander JG, Diamond MS, Crowe JE. Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egress. Cell. 2021 Aug 8/19/2021; 184(17): 4430-4446.e22-4446.e22. PMID: 34416147, PMCID: PMC8418820, PII: S0092-8674(21)00892-8, DOI: 10.1016/j.cell.2021.07.033, ISSN: 1097-4172.

Kim AS, Kafai NM, Winkler ES, Gilliland TC, Cottle EL, Earnest JT, Jethva PN, Kaplonek P, Shah AP, Fong RH, Davidson E, Malonis RJ, Quiroz JA, Williamson LE, Vang L, Mack M, Crowe JE, Doranz BJ, Lai JR, Alter G, Gross ML, Klimstra WB, Fremont DH, Diamond MS. Pan-protective anti-alphavirus human antibodies target a conserved E1 protein epitope. Cell. 2021 Aug 8/19/2021; 184(17): 4414-4429.e19-4429.e19. PMID: 34416146, PMCID: PMC8382027, PII: S0092-8674(21)00832-1, DOI: 10.1016/j.cell.2021.07.006, ISSN: 1097-4172.

Zost SJ, Dong J, Gilchuk IM, Gilchuk P, Thornburg NJ, Bangaru S, Kose N, Finn JA, Bombardi R, Soto C, Chen EC, Nargi RS, Sutton RE, Irving RP, Suryadevara N, Westover JB, Carnahan RH, Turner HL, Li S, Ward AB, Crowe JE. Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interface. J Clin Invest. 2021 Aug 8/2/2021; 131(15): PMID: 34156974, PMCID: PMC8321569, PII: e146791, DOI: 10.1172/JCI146791, ISSN: 1558-8238.

Chen RE, Winkler ES, Case JB, Aziati ID, Bricker TL, Joshi A, Darling TL, Ying B, Errico JM, Shrihari S, VanBlargan LA, Xie X, Gilchuk P, Zost SJ, Droit L, Liu Z, Stumpf S, Wang D, Handley SA, Stine WB, Shi PY, Davis-Gardner ME, Suthar MS, Knight MG, Andino R, Chiu CY, Ellebedy AH, Fremont DH, Whelan SPJ, Crowe JE, Purcell L, Corti D, Boon ACM, Diamond MS. In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains. Nature [print-electronic]. 2021 Aug; 596(7870): 103-8. PMID: 34153975, PMCID: PMC8349859, PII: 10.1038/s41586-021-03720-y, DOI: 10.1038/s41586-021-03720-y, ISSN: 1476-4687.

Alvarado G, Salmen W, Ettayebi K, Hu L, Sankaran B, Estes MK, Venkataram Prasad BV, Crowe JE. Broadly cross-reactive human antibodies that inhibit genogroup I and II noroviruses. Nat Commun. 2021 Jul 7/14/2021; 12(1): 4320. PMID: 34262046, PMCID: PMC8280134, PII: 10.1038/s41467-021-24649-w, DOI: 10.1038/s41467-021-24649-w, ISSN: 2041-1723.

Meyer M, Gunn BM, Malherbe DC, Gangavarapu K, Yoshida A, Pietzsch C, Kuzmina NA, Saphire EO, Collins PL, Crowe JE, Zhu JJ, Suchard MA, Brining DL, Mire CE, Cross RW, Geisbert JB, Samal SK, Andersen KG, Alter G, Geisbert TW, Bukreyev A. Ebola vaccine-induced protection in nonhuman primates correlates with antibody specificity and Fc-mediated effects. Sci Transl Med. 2021 Jul 7/14/2021; 13(602): PMID: 34261800, PMCID: PMC8675601, PII: 13/602/eabg6128, DOI: 10.1126/scitranslmed.abg6128, ISSN: 1946-6242.

Puray-Chavez M, LaPak KM, Schrank TP, Elliott JL, Bhatt DP, Agajanian MJ, Jasuja R, Lawson DQ, Davis K, Rothlauf PW, Liu Z, Jo H, Lee N, Tenneti K, Eschbach JE, Shema Mugisha C, Cousins EM, Cloer EW, Vuong HR, VanBlargan LA, Bailey AL, Gilchuk P, Crowe JE, Diamond MS, Hayes DN, Whelan SPJ, Horani A, Brody SL, Goldfarb D, Major MB, Kutluay SB. Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell. Cell Rep [print-electronic]. 2021 Jul 7/13/2021; 36(2): 109364. PMID: 34214467, PMCID: PMC8220945, PII: S2211-1247(21)00762-2, DOI: 10.1016/j.celrep.2021.109364, ISSN: 2211-1247.

Shiakolas AR, Kramer KJ, Wrapp D, Richardson SI, Schäfer A, Wall S, Wang N, Janowska K, Pilewski KA, Venkat R, Parks R, Manamela NP, Raju N, Fechter EF, Holt CM, Suryadevara N, Chen RE, Martinez DR, Nargi RS, Sutton RE, Ledgerwood JE, Graham BS, Diamond MS, Haynes BF, Acharya P, Carnahan RH, Crowe JE, Baric RS, Morris L, McLellan JS, Georgiev IS. Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions. Cell Rep Med [print-electronic]. 2021 Jun 6/15/2021; 2(6): 100313. PMID: 34056628, PMCID: PMC8139315, PII: S2666-3791(21)00156-7, DOI: 10.1016/j.xcrm.2021.100313, ISSN: 2666-3791.

Engdahl TB, Kuzmina NA, Ronk AJ, Mire CE, Hyde MA, Kose N, Josleyn MD, Sutton RE, Mehta A, Wolters RM, Lloyd NM, Valdivieso FR, Ksiazek TG, Hooper JW, Bukreyev A, Crowe JE. Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infection. Cell Rep. 2021 May 5/4/2021; 35(5): 109086. PMID: 33951434, PMCID: PMC8142553, PII: S2211-1247(21)00419-8, DOI: 10.1016/j.celrep.2021.109086, ISSN: 2211-1247.

Suryadevara N, Shrihari S, Gilchuk P, VanBlargan LA, Binshtein E, Zost SJ, Nargi RS, Sutton RE, Winkler ES, Chen EC, Fouch ME, Davidson E, Doranz BJ, Chen RE, Shi PY, Carnahan RH, Thackray LB, Diamond MS, Crowe JE. Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein. Cell [print-electronic]. 2021 Apr 4/29/2021; 184(9): 2316-2331.e15-2331.e15. PMID: 33773105, PMCID: PMC7962591, PII: S0092-8674(21)00357-3, DOI: 10.1016/j.cell.2021.03.029, ISSN: 1097-4172.

Diamond M, Chen R, Winkler E, Case J, Aziati I, Bricker T, Joshi A, Darling T, Ying B, Errico J, Shrihari S, VanBlargan L, Xie X, Gilchuk P, Zost S, Droit L, Liu Z, Stumpf S, Wang D, Handley S, Stine W, Shi PY, Garcia-Knight M, Andino R, Chiu C, Ellebedy A, Fremont D, Whelan S, Crowe J, Purcell L, Corti D, Boon A. In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains. Res Sq. 2021 Apr 4/23/2021; PMID: 34013259, PMCID: PMC8132254, PII: rs.3.rs-448370, DOI: 10.21203/rs.3.rs-448370/v1.

Murin CD, Gilchuk P, Ilinykh PA, Huang K, Kuzmina N, Shen X, Bruhn JF, Bryan AL, Davidson E, Doranz BJ, Williamson LE, Copps J, Alkutkar T, Flyak AI, Bukreyev A, Crowe JE, Ward AB. Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodies. Cell Rep. 2021 Apr 4/13/2021; 35(2): 108984. PMID: 33852862, PMCID: PMC8133395, PII: S2211-1247(21)00298-9, DOI: 10.1016/j.celrep.2021.108984, ISSN: 2211-1247.

Chapman NS, Zhao H, Kose N, Westover JB, Kalveram B, Bombardi R, Rodriguez J, Sutton R, Genualdi J, LaBeaud AD, Mutuku FM, Pittman PR, Freiberg AN, Gowen BB, Fremont DH, Crowe JE. Potent neutralization of Rift Valley fever virus by human monoclonal antibodies through fusion inhibition. Proc Natl Acad Sci U S A. 2021 Apr 4/6/2021; 118(14): PMID: 33782133, PMCID: PMC8040655, PII: 2025642118, DOI: 10.1073/pnas.2025642118, ISSN: 1091-6490.

Jones T, Day SB, Myers L, Crowe JE, Soto C. ClonoMatch: a tool for identifying homologous immunoglobulin and T-cell receptor sequences in large databases. Bioinformatics. 2021 Apr 4/5/2021; 36(24): 5695-7. PMID: 33325481, PMCID: PMC8023686, PII: 6039106, DOI: 10.1093/bioinformatics/btaa1028, ISSN: 1367-4811.

Winkler ES, Gilchuk P, Yu J, Bailey AL, Chen RE, Chong Z, Zost SJ, Jang H, Huang Y, Allen JD, Case JB, Sutton RE, Carnahan RH, Darling TL, Boon ACM, Mack M, Head RD, Ross TM, Crowe JE, Diamond MS. Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection. Cell [print-electronic]. 2021 Apr 4/1/2021; 184(7): 1804-1820.e16-1820.e16. PMID: 33691139, PMCID: PMC7879018, PII: S0092-8674(21)00176-8, DOI: 10.1016/j.cell.2021.02.026, ISSN: 1097-4172.

Chen RE, Zhang X, Case JB, Winkler ES, Liu Y, VanBlargan LA, Liu J, Errico JM, Xie X, Suryadevara N, Gilchuk P, Zost SJ, Tahan S, Droit L, Turner JS, Kim W, Schmitz AJ, Thapa M, Wang D, Boon ACM, Presti RM, O'Halloran JA, Kim AHJ, Deepak P, Pinto D, Fremont DH, Crowe JE, Corti D, Virgin HW, Ellebedy AH, Shi PY, Diamond MS. Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies. Nat Med [print-electronic]. 2021 Apr; 27(4): 717-26. PMID: 33664494, PMCID: PMC8058618, PII: 10.1038/s41591-021-01294-w, DOI: 10.1038/s41591-021-01294-w, ISSN: 1546-170X.

Dagotto G, Mercado NB, Martinez DR, Hou YJ, Nkolola JP, Carnahan RH, Crowe JE, Baric RS, Barouch DH. Comparison of Subgenomic and Total RNA in SARS-CoV-2 Challenged Rhesus Macaques. J Virol [print-electronic]. 2021 Mar 3/25/2021; 95(8): PMID: 33472939, PMCID: PMC8103707, PII: JVI.02370-20, DOI: 10.1128/JVI.02370-20, ISSN: 1098-5514.

Schoeder CT, Schmitz S, Adolf-Bryfogle J, Sevy AM, Finn JA, Sauer MF, Bozhanova NG, Mueller BK, Sangha AK, Bonet J, Sheehan JH, Kuenze G, Marlow B, Smith ST, Woods H, Bender BJ, Martina CE, Del Alamo D, Kodali P, Gulsevin A, Schief WR, Correia BE, Crowe JE, Meiler J, Moretti R. Modeling Immunity with Rosetta: Methods for Antibody and Antigen Design. Biochemistry [print-electronic]. 2021 Mar 3/23/2021; 60(11): 825-46. PMID: 33705117, PMCID: PMC7992133, DOI: 10.1021/acs.biochem.0c00912, ISSN: 1520-4995.

Diamond M, Chen R, Xie X, Case J, Zhang X, VanBlargan L, Liu Y, Liu J, Errico J, Winkler E, Suryadevara N, Tahan S, Turner J, Kim W, Schmitz A, Thapa M, Wang D, Boon A, Pinto D, Presti R, O'Halloran J, Kim A, Deepak P, Fremont D, Corti D, Virgin H, Crowe J, Droit L, Ellebedy A, Shi PY, Gilchuk P. SARS-CoV-2 variants show resistance to neutralization by many monoclonal and serum-derived polyclonal antibodies. Res Sq. 2021 Feb 2/10/2021; PMID: 33594356, PMCID: PMC7885928, PII: rs.3.rs-228079, DOI: 10.21203/rs.3.rs-228079/v1.

Zhang Q, Jeppesen DK, Higginbotham JN, Franklin JL, Crowe JE, Coffey RJ. Angiotensin-converting Enzyme 2-containing Small Extracellular Vesicles and Exomeres Bind the Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein. Gastroenterology [print-electronic]. 2021 Feb; 160(3): 958-961.e3-961.e3. PMID: 33022277, PMCID: PMC7832655, PII: S0016-5085(20)35227-6, DOI: 10.1053/j.gastro.2020.09.042, ISSN: 1528-0012.

Fibriansah G, Lim EXY, Marzinek JK, Ng TS, Tan JL, Huber RG, Lim XN, Chew VSY, Kostyuchenko VA, Shi J, Anand GS, Bond PJ, Crowe JE, Lok SM. Antibody affinity versus dengue morphology influences neutralization. PLoS Pathog. 2021 Feb; 17(2): e1009331. PMID: 33621239, PMCID: PMC7935256, PII: PPATHOGENS-D-20-02220, DOI: 10.1371/journal.ppat.1009331, ISSN: 1553-7374.

Greaney AJ, Starr TN, Gilchuk P, Zost SJ, Binshtein E, Loes AN, Hilton SK, Huddleston J, Eguia R, Crawford KHD, Dingens AS, Nargi RS, Sutton RE, Suryadevara N, Rothlauf PW, Liu Z, Whelan SPJ, Carnahan RH, Crowe JE, Bloom JD. Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition. Cell Host Microbe [print-electronic]. 2021 Jan 1/13/2021; 29(1): 44-57.e9-57.e9. PMID: 33259788, PMCID: PMC7676316, PII: S1931-3128(20)30624-7, DOI: 10.1016/j.chom.2020.11.007, ISSN: 1934-6069.

Gilchuk P, Guthals A, Bonissone SR, Shaw JB, Ilinykh PA, Huang K, Bombardi RG, Liang J, Grinyo A, Davidson E, Chen EC, Gunn BM, Alter G, Saphire EO, Doranz BJ, Bukreyev A, Zeitlin L, Castellana N, Crowe JE. Proteo-Genomic Analysis Identifies Two Major Sites of Vulnerability on Ebolavirus Glycoprotein for Neutralizing Antibodies in Convalescent Human Plasma. Front Immunol. 2021; 12: 706757. PMID: 34335620, PMCID: PMC8322977, DOI: 10.3389/fimmu.2021.706757, ISSN: 1664-3224.

Murin CD, Gilchuk P, Crowe JE, Ward AB. Structural Biology Illuminates Molecular Determinants of Broad Ebolavirus Neutralization by Human Antibodies for Pan-Ebolavirus Therapeutic Development. Front Immunol. 2021; 12: 808047. PMID: 35082794, PMCID: PMC8784787, DOI: 10.3389/fimmu.2021.808047, ISSN: 1664-3224.

Williamson LE, Gilliland T, Yadav PK, Binshtein E, Bombardi R, Kose N, Nargi RS, Sutton RE, Durie CL, Armstrong E, Carnahan RH, Walker LM, Kim AS, Fox JM, Diamond MS, Ohi MD, Klimstra WB, Crowe JE. Human Antibodies Protect against Aerosolized Eastern Equine Encephalitis Virus Infection. Cell [print-electronic]. 2020 Dec 12/23/2020; 183(7): 1884-1900.e23-1900.e23. PMID: 33301709, PMCID: PMC7806206, PII: S0092-8674(20)31528-2, DOI: 10.1016/j.cell.2020.11.011, ISSN: 1097-4172.

Dong J, Cross RW, Doyle MP, Kose N, Mousa JJ, Annand EJ, Borisevich V, Agans KN, Sutton R, Nargi R, Majedi M, Fenton KA, Reichard W, Bombardi RG, Geisbert TW, Crowe JE. Potent Henipavirus Neutralization by Antibodies Recognizing Diverse Sites on Hendra and Nipah Virus Receptor Binding Protein. Cell. 2020 Dec 12/10/2020; 183(6): 1536-1550.e17-1550.e17. PMID: 33306954, PMCID: PMC7771633, PII: S0092-8674(20)31540-3, DOI: 10.1016/j.cell.2020.11.023, ISSN: 1097-4172.

Bozhanova NG, Sangha AK, Sevy AM, Gilchuk P, Huang K, Nargi RS, Reidy JX, Trivette A, Carnahan RH, Bukreyev A, Crowe JE, Meiler J. Discovery of Marburg virus neutralizing antibodies from virus-naïve human antibody repertoires using large-scale structural predictions. Proc Natl Acad Sci U S A [print-electronic]. 2020 Dec 12/8/2020; 117(49): 31142-8. PMID: 33229516, PMCID: PMC7733803, PII: 1922654117, DOI: 10.1073/pnas.1922654117, ISSN: 1091-6490.

Woodruff MC, Ramonell RP, Nguyen DC, Cashman KS, Saini AS, Haddad NS, Ley AM, Kyu S, Howell JC, Ozturk T, Lee S, Suryadevara N, Case JB, Bugrovsky R, Chen W, Estrada J, Morrison-Porter A, Derrico A, Anam FA, Sharma M, Wu HM, Le SN, Jenks SA, Tipton CM, Staitieh B, Daiss JL, Ghosn E, Diamond MS, Carnahan RH, Crowe JE, Hu WT, Lee FE, Sanz I. Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19. Nat Immunol [print-electronic]. 2020 Dec; 21(12): 1506-16. PMID: 33028979, PMCID: PMC7739702, PII: 10.1038/s41590-020-00814-z, DOI: 10.1038/s41590-020-00814-z, ISSN: 1529-2916.

Powell LA, Miller A, Fox JM, Kose N, Klose T, Kim AS, Bombardi R, Tennekoon RN, Dharshan de Silva A, Carnahan RH, Diamond MS, Rossmann MG, Kuhn RJ, Crowe JE. Human mAbs Broadly Protect against Arthritogenic Alphaviruses by Recognizing Conserved Elements of the Mxra8 Receptor-Binding Site. Cell Host Microbe [print-electronic]. 2020 Nov 11/11/2020; 28(5): 699-711.e7-711.e7. PMID: 32783883, PMCID: PMC7666055, PII: S1931-3128(20)30404-2, DOI: 10.1016/j.chom.2020.07.008, ISSN: 1934-6069.

Gilchuk P, Bombardi RG, Erasmus JH, Tan Q, Nargi R, Soto C, Abbink P, Suscovich TJ, Durnell LA, Khandhar A, Archer J, Liang J, Fouch ME, Davidson E, Doranz BJ, Jones T, Larson E, Ertel S, Granger B, Fuerte-Stone J, Roy V, Broge T, Linnekin TC, Linde CH, Gorman MJ, Nkolola J, Alter G, Reed SG, Barouch DH, Diamond MS, Crowe JE, Van Hoeven N, Thackray LB, Carnahan RH. Integrated pipeline for the accelerated discovery of antiviral antibody therapeutics. Nat Biomed Eng [print-electronic]. 2020 Nov; 4(11): 1030-43. PMID: 32747832, PMCID: PMC7655621, PII: 10.1038/s41551-020-0594-x, DOI: 10.1038/s41551-020-0594-x, ISSN: 2157-846X.

Wessel AW, Kose N, Bombardi RG, Roy V, Chantima W, Mongkolsapaya J, Edeling MA, Nelson CA, Bosch I, Alter G, Screaton GR, Fremont DH, Crowe JE, Diamond MS. Antibodies targeting epitopes on the cell-surface form of NS1 protect against Zika virus infection during pregnancy. Nat Commun. 2020 Oct 10/19/2020; 11(1): 5278. PMID: 33077712, PMCID: PMC7572419, PII: 10.1038/s41467-020-19096-y, DOI: 10.1038/s41467-020-19096-y, ISSN: 2041-1723.

Sevy AM, Gilchuk IM, Brown BP, Bozhanova NG, Nargi R, Jensen M, Meiler J, Crowe JE. Computationally Designed Cyclic Peptides Derived from an Antibody Loop Increase Breadth of Binding for Influenza Variants. Structure [print-electronic]. 2020 Oct 10/6/2020; 28(10): 1114-1123.e4-1123.e4. PMID: 32610044, PMCID: PMC7544621, PII: S0969-2126(20)30124-6, DOI: 10.1016/j.str.2020.04.005, ISSN: 1878-4186.

Finn JA, Dong J, Sevy AM, Parrish E, Gilchuk I, Nargi R, Scarlett-Jones M, Reichard W, Bombardi R, Voss TG, Meiler J, Crowe JE. Identification of Structurally Related Antibodies in Antibody Sequence Databases Using Rosetta-Derived Position-Specific Scoring. Structure [print-electronic]. 2020 Oct 10/6/2020; 28(10): 1124-1130.e5-1130.e5. PMID: 32783953, PMCID: PMC7544681, PII: S0969-2126(20)30245-8, DOI: 10.1016/j.str.2020.07.012, ISSN: 1878-4186.

Greaney AJ, Starr TN, Gilchuk P, Zost SJ, Binshtein E, Loes AN, Hilton SK, Huddleston J, Eguia R, Crawford KHD, Dingens AS, Nargi RS, Sutton RE, Suryadevara N, Rothlauf PW, Liu Z, Whelan SPJ, Carnahan RH, Crowe JE, Bloom JD. Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition. BioRxiv. 2020 Sep 9/28/2020; PMID: 32935107, PMCID: PMC7491521, PII: 2020.09.10.292078, DOI: 10.1101/2020.09.10.292078.

Vogt MR, Fu J, Kose N, Williamson LE, Bombardi R, Setliff I, Georgiev IS, Klose T, Rossmann MG, Hurst BL, Tarbet EB, Bochkov YA, Gern JE, Kuhn RJ, Crowe JE. Erratum for Research Article "Human antibodies neutralize enterovirus D68 and protect against infection and paralytic disease," by Matthew R. Vogt, Jianing Fu, Nurgun Kose, Lauren E. Williamson, Robin Bombardi, Ian Setliff, Ivelin S. Georgiev, Thomas Klose, Michael G. Rossmann, Yury A. Bochkov, James E. Gern, Richard J. Kuhn, James E. Crowe Jr. Sci Immunol. 2020 Sep 9/18/2020; 5(51): PMID: 32948673, PMCID: PMC8194106, PII: 5/51/eabe5512, DOI: 10.1126/sciimmunol.abe5512, ISSN: 2470-9468.

Reif DM, Chanock SJ, Edwards KM, Crowe JE. Inappropriate Citation of Vaccine Article [letter]. J Infect Dis. 2020 Sep 9/14/2020; 222(8): 1413-4. PMID: 31158294, PMCID: PMC7749189, PII: 5510417, DOI: 10.1093/infdis/jiz287, ISSN: 1537-6613.

Erasmus JH, Archer J, Fuerte-Stone J, Khandhar AP, Voigt E, Granger B, Bombardi RG, Govero J, Tan Q, Durnell LA, Coler RN, Diamond MS, Crowe JE, Reed SG, Thackray LB, Carnahan RH, Van Hoeven N. Intramuscular Delivery of Replicon RNA Encoding ZIKV-117 Human Monoclonal Antibody Protects against Zika Virus Infection. Mol Ther Methods Clin Dev. 2020 Sep 9/11/2020; 18: 402-14. PMID: 32695842, PMCID: PMC7363633, PII: S2329-0501(20)30135-2, DOI: 10.1016/j.omtm.2020.06.011, ISSN: 2329-0501.

Zost SJ, Gilchuk P, Chen RE, Case JB, Reidy JX, Trivette A, Nargi RS, Sutton RE, Suryadevara N, Chen EC, Binshtein E, Shrihari S, Ostrowski M, Chu HY, Didier JE, MacRenaris KW, Jones T, Day S, Myers L, Eun-Hyung Lee F, Nguyen DC, Sanz I, Martinez DR, Rothlauf PW, Bloyet LM, Whelan SPJ, Baric RS, Thackray LB, Diamond MS, Carnahan RH, Crowe JE. Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein. Nat Med [print-electronic]. 2020 Sep; 26(9): 1422-7. PMID: 32651581, PMCID: PMC8194108, PII: 10.1038/s41591-020-0998-x, DOI: 10.1038/s41591-020-0998-x, ISSN: 1546-170X.

Dong J, Gilchuk I, Li S, Irving R, Goff MT, Turner HL, Ward AB, Carnahan RH, Crowe JE. Anti-influenza H7 human antibody targets antigenic site in hemagglutinin head domain interface. J Clin Invest. 2020 Sep 9/1/2020; 130(9): 4734-9. PMID: 32749241, PMCID: PMC7456233, PII: 136032, DOI: 10.1172/JCI136032, ISSN: 1558-8238.

Zost SJ, Gilchuk P, Case JB, Binshtein E, Chen RE, Nkolola JP, Schäfer A, Reidy JX, Trivette A, Nargi RS, Sutton RE, Suryadevara N, Martinez DR, Williamson LE, Chen EC, Jones T, Day S, Myers L, Hassan AO, Kafai NM, Winkler ES, Fox JM, Shrihari S, Mueller BK, Meiler J, Chandrashekar A, Mercado NB, Steinhardt JJ, Ren K, Loo YM, Kallewaard NL, McCune BT, Keeler SP, Holtzman MJ, Barouch DH, Gralinski LE, Baric RS, Thackray LB, Diamond MS, Carnahan RH, Crowe JE. Potently neutralizing and protective human antibodies against SARS-CoV-2. Nature [print-electronic]. 2020 Aug; 584(7821): 443-9. PMID: 32668443, PMCID: PMC7584396, PII: 10.1038/s41586-020-2548-6, DOI: 10.1038/s41586-020-2548-6, ISSN: 1476-4687.

Fox JM, Huang L, Tahan S, Powell LA, Crowe JE, Wang D, Diamond MS. A cross-reactive antibody protects against Ross River virus musculoskeletal disease despite rapid neutralization escape in mice. PLoS Pathog. 2020 Aug; 16(8): e1008743. PMID: 32760128, PMCID: PMC7433899, PII: PPATHOGENS-D-20-00591, DOI: 10.1371/journal.ppat.1008743, ISSN: 1553-7374.

Soto C, Finn JA, Willis JR, Day SB, Sinkovits RS, Jones T, Schmitz S, Meiler J, Branchizio A, Crowe JE. PyIR: a scalable wrapper for processing billions of immunoglobulin and T cell receptor sequences using IgBLAST. BMC Bioinformatics. 2020 Jul 7/16/2020; 21(1): 314. PMID: 32677886, PMCID: PMC7364545, PII: 10.1186/s12859-020-03649-5, DOI: 10.1186/s12859-020-03649-5, ISSN: 1471-2105.

Engdahl TB, Crowe JE. Humoral Immunity to Hantavirus Infection. MSphere. 2020 Jul 7/15/2020; 5(4): PMID: 32669473, PMCID: PMC7364217, PII: 5/4/e00482-20, DOI: 10.1128/mSphere.00482-20, ISSN: 2379-5042.

Soto C, Bombardi RG, Kozhevnikov M, Sinkovits RS, Chen EC, Branchizio A, Kose N, Day SB, Pilkinton M, Gujral M, Mallal S, Crowe JE. High Frequency of Shared Clonotypes in Human T Cell Receptor Repertoires. Cell Rep. 2020 Jul 7/14/2020; 32(2): 107882. PMID: 32668251, PMCID: PMC7433715, PII: S2211-1247(20)30863-9, DOI: 10.1016/j.celrep.2020.107882, ISSN: 2211-1247.

Vogt MR, Fu J, Kose N, Williamson LE, Bombardi R, Setliff I, Georgiev IS, Klose T, Rossmann MG, Bochkov YA, Gern JE, Kuhn RJ, Crowe JE. Human antibodies neutralize enterovirus D68 and protect against infection and paralytic disease. Sci Immunol. 2020 Jul 7/3/2020; 5(49): PMID: 32620559, PMCID: PMC7418079, PII: 5/49/eaba4902, DOI: 10.1126/sciimmunol.aba4902, ISSN: 2470-9468.

Ilinykh PA, Huang K, Santos RI, Gilchuk P, Gunn BM, Karim MM, Liang J, Fouch ME, Davidson E, Parekh DV, Kimble JB, Pietzsch CA, Meyer M, Kuzmina NA, Zeitlin L, Saphire EO, Alter G, Crowe JE, Bukreyev A. Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other Antibodies. Cell Host Microbe [print-electronic]. 2020 Jun 6/10/2020; 27(6): 976-991.e11-991.e11. PMID: 32320678, PMCID: PMC7292764, PII: S1931-3128(20)30189-X, DOI: 10.1016/j.chom.2020.03.025, ISSN: 1934-6069.

Young E, Carnahan RH, Andrade DV, Kose N, Nargi RS, Fritch EJ, Munt JE, Doyle MP, White L, Baric TJ, Stoops M, DeSilva A, Tse LV, Martinez DR, Zhu D, Metz S, Wong MP, Espinosa DA, Montoya M, Biering SB, Sukulpolvi-Petty S, Kuan G, Balmaseda A, Diamond MS, Harris E, Crowe JE, Baric RS. Identification of Dengue Virus Serotype 3 Specific Antigenic Sites Targeted by Neutralizing Human Antibodies. Cell Host Microbe. 2020 May 5/13/2020; 27(5): 710-724.e7-724.e7. PMID: 32407709, PMCID: PMC7309352, PII: S1931-3128(20)30234-1, DOI: 10.1016/j.chom.2020.04.007, ISSN: 1934-6069.

Powell LA, Fox JM, Kose N, Kim AS, Majedi M, Bombardi R, Carnahan RH, Slaughter JC, Morrison TE, Diamond MS, Crowe JE. Human monoclonal antibodies against Ross River virus target epitopes within the E2 protein and protect against disease. PLoS Pathog. 2020 May; 16(5): e1008517. PMID: 32365139, PMCID: PMC7252634, PII: PPATHOGENS-D-19-01537, DOI: 10.1371/journal.ppat.1008517, ISSN: 1553-7374.

Hirsch J, Faber BW, Crowe JE, Verstrepen B, Cornelissen G. E. coli production process yields stable dengue 1 virus-sized particles (VSPs). Vaccine [print-electronic]. 2020 Apr 4/9/2020; 38(17): 3305-12. PMID: 32197924, PII: S0264-410X(20)30332-7, DOI: 10.1016/j.vaccine.2020.03.003, ISSN: 1873-2518.

Gilchuk P, Murin CD, Milligan JC, Cross RW, Mire CE, Ilinykh PA, Huang K, Kuzmina N, Altman PX, Hui S, Gunn BM, Bryan AL, Davidson E, Doranz BJ, Turner HL, Alkutkar T, Flinko R, Orlandi C, Carnahan R, Nargi R, Bombardi RG, Vodzak ME, Li S, Okoli A, Ibeawuchi M, Ohiaeri B, Lewis GK, Alter G, Bukreyev A, Saphire EO, Geisbert TW, Ward AB, Crowe JE. Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization. Immunity [print-electronic]. 2020 Feb 2/18/2020; 52(2): 388-403.e12-403.e12. PMID: 32023489, PMCID: PMC7111202, PII: S1074-7613(20)30028-5, DOI: 10.1016/j.immuni.2020.01.001, ISSN: 1097-4180.

Zhao H, Xu L, Bombardi R, Nargi R, Deng Z, Errico JM, Nelson CA, Dowd KA, Pierson TC, Crowe JE, Diamond MS, Fremont DH. Mechanism of differential Zika and dengue virus neutralization by a public antibody lineage targeting the DIII lateral ridge. J Exp Med. 2020 Feb 2/3/2020; 217(2): PMID: 31757867, PMCID: PMC7041715, PII: jem.20191792, DOI: 10.1084/jem.20191792, ISSN: 1540-9538.

Cable J, Srikantiah P, Crowe JE, Pulendran B, Hill A, Ginsberg A, Koff W, Mathew A, Ng T, Jansen K, Glenn G, Permar S, Wilson I, Weiner DB, Weissman D, Rappuoli R. Vaccine innovations for emerging infectious diseases-a symposium report. Ann N Y Acad Sci [print-electronic]. 2020 Feb; 1462(1): 14-26. PMID: 31659752, DOI: 10.1111/nyas.14235, ISSN: 1749-6632.

Sauer MF, Sevy AM, Crowe JE, Meiler J. Multi-state design of flexible proteins predicts sequences optimal for conformational change. PLoS Comput Biol. 2020 Feb; 16(2): e1007339. PMID: 32032348, PMCID: PMC7032724, PII: PCOMPBIOL-D-19-01368, DOI: 10.1371/journal.pcbi.1007339, ISSN: 1553-7358.

Schmitz S, Soto C, Crowe JE, Meiler J. Human-likeness of antibody biologics determined by back-translation and comparison with large antibody variable gene repertoires. MAbs. 2020; 12(1): 1758291. PMID: 32397786, PMCID: PMC8648325, DOI: 10.1080/19420862.2020.1758291, ISSN: 1942-0870.

Buchman A, Gamez S, Li M, Antoshechkin I, Li HH, Wang HW, Chen CH, Klein MJ, Duchemin JB, Crowe JE, Paradkar PN, Akbari OS. Broad dengue neutralization in mosquitoes expressing an engineered antibody. PLoS Pathog. 2020 Jan; 16(1): e1008103. PMID: 31945137, PMCID: PMC6964813, PII: PPATHOGENS-D-19-01283, DOI: 10.1371/journal.ppat.1008103, ISSN: 1553-7374.

Chen EC, Rubinstein S, Soto C, Bombardi RG, Day SB, Myers L, Zaytsev A, Majedi M, Cornell RF, Crowe JE. Diverse patterns of antibody variable gene repertoire disruption in patients with amyloid light chain (AL) amyloidosis. PLoS One. 2020; 15(7): e0235713. PMID: 32634163, PMCID: PMC7340310, PII: PONE-D-20-09222, DOI: 10.1371/journal.pone.0235713, ISSN: 1932-6203.

Gilchuk IM, Bangaru S, Gilchuk P, Irving RP, Kose N, Bombardi RG, Thornburg NJ, Creech CB, Edwards KM, Li S, Turner HL, Yu W, Zhu X, Wilson IA, Ward AB, Crowe JE. Influenza H7N9 Virus Neuraminidase-Specific Human Monoclonal Antibodies Inhibit Viral Egress and Protect from Lethal Influenza Infection in Mice. Cell Host Microbe [print-electronic]. 2019 Dec 12/11/2019; 26(6): 715-728.e8-728.e8. PMID: 31757769, PMCID: PMC6941661, PII: S1931-3128(19)30527-X, DOI: 10.1016/j.chom.2019.10.003, ISSN: 1934-6069.

Zhu X, Turner HL, Lang S, McBride R, Bangaru S, Gilchuk IM, Yu W, Paulson JC, Crowe JE, Ward AB, Wilson IA. Structural Basis of Protection against H7N9 Influenza Virus by Human Anti-N9 Neuraminidase Antibodies. Cell Host Microbe [print-electronic]. 2019 Dec 12/11/2019; 26(6): 729-738.e4-738.e4. PMID: 31757767, PMCID: PMC6908751, PII: S1931-3128(19)30526-8, DOI: 10.1016/j.chom.2019.10.002, ISSN: 1934-6069.

Sevy AM, Soto C, Bombardi RG, Meiler J, Crowe JE. Immune repertoire fingerprinting by principal component analysis reveals shared features in subject groups with common exposures. BMC Bioinformatics. 2019 Dec 12/4/2019; 20(1): 629. PMID: 31801472, PMCID: PMC6894320, PII: 10.1186/s12859-019-3281-8, DOI: 10.1186/s12859-019-3281-8, ISSN: 1471-2105.

Velayutham TS, Kumar S, Zhang X, Kose N, Walker DH, Winslow G, Crowe JE, McBride JW. Ehrlichia chaffeensis Outer Membrane Protein 1-Specific Human Antibody-Mediated Immunity Is Defined by Intracellular TRIM21-Dependent Innate Immune Activation and Extracellular Neutralization. Infect Immun [electronic-print]. 2019 Dec; 87(12): PMID: 31548319, PMCID: PMC6867850, PII: IAI.00383-19, DOI: 10.1128/IAI.00383-19, ISSN: 1098-5522.

Bennett MR, Dong J, Bombardi RG, Soto C, Parrington HM, Nargi RS, Schoeder CT, Nagel MB, Schey KL, Meiler J, Skaar EP, Crowe JE. Human V_H1-69 Gene-Encoded Human Monoclonal Antibodies against Staphylococcus aureus IsdB Use at Least Three Distinct Modes of Binding To Inhibit Bacterial Growth and Pathogenesis. MBio. 2019 Oct 10/22/2019; 10(5): PMID: 31641091, PMCID: PMC6805997, PII: mBio.02473-19, DOI: 10.1128/mBio.02473-19, ISSN: 2150-7511.

Knight FC, Gilchuk P, Kumar A, Becker KW, Sevimli S, Jacobson ME, Suryadevara N, Wang-Bishop L, Boyd KL, Crowe JE, Joyce S, Wilson JT. Mucosal Immunization with a pH-Responsive Nanoparticle Vaccine Induces Protective CD8⁺ Lung-Resident Memory T Cells. ACS Nano [print-electronic]. 2019 Oct 10/22/2019; 13(10): 10939-60. PMID: 31553872, PMCID: PMC6832804, DOI: 10.1021/acsnano.9b00326, ISSN: 1936-086X.

Kinchen VJ, Massaccesi G, Flyak AI, Mankowski MC, Colbert MD, Osburn WO, Ray SC, Cox AL, Crowe JE, Bailey JR. Plasma deconvolution identifies broadly neutralizing antibodies associated with hepatitis C virus clearance. J Clin Invest. 2019 Aug 8/13/2019; 129(11): 4786-96. PMID: 31408439, PMCID: PMC6819096, PII: 130720, DOI: 10.1172/JCI130720, ISSN: 1558-8238.

Colbert MD, Flyak AI, Ogega CO, Kinchen VJ, Massaccesi G, Hernandez M, Davidson E, Doranz BJ, Cox AL, Crowe JE, Bailey JR. Broadly Neutralizing Antibodies Targeting New Sites of Vulnerability in Hepatitis C Virus E1E2. J Virol [electronic-print]. 2019 Jul 7/15/2019; 93(14): PMID: 31068427, PMCID: PMC6600205, PII: JVI.02070-18, DOI: 10.1128/JVI.02070-18, ISSN: 1098-5514.

Engelhardt BG, Savani U, Jung DK, Powers AC, Jagasia M, Chen H, Winnick JJ, Tamboli RA, Crowe JE, Abumrad NN. New-Onset Post-Transplant Diabetes Mellitus after Allogeneic Hematopoietic Cell Transplant Is Initiated by Insulin Resistance, Not Immunosuppressive Medications. Biol Blood Marrow Transplant [print-electronic]. 2019 Jun; 25(6): 1225-31. PMID: 30738170, PMCID: PMC6559863, PII: S1083-8791(19)30096-5, DOI: 10.1016/j.bbmt.2019.02.001, ISSN: 1523-6536.

Kose N, Fox JM, Sapparapu G, Bombardi R, Tennekoon RN, de Silva AD, Elbashir SM, Theisen MA, Humphris-Narayanan E, Ciaramella G, Himansu S, Diamond MS, Crowe JE. A lipid-encapsulated mRNA encoding a potently neutralizing human monoclonal antibody protects against chikungunya infection. Sci Immunol. 2019 May 5/17/2019; 4(35): PMID: 31101672, PMCID: PMC6629435, PII: 4/35/eaaw6647, DOI: 10.1126/sciimmunol.aaw6647, ISSN: 2470-9468.

Bangaru S, Lang S, Schotsaert M, Vanderven HA, Zhu X, Kose N, Bombardi R, Finn JA, Kent SJ, Gilchuk P, Gilchuk I, Turner HL, García-Sastre A, Li S, Ward AB, Wilson IA, Crowe JE. A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface. Cell. 2019 May 5/16/2019; 177(5): 1136-1152.e18-1152.e18. PMID: 31100268, PMCID: PMC6629437, PII: S0092-8674(19)30397-6, DOI: 10.1016/j.cell.2019.04.011, ISSN: 1097-4172.

King LB, West BR, Moyer CL, Gilchuk P, Flyak A, Ilinykh PA, Bombardi R, Hui S, Huang K, Bukreyev A, Crowe JE, Saphire EO. Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk. Nat Commun. 2019 Apr 4/17/2019; 10(1): 1788. PMID: 30996276, PMCID: PMC6470140, PII: 10.1038/s41467-019-09732-7, DOI: 10.1038/s41467-019-09732-7, ISSN: 2041-1723.

Kimble JB, Malherbe DC, Meyer M, Gunn BM, Karim MM, Ilinykh PA, Iampietro M, Mohamed KS, Negi S, Gilchuk P, Huang K, Wolf YI, Braun W, Crowe JE, Alter G, Bukreyev A. Antibody-Mediated Protective Mechanisms Induced by a Trivalent Parainfluenza Virus-Vectored Ebolavirus Vaccine. J. Virol [electronic-print]. 2019 Feb 2/15/2019; 93(4): PMID: 30518655, PII: JVI.01845-18, DOI: 10.1128/JVI.01845-18, ISSN: 1098-5514.

Williamson L, Flyak AI, Kose N, Bombardi R, Branchizio A, Reddy S, Davidson E, Doranz B, Fusco ML, Saphire EO, Halfmann PJ, Kawaoka Y, Piper AE, Glass PJ, Crowe JE. Early human B cell response to Ebola virus in four U.S. survivors of infection. J. Virol [print-electronic]. 2019 Feb 2/6/2019; PMID: 30728263, PII: JVI.01439-18, DOI: 10.1128/JVI.01439-18, ISSN: 1098-5514.

Wirawan M, Fibriansah G, Marzinek JK, Lim XX, Ng TS, Sim AYL, Zhang Q, Kostyuchenko VA, Shi J, Smith SA, Verma CS, Anand G, Crowe JE, Bond PJ, Lok SM. Mechanism of Enhanced Immature Dengue Virus Attachment to Endosomal Membrane Induced by prM Antibody. Structure [print-electronic]. 2019 Feb 2/5/2019; 27(2): 253-267.e8. PMID: 30471923, PMCID: PMC6365167, PII: S0969-2126(18)30370-8, DOI: 10.1016/j.str.2018.10.009, ISSN: 1878-4186.

Salazar V, Jagger BW, Mongkolsapaya J, Burgomaster KE, Dejnirattisai W, Winkler ES, Fernandez E, Nelson CA, Fremont DH, Pierson TC, Crowe JE, Screaton GR, Diamond MS. Dengue and Zika Virus Cross-Reactive Human Monoclonal Antibodies Protect against Spondweni Virus Infection and Pathogenesis in Mice. Cell Rep. 2019 Feb 2/5/2019; 26(6): 1585-1597.e4. PMID: 30726740, PII: S2211-1247(19)30081-6, DOI: 10.1016/j.celrep.2019.01.052, ISSN: 2211-1247.

Turner HL, Pallesen J, Lang S, Bangaru S, Urata S, Li S, Cottrell CA, Bowman CA, Crowe JE, Wilson IA, Ward AB. Potent anti-influenza H7 human monoclonal antibody induces separation of hemagglutinin receptor-binding head domains. PLoS Biol [print-electronic]. 2019 Feb 2/4/2019; 17(2): e3000139. PMID: 30716060, PII: PBIOLOGY-D-18-00830, DOI: 10.1371/journal.pbio.3000139, ISSN: 1545-7885.

Soto C, Bombardi RG, Branchizio A, Kose N, Matta P, Sevy AM, Sinkovits RS, Gilchuk P, Finn JA, Crowe JE. High frequency of shared clonotypes in human B cell receptor repertoires. Nature [print-electronic]. 2019 Feb; 566(7744): 398-402. PMID: 30760926, PMCID: PMC6949180, PII: 10.1038/s41586-019-0934-8, DOI: 10.1038/s41586-019-0934-8, ISSN: 1476-4687.

Crowe JE. Antibody Determinants of Influenza Immunity. J. Infect. Dis [print-electronic]. 2019 Jan 1/31/2019; PMID: 30715373, PII: 5304924, DOI: 10.1093/infdis/jiz010, ISSN: 1537-6613.

Long F, Doyle M, Fernandez E, Miller AS, Klose T, Sevvana M, Bryan A, Davidson E, Doranz BJ, Kuhn RJ, Diamond MS, Crowe JE, Rossmann MG. Structural basis of a potent human monoclonal antibody against Zika virus targeting a quaternary epitope. Proc. Natl. Acad. Sci. U.S.A [print-electronic]. 2019 Jan 1/29/2019; 116(5): 1591-6. PMID: 30642974, PMCID: PMC6358714, PII: 1815432116, DOI: 10.1073/pnas.1815432116, ISSN: 1091-6490.

Sevy AM, Wu NC, Gilchuk IM, Parrish EH, Burger S, Yousif D, Nagel MBM, Schey KL, Wilson IA, Crowe JE, Meiler J. Multistate design of influenza antibodies improves affinity and breadth against seasonal viruses. Proc. Natl. Acad. Sci. U.S.A [print-electronic]. 2019 Jan 1/29/2019; 116(5): 1597-602. PMID: 30642961, PMCID: PMC6358683, PII: 1806004116, DOI: 10.1073/pnas.1806004116, ISSN: 1091-6490.

Crowe JE. Influenza Virus-Specific Human Antibody Repertoire Studies. J. Immunol. 2019 Jan 1/15/2019; 202(2): 368-73. PMID: 30617118, PMCID: PMC6327975, PII: 202/2/368, DOI: 10.4049/jimmunol.1801459, ISSN: 1550-6606.

Goo L, Debbink K, Kose N, Sapparapu G, Doyle MP, Wessel AW, Richner JM, Burgomaster KE, Larman BC, Dowd KA, Diamond MS, Crowe JE, Pierson TC. A protective human monoclonal antibody targeting the West Nile virus E protein preferentially recognizes mature virions. Nat Microbiol [print-electronic]. 2019 Jan; 4(1): 71-7. PMID: 30455471, PII: 10.1038/s41564-018-0283-7, DOI: 10.1038/s41564-018-0283-7, ISSN: 2058-5276.

Kim AS, Austin SK, Gardner CL, Zuiani A, Reed DS, Trobaugh DW, Sun C, Basore K, Williamson LE, Crowe JE, Slifka MK, Fremont DH, Klimstra WB, Diamond MS. Protective antibodies against Eastern equine encephalitis virus bind to epitopes in domains A and B of the E2 glycoprotein. Nat Microbiol [print-electronic]. 2019 Jan; 4(1): 187-97. PMID: 30455470, PMCID: PMC6294662, PII: 10.1038/s41564-018-0286-4, DOI: 10.1038/s41564-018-0286-4, ISSN: 2058-5276.

Dong J, Finn JA, Larsen PA, Smith TPL, Crowe JE. Structural Diversity of Ultralong CDRH3s in Seven Bovine Antibody Heavy Chains. Front Immunol. 2019; 10: 558. PMID: 30967877, PMCID: PMC6440498, DOI: 10.3389/fimmu.2019.00558, ISSN: 1664-3224.

Martinez Viedma MDP, Kose N, Parham L, Balmaseda A, Kuan G, Lorenzana I, Harris E, Crowe JE, Pickett BE. Peptide arrays incubated with three collections of human sera from patients infected with mosquito-borne viruses. F1000Res. 2019; 8: 1875. PMID: 32201571, PMCID: PMC7065662, DOI: 10.12688/f1000research.20981.3, ISSN: 2046-1402.

Vogt MR, Crowe JE. Current Understanding of Humoral Immunity to Enterovirus D68. J Pediatric Infect Dis Soc. 2018 Dec 12/26/2018; 7(suppl_2): S49-S53. PMID: 30590621, PII: 5261307, DOI: 10.1093/jpids/piy124, ISSN: 2048-7207.

Alvarado G, Ettayebi K, Atmar RL, Bombardi RG, Kose N, Estes MK, Crowe JE. Human Monoclonal Antibodies That Neutralize Pandemic GII.4 Noroviruses. Gastroenterology [print-electronic]. 2018 Dec; 155(6): 1898-907. PMID: 30170116, PII: S0016-5085(18)34926-6, DOI: 10.1053/j.gastro.2018.08.039, ISSN: 1528-0012.

Tsai WY, Chen HL, Tsai JJ, Dejnirattisai W, Jumnainsong A, Mongkolsapaya J, Screaton G, Crowe JE, Wang WK. Potent Neutralizing Human Monoclonal Antibodies Preferentially Target Mature Dengue Virus Particles: Implication for Novel Strategy for Dengue Vaccine. J. Virol [electronic-print]. 2018 Dec 12/1/2018; 92(23): PMID: 30185598, PMCID: PMC6232466, PII: JVI.00556-18, DOI: 10.1128/JVI.00556-18, ISSN: 1098-5514.

Bennett MR, Bombardi RG, Kose N, Parrish EH, Nagel MB, Petit RA, Read TD, Schey KL, Thomsen IP, Skaar EP, Crowe JE. Human mAbs to Staphylococcus aureus IsdA Provide Protection Through Both Heme-Blocking and Fc-Mediated Mechanisms. J. Infect. Dis [print-electronic]. 2018 Nov 11/29/2018; PMID: 30496483, PII: 5218956, DOI: 10.1093/infdis/jiy635, ISSN: 1537-6613.

Gilchuk P, Mire CE, Geisbert JB, Agans KN, Deer DJ, Cross RW, Slaughter JC, Flyak AI, Mani J, Pauly MH, Velasco J, Whaley KJ, Zeitlin L, Geisbert TW, Crowe JE. Efficacy of Human Monoclonal Antibody Monotherapy Against Bundibugyo Virus Infection in Nonhuman Primates. J. Infect. Dis. 2018 Nov 11/22/2018; 218(suppl_5): S565-S573. PMID: 29982718, PMCID: PMC6249568, PII: 5049157, DOI: 10.1093/infdis/jiy295, ISSN: 1537-6613.

Ilinykh PA, Graber J, Kuzmina NA, Huang K, Ksiazek TG, Crowe JE, Bukreyev A. Ebolavirus Chimerization for the Development of a Mouse Model for Screening of Bundibugyo-Specific Antibodies. J. Infect. Dis. 2018 Nov 11/22/2018; 218(suppl_5): S418-S422. PMID: 30060231, PMCID: PMC6249583, PII: 5061041, DOI: 10.1093/infdis/jiy423, ISSN: 1537-6613.

Kinchen VJ, Zahid MN, Flyak AI, Soliman MG, Learn GH, Wang S, Davidson E, Doranz BJ, Ray SC, Cox AL, Crowe JE, Bjorkman PJ, Shaw GM, Bailey JR. Broadly Neutralizing Antibody Mediated Clearance of Human Hepatitis C Virus Infection. Cell Host Microbe. 2018 Nov 11/14/2018; 24(5): 717-730.e5. PMID: 30439341, PMCID: PMC6250073, PII: S1931-3128(18)30550-X, DOI: 10.1016/j.chom.2018.10.012, ISSN: 1934-6069.

Flyak AI, Ruiz S, Colbert MD, Luong T, Crowe JE, Bailey JR, Bjorkman PJ. HCV Broadly Neutralizing Antibodies Use a CDRH3 Disulfide Motif to Recognize an E2 Glycoprotein Site that Can Be Targeted for Vaccine Design. Cell Host Microbe. 2018 Nov 11/14/2018; 24(5): 703-716.e3. PMID: 30439340, PMCID: PMC6258177, PII: S1931-3128(18)30547-X, DOI: 10.1016/j.chom.2018.10.009, ISSN: 1934-6069.

Patel A, Park DH, Davis CW, Smith TRF, Leung A, Tierney K, Bryan A, Davidson E, Yu X, Racine T, Reed C, Gorman ME, Wise MC, Elliott STC, Esquivel R, Yan J, Chen J, Muthumani K, Doranz BJ, Saphire EO, Crowe JE, Broderick KE, Kobinger GP, He S, Qiu X, Kobasa D, Humeau L, Sardesai NY, Ahmed R, Weiner DB. In Vivo Delivery of Synthetic Human DNA-Encoded Monoclonal Antibodies Protect against Ebolavirus Infection in a Mouse Model. Cell Rep. 2018 Nov 11/13/2018; 25(7): 1982-1993.e4. PMID: 30428362, PMCID: PMC6319964, PII: S2211-1247(18)31651-6, DOI: 10.1016/j.celrep.2018.10.062, ISSN: 2211-1247.

Bramble MS, Hoff N, Gilchuk P, Mukadi P, Lu K, Doshi RH, Steffen I, Nicholson BP, Lipson A, Vashist N, Sinai C, Spencer D, Olinger G, Wemakoy EO, Illunga BK, Pettitt J, Logue J, Marchand J, Varughese J, Bennett RS, Jahrling P, Cavet G, Serafini T, Ollmann Saphire E, Vilain E, Muyembe-Tamfum JJ, Hensely LE, Simmons G, Crowe JE, Rimoin AW. Pan-Filovirus Serum Neutralizing Antibodies in a Subset of Congolese Ebolavirus Infection Survivors. J. Infect. Dis. 2018 Nov 11/5/2018; 218(12): 1929-36. PMID: 30107445, PMCID: PMC6217721, PII: 5071788, DOI: 10.1093/infdis/jiy453, ISSN: 1537-6613.

Gilchuk P, Kuzmina N, Ilinykh PA, Huang K, Gunn BM, Bryan A, Davidson E, Doranz BJ, Turner HL, Fusco ML, Bramble MS, Hoff NA, Binshtein E, Kose N, Flyak AI, Flinko R, Orlandi C, Carnahan R, Parrish EH, Sevy AM, Bombardi RG, Singh PK, Mukadi P, Muyembe-Tamfum JJ, Ohi MD, Saphire EO, Lewis GK, Alter G, Ward AB, Rimoin AW, Bukreyev A, Crowe JE. Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein. Immunity [print-electronic]. 2018 Aug 8/21/2018; 49(2): 363-374.e10. PMID: 30029854, PMCID: PMC6104738, PII: S1074-7613(18)30300-5, DOI: 10.1016/j.immuni.2018.06.018, ISSN: 1097-4180.

Meyer M, Yoshida A, Ramanathan P, Saphire EO, Collins PL, Crowe JE, Samal S, Bukreyev A. Antibody Repertoires to the Same Ebola Vaccine Antigen Are Differentially Affected by Vaccine Vectors. Cell Rep. 2018 Aug 8/14/2018; 24(7): 1816-29. PMID: 30110638, PMCID: PMC6145141, PII: S2211-1247(18)31147-1, DOI: 10.1016/j.celrep.2018.07.044, ISSN: 2211-1247.

Kuzmina NA, Younan P, Gilchuk P, Santos RI, Flyak AI, Ilinykh PA, Huang K, Lubaki NM, Ramanathan P, Crowe JE, Bukreyev A. Antibody-Dependent Enhancement of Ebola Virus Infection by Human Antibodies Isolated from Survivors. Cell Rep. 2018 Aug 8/14/2018; 24(7): 1802-1815.e5. PMID: 30110637, PII: S2211-1247(18)31125-2, DOI: 10.1016/j.celrep.2018.07.035, ISSN: 2211-1247.

Saphire EO, Schendel SL, Fusco ML, Gangavarapu K, Gunn BM, Wec AZ, Halfmann PJ, Brannan JM, Herbert AS, Qiu X, Wagh K, He S, Giorgi EE, Theiler J, Pommert KBJ, Krause TB, Turner HL, Murin CD, Pallesen J, Davidson E, Ahmed R, Aman MJ, Bukreyev A, Burton DR, Crowe JE, Davis CW, Georgiou G, Krammer F, Kyratsous CA, Lai JR, Nykiforuk C, Pauly MH, Rijal P, Takada A, Townsend AR, Volchkov V, Walker LM, Wang CI, Zeitlin L, Doranz BJ, Ward AB, Korber B, Kobinger GP, Andersen KG, Kawaoka Y, Alter G, Chandran K, Dye JM, . Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection. Cell. 2018 Aug 8/9/2018; 174(4): 938-952.e13. PMID: 30096313, PMCID: PMC6102396, PII: S0092-8674(18)30960-7, DOI: 10.1016/j.cell.2018.07.033, ISSN: 1097-4172.

Gunn BM, Yu WH, Karim MM, Brannan JM, Herbert AS, Wec AZ, Halfmann PJ, Fusco ML, Schendel SL, Gangavarapu K, Krause T, Qiu X, He S, Das J, Suscovich TJ, Lai J, Chandran K, Zeitlin L, Crowe JE, Lauffenburger D, Kawaoka Y, Kobinger GP, Andersen KG, Dye JM, Saphire EO, Alter G. A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus. Cell Host Microbe. 2018 Aug 8/8/2018; 24(2): 221-233.e5. PMID: 30092199, PMCID: PMC6298217, PII: S1931-3128(18)30379-2, DOI: 10.1016/j.chom.2018.07.009, ISSN: 1934-6069.

Ilinykh PA, Santos RI, Gunn BM, Kuzmina NA, Shen X, Huang K, Gilchuk P, Flyak AI, Younan P, Alter G, Crowe JE, Bukreyev A. Asymmetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan cap. PLoS Pathog. 2018 Aug; 14(8): e1007204. PMID: 30138408, PMCID: PMC6107261, PII: PPATHOGENS-D-18-00318, DOI: 10.1371/journal.ppat.1007204, ISSN: 1553-7374.

Bangaru S, Zhang H, Gilchuk IM, Voss TG, Irving RP, Gilchuk P, Matta P, Zhu X, Lang S, Nieusma T, Richt JA, Albrecht RA, Vanderven HA, Bombardi R, Kent SJ, Ward AB, Wilson IA, Crowe JE. A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA. Nat Commun. 2018 Jul 7/10/2018; 9(1): 2669. PMID: 29991715, PMCID: PMC6039445, PII: 10.1038/s41467-018-04704-9, DOI: 10.1038/s41467-018-04704-9, ISSN: 2041-1723.

Setliff I, McDonnell WJ, Raju N, Bombardi RG, Murji AA, Scheepers C, Ziki R, Mynhardt C, Shepherd BE, Mamchak AA, Garrett N, Karim SA, Mallal SA, Crowe JE, Morris L, Georgiev IS. Multi-Donor Longitudinal Antibody Repertoire Sequencing Reveals the Existence of Public Antibody Clonotypes in HIV-1 Infection. Cell Host Microbe [print-electronic]. 2018 Jun 6/13/2018; 23(6): 845-854.e6. PMID: 29861170, PMCID: PMC6002606, PII: S1931-3128(18)30228-2, DOI: 10.1016/j.chom.2018.05.001, ISSN: 1934-6069.

Flyak AI, Kuzmina N, Murin CD, Bryan C, Davidson E, Gilchuk P, Gulka CP, Ilinykh PA, Shen X, Huang K, Ramanathan P, Turner H, Fusco ML, Lampley R, Kose N, King H, Sapparapu G, Doranz BJ, Ksiazek TG, Wright DW, Saphire EO, Ward AB, Bukreyev A, Crowe JE. Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2-MPER region. Nat Microbiol [print-electronic]. 2018 Jun; 3(6): 670-7. PMID: 29736037, PMCID: PMC6030461, PII: 10.1038/s41564-018-0157-z, DOI: 10.1038/s41564-018-0157-z, ISSN: 2058-5276.

Zhang R, Kim AS, Fox JM, Nair S, Basore K, Klimstra WB, Rimkunas R, Fong RH, Lin H, Poddar S, Crowe JE, Doranz BJ, Fremont DH, Diamond MS. Mxra8 is a receptor for multiple arthritogenic alphaviruses. Nature [print-electronic]. 2018 May; 557(7706): 570-4. PMID: 29769725, PMCID: PMC5970976, PII: 10.1038/s41586-018-0121-3, DOI: 10.1038/s41586-018-0121-3, ISSN: 1476-4687.

Lecouturier V, Berry C, Saulnier A, Naville S, Manin C, Girerd-Chambaz Y, Crowe JE, Jackson N, Guy B. Characterization of recombinant yellow fever-dengue vaccine viruses with human monoclonal antibodies targeting key conformational epitopes. Vaccine [print-electronic]. 2018 Apr 4/26/2018; PMID: 29706291, PII: S0264-410X(18)30562-0, DOI: 10.1016/j.vaccine.2018.04.065, ISSN: 1873-2518.

Fernandez E, Kose N, Edeling MA, Adhikari J, Sapparapu G, Lazarte SM, Nelson CA, Govero J, Gross ML, Fremont DH, Crowe JE, Diamond MS. Mouse and Human Monoclonal Antibodies Protect against Infection by Multiple Genotypes of Japanese Encephalitis Virus. MBio. 2018 Feb 2/27/2018; 9(1): PMID: 29487230, PMCID: PMC5829823, PII: mBio.00008-18, DOI: 10.1128/mBio.00008-18, ISSN: 2150-7511.

Sevy AM, Panda S, Crowe JE, Meiler J, Vorobeychik Y. Integrating linear optimization with structural modeling to increase HIV neutralization breadth. PLoS Comput. Biol. 2018 Feb; 14(2): e1005999. PMID: 29451898, PMCID: PMC5833279, PII: PCOMPBIOL-D-17-01621, DOI: 10.1371/journal.pcbi.1005999, ISSN: 1553-7358.

Mousa JJ, Binshtein E, Human S, Fong RH, Alvarado G, Doranz BJ, Moore ML, Ohi MD, Crowe JE. Human antibody recognition of antigenic site IV on Pneumovirus fusion proteins. PLoS Pathog. 2018 Feb; 14(2): e1006837. PMID: 29470533, PMCID: PMC5823459, PII: PPATHOGENS-D-17-02222, DOI: 10.1371/journal.ppat.1006837, ISSN: 1553-7374.

King LB, Fusco ML, Flyak AI, Ilinykh PA, Huang K, Gunn B, Kirchdoerfer RN, Hastie KM, Sangha AK, Meiler J, Alter G, Bukreyev A, Crowe JE, Saphire EO. The Marburgvirus-Neutralizing Human Monoclonal Antibody MR191 Targets a Conserved Site to Block Virus Receptor Binding. Cell Host Microbe. 2018 Jan 1/10/2018; 23(1): 101-109.e4. PMID: 29324225, PMCID: PMC5772738, PII: S1931-3128(17)30539-5, DOI: 10.1016/j.chom.2017.12.003, ISSN: 1934-6069.

Matho MH, Schlossman A, Gilchuk IM, Miller G, Mikulski Z, Hupfer M, Wang J, Bitra A, Meng X, Xiang Y, Kaever T, Doukov T, Ley K, Crotty S, Peters B, Hsieh-Wilson LC, Crowe JE, Zajonc DM. Structure-function characterization of three human antibodies targeting the vaccinia virus adhesion molecule D8. J. Biol. Chem [print-electronic]. 2018 Jan 1/5/2018; 293(1): 390-401. PMID: 29123031, PMCID: PMC5766908, PII: M117.814541, DOI: 10.1074/jbc.M117.814541, ISSN: 1083-351X.

Mankowski MC, Kinchen VJ, Wasilewski LN, Flyak AI, Ray SC, Crowe JE, Bailey JR. Synergistic anti-HCV broadly neutralizing human monoclonal antibodies with independent mechanisms. Proc. Natl. Acad. Sci. U.S.A [print-electronic]. 2018 Jan 1/2/2018; 115(1): E82-E91. PMID: 29255018, PMCID: PMC5776832, PII: 1718441115, DOI: 10.1073/pnas.1718441115, ISSN: 1091-6490.

Chukwuma VU, Kose N, Sather DN, Sapparapu G, Falk R, King H, Singh V, Lampley R, Malherbe DC, Ditto NT, Sullivan JT, Barnes T, Doranz BJ, Labranche CC, Montefiori DC, Kalams SA, Haigwood NL, Crowe JE. Increased breadth of HIV-1 neutralization achieved by diverse antibody clones each with limited neutralization breadth. PLoS ONE. 2018; 13(12): e0209437. PMID: 30566528, PMCID: PMC6300260, PII: PONE-D-18-24431, DOI: 10.1371/journal.pone.0209437, ISSN: 1932-6203.

Sangha AK, Dong J, Williamson L, Hashiguchi T, Saphire EO, Crowe JE, Meiler J. Role of Non-local Interactions between CDR Loops in Binding Affinity of MR78 Antibody to Marburg Virus Glycoprotein. Structure [print-electronic]. 2017 Dec 12/5/2017; 25(12): 1820-1828.e2. PMID: 29153506, PMCID: PMC5718948, PII: S0969-2126(17)30333-7, DOI: 10.1016/j.str.2017.10.005, ISSN: 1878-4186.

Grifoni A, Pham J, Sidney J, O'Rourke PH, Paul S, Peters B, Martini SR, de Silva AD, Ricciardi MJ, Magnani DM, Silveira CGT, Maestri A, Costa PR, de-Oliveira-Pinto LM, de Azeredo EL, Damasco PV, Phillips E, Mallal S, de Silva AM, Collins M, Durbin A, Diehl SA, Cerpas C, Balmaseda A, Kuan G, Coloma J, Harris E, Crowe JE, Stone M, Norris PJ, Busch M, Vivanco-Cid H, Cox J, Graham BS, Ledgerwood JE, Turtle L, Solomon T, Kallas EG, Watkins DI, Weiskopf D, Sette A. Prior Dengue virus exposure shapes T cell immunity to Zika virus in humans. J. Virol [print-electronic]. 2017 Oct 10/4/2017; PMID: 28978707, PMCID: PMC5709580, PII: JVI.01469-17, DOI: 10.1128/JVI.01469-17, ISSN: 1098-5514.

Lim XX, Chandramohan A, Lim XE, Crowe JE, Lok SM, Anand GS. Epitope and Paratope Mapping Reveals Temperature-Dependent Alterations in the Dengue-Antibody Interface. Structure [print-electronic]. 2017 Sep 9/5/2017; 25(9): 1391-1402.e3. PMID: 28823471, PII: S0969-2126(17)30222-8, DOI: 10.1016/j.str.2017.07.007, ISSN: 1878-4186.

Crowe JE. Principles of Broad and Potent Antiviral Human Antibodies: Insights for Vaccine Design. Cell Host Microbe. 2017 Aug 8/9/2017; 22(2): 193-206. PMID: 28799905, PII: S1931-3128(17)30296-2, DOI: 10.1016/j.chom.2017.07.013, ISSN: 1934-6069.

Crowe JE. Is It Possible to Develop a "Universal" Influenza Virus Vaccine? Potential for a Universal Influenza Vaccine. Cold Spring Harb Perspect Biol [print-electronic]. 2017 Jun 6/29/2017; PMID: 28663208, PII: cshperspect.a029496, DOI: 10.1101/cshperspect.a029496, ISSN: 1943-0264.

Broeckel R, Fox JM, Haese N, Kreklywich CN, Sukulpovi-Petty S, Legasse A, Smith PP, Denton M, Corvey C, Krishnan S, Colgin LMA, Ducore RM, Lewis AD, Axthelm MK, Mandron M, Cortez P, Rothblatt J, Rao E, Focken I, Carter K, Sapparapau G, Crowe JE, Diamond MS, Streblow DN. Therapeutic administration of a recombinant human monoclonal antibody reduces the severity of chikungunya virus disease in rhesus macaques. PLoS Negl Trop Dis. 2017 Jun; 11(6): e0005637. PMID: 28628616, PMCID: PMC5491320, PII: PNTD-D-16-02246, DOI: 10.1371/journal.pntd.0005637, ISSN: 1935-2735.

Bailey JR, Flyak AI, Cohen VJ, Li H, Wasilewski LN, Snider AE, Wang S, Learn GH, Kose N, Loerinc L, Lampley R, Cox AL, Pfaff JM, Doranz BJ, Shaw GM, Ray SC, Crowe JE. Broadly neutralizing antibodies with few somatic mutations and hepatitis C virus clearance. JCI Insight. 2017 May 5/4/2017; 2(9): PMID: 28469084, PMCID: PMC5414559, PII: 92872, DOI: 10.1172/jci.insight.92872, ISSN: 2379-3708.

Crowe JE. Treating Flu with Skin of Frog. Immunity. 2017 Apr 4/18/2017; 46(4): 517-8. PMID: 28423328, PII: S1074-7613(17)30140-1, DOI: 10.1016/j.immuni.2017.04.007, ISSN: 1097-4180.

Mire CE, Geisbert JB, Borisevich V, Fenton KA, Agans KN, Flyak AI, Deer DJ, Steinkellner H, Bohorov O, Bohorova N, Goodman C, Hiatt A, Kim DH, Pauly MH, Velasco J, Whaley KJ, Crowe JE, Zeitlin L, Geisbert TW. Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibody. Sci Transl Med. 2017 Apr 4/5/2017; 9(384): PMID: 28381540, PII: 9/384/eaai8711, DOI: 10.1126/scitranslmed.aai8711, ISSN: 1946-6242.

Hasan SS, Miller A, Sapparapu G, Fernandez E, Klose T, Long F, Fokine A, Porta JC, Jiang W, Diamond MS, Crowe JE, Kuhn RJ, Rossmann MG. A human antibody against Zika virus crosslinks the E protein to prevent infection. Nat Commun. 2017 Mar 3/16/2017; 8: 14722. PMID: 28300075, PII: ncomms14722, DOI: 10.1038/ncomms14722, ISSN: 2041-1723.

Nivarthi UK, Kose N, Sapparapu G, Widman D, Gallichotte E, Pfaff JM, Doranz BJ, Weiskopf D, Sette A, Durbin AP, Whitehead SS, Baric R, Crowe JE, de Silva AM. Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and Vaccination. J. Virol [electronic-print]. 2017 Mar 3/1/2017; 91(5): PMID: 28031369, PII: JVI.02041-16, DOI: 10.1128/JVI.02041-16, ISSN: 1098-5514.

Thomsen IP, Sapparapu G, James DB, Cassat JE, Nagarsheth M, Kose N, Putnam N, Boguslawski KM, Jones LS, Wood JB, Creech CB, Torres VJ, Crowe JE. Monoclonal antibodies against the Staphylococcus aureus bicomponent leukotoxin AB (LukAB) isolated following invasive human infection reveal diverse binding and modes of action. J. Infect. Dis [print-electronic]. 2017 Feb 2/10/2017; PMID: 28186295, PII: 2982058, DOI: 10.1093/infdis/jix071, ISSN: 1537-6613.

Miner JJ, Cook LE, Hong JP, Smith AM, Richner JM, Shimak RM, Young AR, Monte K, Poddar S, Crowe JE, Lenschow DJ, Diamond MS. Therapy with CTLA4-Ig and an antiviral monoclonal antibody controls chikungunya virus arthritis. Sci Transl Med. 2017 Feb 2/1/2017; 9(375): PMID: 28148840, PII: 9/375/eaah3438, DOI: 10.1126/scitranslmed.aah3438, ISSN: 1946-6242.

Mousa JJ, Kose N, Matta P, Gilchuk P, Crowe JE. A novel pre-fusion conformation-specific neutralizing epitope on the respiratory syncytial virus fusion protein. Nat Microbiol. 2017 Jan 1/30/2017; 2: 16271. PMID: 28134924, PII: nmicrobiol2016271, DOI: 10.1038/nmicrobiol.2016.271, ISSN: 2058-5276.

Wen X, Mousa JJ, Bates JT, Lamb RA, Crowe JE, Jardetzky TS. Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirus. Nat Microbiol. 2017 Jan 1/30/2017; 2: 16272. PMID: 28134915, PMCID: PMC5308794, PII: nmicrobiol2016272, DOI: 10.1038/nmicrobiol.2016.272, ISSN: 2058-5276.

Sapparapu G, Fernandez E, Kose N, Bin Cao, Fox JM, Bombardi RG, Zhao H, Nelson CA, Bryan AL, Barnes T, Davidson E, Mysorekar IU, Fremont DH, Doranz BJ, Diamond MS, Crowe JE. Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice. Nature [print-electronic]. 2016 Dec 12/15/2016; 540(7633): 443-7. PMID: 27819683, PII: nature20564, DOI: 10.1038/nature20564, ISSN: 1476-4687.

Mousa JJ, Sauer MF, Sevy AM, Finn JA, Bates JT, Alvarado G, King HG, Loerinc LB, Fong RH, Doranz BJ, Correia BE, Kalyuzhniy O, Wen X, Jardetzky TS, Schief WR, Ohi MD, Meiler J, Crowe JE. Structural basis for nonneutralizing antibody competition at antigenic site II of the respiratory syncytial virus fusion protein. Proc. Natl. Acad. Sci. U.S.A [print-electronic]. 2016 Nov 11/1/2016; 113(44): E6849-E6858. PMID: 27791117, PII: 1609449113, DOI: 10.1073/pnas.1609449113, ISSN: 1091-6490.

Gilchuk I, Gilchuk P, Sapparapu G, Lampley R, Singh V, Kose N, Blum DL, Hughes LJ, Satheshkumar PS, Townsend MB, Kondas AV, Reed Z, Weiner Z, Olson VA, Hammarlund E, Raue HP, Slifka MK, Slaughter JC, Graham BS, Edwards KM, Eisenberg RJ, Cohen GH, Joyce S, Crowe JE. Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus Infections. Cell. 2016 Oct 10/20/2016; 167(3): 684-694.e9. PMID: 27768891, PMCID: PMC5093772, PII: S0092-8674(16)31334-4, DOI: 10.1016/j.cell.2016.09.049, ISSN: 0092-8674.

Shanker S, Czakó R, Sapparapu G, Alvarado G, Viskovska M, Sankaran B, Atmar RL, Crowe JE, Estes MK, Prasad BV. Structural basis for norovirus neutralization by an HBGA blocking human IgA antibody. Proc. Natl. Acad. Sci. U.S.A [print-electronic]. 2016 Oct 10/4/2016; 113(40): E5830-E5837. PMID: 27647885, PMCID: PMC5056091, PII: 1609990113, DOI: 10.1073/pnas.1609990113, ISSN: 0027-8424.

Crowe JE. Teaching a Clone to Walk, One Step at a Time. Cell. 2016 Sep 9/8/2016; 166(6): 1360-1. PMID: 27610559, PII: S0092-8674(16)31136-9, DOI: 10.1016/j.cell.2016.08.039, ISSN: 0092-8674.

Wec AZ, Nyakatura EK, Herbert AS, Howell KA, Holtsberg FW, Bakken RR, Mittler E, Christin JR, Shulenin S, Jangra RK, Bharrhan S, Kuehne AI, Bornholdt ZA, Flyak AI, Saphire EO, Crowe JE, Aman MJ, Dye JM, Lai JR, Chandran K. A "Trojan horse" bispecific antibody strategy for broad protection against ebolaviruses. Science [print-electronic]. 2016 Sep 9/8/2016; PMID: 27608667, PII: science.aag3267, DOI: 10.1126/science.aag3267, ISSN: 1095-9203.

Cho MJ, Ellebrecht CT, Hammers CM, Mukherjee EM, Sapparapu G, Boudreaux CE, McDonald SM, Crowe JE, Payne AS. Determinants of VH1-46 Cross-Reactivity to Pemphigus Vulgaris Autoantigen Desmoglein 3 and Rotavirus Antigen VP6. J. Immunol [print-electronic]. 2016 Aug 8/15/2016; 197(4): 1065-73. PMID: 27402694, PMCID: PMC4976025, PII: jimmunol.1600567, DOI: 10.4049/jimmunol.1600567, ISSN: 1550-6606.

Pallesen J, Murin CD, de Val N, Cottrell CA, Hastie KM, Turner HL, Fusco ML, Flyak AI, Zeitlin L, Crowe JE, Andersen KG, Saphire EO, Ward AB. Structures of Ebola virus GP and sGP in complex with therapeutic antibodies. Nat Microbiol. 2016 Aug 8/8/2016; 1(9): 16128. PMID: 27562261, PMCID: PMC5003320, PII: nmicrobiol2016128, DOI: 10.1038/nmicrobiol.2016.128, ISSN: 2058-5276.

Hawman DW, Fox JM, Ashbrook AW, May NA, Schroeder KM, Torres RM, Crowe JE, Dermody TS, Diamond MS, Morrison TE. Pathogenic Chikungunya Virus Evades B Cell Responses to Establish Persistence. Cell Rep [print-electronic]. 2016 Aug 8/2/2016; 16(5): 1326-38. PMID: 27452455, PII: S2211-1247(16)30845-2, DOI: 10.1016/j.celrep.2016.06.076, ISSN: 2211-1247.

Bangaru S, Nieusma T, Kose N, Thornburg NJ, Finn JA, Kaplan BS, King HG, Singh V, Lampley RM, Sapparapu G, Cisneros A, Edwards KM, Slaughter JC, Edupuganti S, Lai L, Richt JA, Webby RJ, Ward AB, Crowe JE. Recognition of influenza H3N2 variant virus by human neutralizing antibodies. JCI Insight. 2016 Jul 7/7/2016; 1(10): PMID: 27482543, PMCID: PMC4962875, DOI: 10.1172/jci.insight.86673, ISSN: 2379-3708.

Sapparapu G, Czakó R, Alvarado G, Shanker S, Prasad BV, Atmar RL, Estes MK, Crowe JE. Frequent Use of the IgA Isotype in Human B Cells Encoding Potent Norovirus-Specific Monoclonal Antibodies That Block HBGA Binding. PLoS Pathog. 2016 Jun; 12(6): e1005719. PMID: 27355511, PMCID: PMC4927092, PII: PPATHOGENS-D-15-02532, DOI: 10.1371/journal.ppat.1005719, ISSN: 1553-7374.

Messer WB, Yount BL, Royal SR, de Alwis R, Widman DG, Smith SA, Crowe JE, Pfaff JM, Kahle KM, Doranz BJ, Ibarra KD, Harris E, de Silva AM, Baric RS. Functional Transplant of a Dengue Virus Serotype 3 (DENV3)-Specific Human Monoclonal Antibody Epitope into DENV1. J. Virol [electronic-print]. 2016 May 5/15/2016; 90(10): 5090-7. PMID: 26962223, PII: JVI.00155-16, DOI: 10.1128/JVI.00155-16, ISSN: 1098-5514.

Engelhardt BG, Paczesny S, Jung DK, Daguindau E, Jagasia M, Savani BN, Chinratanalab W, Cornell RF, Goodman S, Greer JP, Kassim AA, Sengsayadeth S, Yoder SM, Rock MT, Crowe JE. Early Th1 immunity promotes immune tolerance and may impair graft-versus-leukemia effect after allogeneic hematopoietic cell transplantation. Haematologica [print-electronic]. 2016 May; 101(5): e204-e208. PMID: 26819055, PII: haematol.2015.139501, DOI: 10.3324/haematol.2015.139501, ISSN: 1592-8721.

Boehme KW, Ikizler M, Iskarpatyoti JA, Wetzel JD, Willis J, Crowe JE, LaBranche CC, Montefiori DC, Wilson GJ, Dermody TS. Engineering Recombinant Reoviruses To Display gp41 Membrane-Proximal External-Region Epitopes from HIV-1. MSphere. 2016 May; 1(3): PMID: 27303748, PMCID: PMC4888892, PII: mSphere00086-16, DOI: 10.1128/mSphere.00086-16, ISSN: 2379-5042.

Willis JR, Finn JA, Briney B, Sapparapu G, Singh V, King H, LaBranche CC, Montefiori DC, Meiler J, Crowe JE. Long antibody HCDR3s from HIV-naïve donors presented on a PG9 neutralizing antibody background mediate HIV neutralization. Proc. Natl. Acad. Sci. U.S.A [print-electronic]. 2016 Apr 4/19/2016; 113(16): 4446-51. PMID: 27044078, PII: 1518405113, DOI: 10.1073/pnas.1518405113, ISSN: 1091-6490.

Ilinykh PA, Shen X, Flyak AI, Kuzmina N, Ksiazek TG, Crowe JE, Bukreyev A. Chimeric Filoviruses for Identification and Characterization of Monoclonal Antibodies. J. Virol [electronic-print]. 2016 Apr 4/15/2016; 90(8): 3890-901. PMID: 26819310, PMCID: PMC4810552, PII: JVI.00101-16, DOI: 10.1128/JVI.00101-16, ISSN: 1098-5514.

Boyd SD, Crowe JE. Deep sequencing and human antibody repertoire analysis. Curr. Opin. Immunol [print-electronic]. 2016 Apr 4/8/2016; 40: 103-9. PMID: 27065089, PII: S0952-7915(16)30025-5, DOI: 10.1016/j.coi.2016.03.008, ISSN: 1879-0372.

Clark KB, Hsiao HM, Bassit L, Crowe JE, Schinazi RF, Perng GC, Villinger F. Characterization of dengue virus 2 growth in megakaryocyte-erythrocyte progenitor cells. Virology [print-electronic]. 2016 Apr 4/5/2016; 493: 162-72. PMID: 27058763, PII: S0042-6822(16)30053-8, DOI: 10.1016/j.virol.2016.03.024, ISSN: 1096-0341.

Bates JT, Pickens JA, Schuster JE, Johnson M, Tollefson SJ, Williams JV, Davis NL, Johnston RE, Schultz-Darken N, Slaughter JC, Smith-House F, Crowe JE. Immunogenicity and efficacy of alphavirus-derived replicon vaccines for respiratory syncytial virus and human metapneumovirus in nonhuman primates. Vaccine [print-electronic]. 2016 Feb 2/10/2016; 34(7): 950-6. PMID: 26772634, PMCID: PMC4731299, PII: S0264-410X(15)01842-3, DOI: 10.1016/j.vaccine.2015.12.045, ISSN: 1873-2518.

Flyak AI, Shen X, Murin CD, Turner HL, David JA, Fusco ML, Lampley R, Kose N, Ilinykh PA, Kuzmina N, Branchizio A, King H, Brown L, Bryan C, Davidson E, Doranz BJ, Slaughter JC, Sapparapu G, Klages C, Ksiazek TG, Saphire EO, Ward AB, Bukreyev A, Crowe JE. Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection. Cell [print-electronic]. 2016 Jan 1/28/2016; 164(3): 392-405. PMID: 26806128, PMCID: PMC4733404, PII: S0092-8674(15)01686-4, DOI: 10.1016/j.cell.2015.12.022, ISSN: 1097-4172.

Smith SA, Nivarthi UK, de Alwis R, Kose N, Sapparapu G, Bombardi R, Kahle KM, Pfaff JM, Lieberman S, Doranz BJ, de Silva AM, Crowe JE. Dengue Virus prM-Specific Human Monoclonal Antibodies with Virus Replication-Enhancing Properties Recognize a Single Immunodominant Antigenic Site. J. Virol. 2016 Jan; 90(2): 780-9. PMID: 26512092, PMCID: PMC4702676, PII: JVI.01805-15, DOI: 10.1128/JVI.01805-15, ISSN: 1098-5514.

Bornholdt ZA, Ndungo E, Fusco ML, Bale S, Flyak AI, Crowe JE, Chandran K, Saphire EO. Host-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing Antibodies. MBio. 2016; 7(1): e02154-15. PMID: 26908579, PMCID: PMC4791852, PII: mBio.02154-15, DOI: 10.1128/mBio.02154-15, ISSN: 2150-7511.

Finn JA, Koehler Leman J, Willis JR, Cisneros A, Crowe JE, Meiler J. Improving Loop Modeling of the Antibody Complementarity-Determining Region 3 Using Knowledge-Based Restraints. PLoS ONE. 2016; 11(5): e0154811. PMID: 27182833, PMCID: PMC4868311, PII: PONE-D-16-04673, DOI: 10.1371/journal.pone.0154811, ISSN: 1932-6203.

Wen X, Pickens J, Mousa JJ, Leser GP, Lamb RA, Crowe JE, Jardetzky TS. A Chimeric Pneumovirus Fusion Protein Carrying Neutralizing Epitopes of Both MPV and RSV. PLoS ONE. 2016; 11(5): e0155917. PMID: 27224013, PMCID: PMC4880302, PII: PONE-D-16-06940, DOI: 10.1371/journal.pone.0155917, ISSN: 1932-6203.

Hicar MD, Chen X, Sulli C, Barnes T, Goodman J, Sojar H, Briney B, Willis J, Chukwuma VU, Kalams SA, Doranz BJ, Spearman P, Crowe JE. Human Antibodies that Recognize Novel Immunodominant Quaternary Epitopes on the HIV-1 Env Protein. PLoS ONE. 2016; 11(7): e0158861. PMID: 27411063, PMCID: PMC4943599, PII: PONE-D-15-31394, DOI: 10.1371/journal.pone.0158861, ISSN: 1932-6203.

Alvarado G, Crowe JE. Development of Human Monoclonal Antibodies Against Respiratory Syncytial Virus Using a High Efficiency Human Hybridoma Technique. Methods Mol. Biol. 2016; 1442: 63-76. PMID: 27464688, DOI: 10.1007/978-1-4939-3687-8_6, ISSN: 1940-6029.

Verma A, Basile AO, Bradford Y, Kuivaniemi H, Tromp G, Carey D, Gerhard GS, Crowe JE, Ritchie MD, Pendergrass SA. Phenome-Wide Association Study to Explore Relationships between Immune System Related Genetic Loci and Complex Traits and Diseases. PLoS ONE. 2016; 11(8): e0160573. PMID: 27508393, PMCID: PMC4980020, PII: PONE-D-16-15904, DOI: 10.1371/journal.pone.0160573, ISSN: 1932-6203.

Hicar MD, Chen X, Kalams SA, Sojar H, Landucci G, Forthal DN, Spearman P, Crowe JE. Low frequency of broadly neutralizing HIV antibodies during chronic infection even in quaternary epitope targeting antibodies containing large numbers of somatic mutations. Mol. Immunol [print-electronic]. 2015 Dec 12/31/2015; 70: 94-103. PMID: 26748387, PII: S0161-5890(15)30125-5, DOI: 10.1016/j.molimm.2015.12.002, ISSN: 1872-9142.

Fox JM, Long F, Edeling MA, Lin H, van Duijl-Richter MK, Fong RH, Kahle KM, Smit JM, Jin J, Simmons G, Doranz BJ, Crowe JE, Fremont DH, Rossmann MG, Diamond MS. Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress. Cell [print-electronic]. 2015 Nov 11/19/2015; 163(5): 1095-107. PMID: 26553503, PMCID: PMC4659373, PII: S0092-8674(15)01406-3, DOI: 10.1016/j.cell.2015.10.050, ISSN: 1097-4172.

Fox JM, Long F, Edeling MA, Lin H, van Duijl-Richter MK, Fong RH, Kahle KM, Smit JM, Jin J, Simmons G, Doranz BJ, Crowe JE, Fremont DH, Rossmann MG, Diamond MS. Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress. Cell [print-electronic]. 2015 Nov 11/19/2015; 163(5): 1095-107. PMID: 26553503, PMCID: PMC4659373, PII: S0092-8674(15)01406-3, DOI: 10.1016/j.cell.2015.10.050, ISSN: 1097-4172.

Long F, Fong RH, Austin SK, Chen Z, Klose T, Fokine A, Liu Y, Porta J, Sapparapu G, Akahata W, Doranz BJ, Crowe JE, Diamond MS, Rossmann MG. Cryo-EM structures elucidate neutralizing mechanisms of anti-chikungunya human monoclonal antibodies with therapeutic activity. Proc. Natl. Acad. Sci. U.S.A [print-electronic]. 2015 Nov 11/10/2015; 112(45): 13898-903. PMID: 26504196, PMCID: PMC4653152, PII: 1515558112, DOI: 10.1073/pnas.1515558112, ISSN: 1091-6490.

Long F, Fong RH, Austin SK, Chen Z, Klose T, Fokine A, Liu Y, Porta J, Sapparapu G, Akahata W, Doranz BJ, Crowe JE, Diamond MS, Rossmann MG. Cryo-EM structures elucidate neutralizing mechanisms of anti-chikungunya human monoclonal antibodies with therapeutic activity. Proc. Natl. Acad. Sci. U.S.A [print-electronic]. 2015 Nov 11/10/2015; 112(45): 13898-903. PMID: 26504196, PMCID: PMC4653152, PII: 1515558112, DOI: 10.1073/pnas.1515558112, ISSN: 1091-6490.

Crowe JE, Koff WC. Deciphering the human immunome. Expert Rev Vaccines [print-electronic]. 2015 Nov; 14(11): 1421-5. PMID: 26485213, DOI: 10.1586/14760584.2015.1082427, ISSN: 1744-8395.

Crowe JE, Koff WC. Deciphering the human immunome. Expert Rev Vaccines [print-electronic]. 2015 Nov; 14(11): 1421-5. PMID: 26485213, DOI: 10.1586/14760584.2015.1082427, ISSN: 1744-8395.

Winarski KL, Thornburg NJ, Yu Y, Sapparapu G, Crowe JE, Spiller BW. Vaccine-elicited antibody that neutralizes H5N1 influenza and variants binds the receptor site and polymorphic sites. Proc. Natl. Acad. Sci. U.S.A [print-electronic]. 2015 Jul 7/28/2015; 112(30): 9346-51. PMID: 26170302, PMCID: PMC4522792, PII: 1502762112, DOI: 10.1073/pnas.1502762112, ISSN: 1091-6490.

Winarski KL, Thornburg NJ, Yu Y, Sapparapu G, Crowe JE, Spiller BW. Vaccine-elicited antibody that neutralizes H5N1 influenza and variants binds the receptor site and polymorphic sites. Proc. Natl. Acad. Sci. U.S.A [print-electronic]. 2015 Jul 7/28/2015; 112(30): 9346-51. PMID: 26170302, PMCID: PMC4522792, PII: 1502762112, DOI: 10.1073/pnas.1502762112, ISSN: 1091-6490.

Callaway JB, Smith SA, McKinnon KP, de Silva AM, Crowe JE, Ting JP. Spleen Tyrosine Kinase (Syk) Mediates IL-1ß Induction by Primary Human Monocytes during Antibody-enhanced Dengue Virus Infection. J. Biol. Chem [print-electronic]. 2015 Jul 7/10/2015; 290(28): 17306-20. PMID: 26032420, PMCID: PMC4498069, PII: M115.664136, DOI: 10.1074/jbc.M115.664136, ISSN: 1083-351X.

Callaway JB, Smith SA, McKinnon KP, de Silva AM, Crowe JE, Ting JP. Spleen Tyrosine Kinase (Syk) Mediates IL-1ß Induction by Primary Human Monocytes during Antibody-enhanced Dengue Virus Infection. J. Biol. Chem [print-electronic]. 2015 Jul 7/10/2015; 290(28): 17306-20. PMID: 26032420, PMCID: PMC4498069, PII: M115.664136, DOI: 10.1074/jbc.M115.664136, ISSN: 1083-351X.

Smith SA, Silva LA, Fox JM, Flyak AI, Kose N, Sapparapu G, Khomandiak S, Ashbrook AW, Kahle KM, Fong RH, Swayne S, Doranz BJ, McGee CE, Heise MT, Pal P, Brien JD, Austin SK, Diamond MS, Dermody TS, Crowe JE. Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus. Cell Host Microbe. 2015 Jul 7/8/2015; 18(1): 86-95. PMID: 26159721, PMCID: PMC4501771, PII: S1931-3128(15)00257-7, DOI: 10.1016/j.chom.2015.06.009, ISSN: 1934-6069.

Smith SA, Silva LA, Fox JM, Flyak AI, Kose N, Sapparapu G, Khomandiak S, Ashbrook AW, Kahle KM, Fong RH, Swayne S, Doranz BJ, McGee CE, Heise MT, Pal P, Brien JD, Austin SK, Diamond MS, Dermody TS, Crowe JE. Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus. Cell Host Microbe. 2015 Jul 7/8/2015; 18(1): 86-95. PMID: 26159721, PMCID: PMC4501771, PII: S1931-3128(15)00257-7, DOI: 10.1016/j.chom.2015.06.009, ISSN: 1934-6069.

Fibriansah G, Ibarra KD, Ng TS, Smith SA, Tan JL, Lim XN, Ooi JS, Kostyuchenko VA, Wang J, de Silva AM, Harris E, Crowe JE, Lok SM. DENGUE VIRUS. Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers. Science. 2015 Jul 7/3/2015; 349(6243): 88-91. PMID: 26138979, PMCID: PMC4672004, PII: 349/6243/88, DOI: 10.1126/science.aaa8651, ISSN: 1095-9203.

Fibriansah G, Ibarra KD, Ng TS, Smith SA, Tan JL, Lim XN, Ooi JS, Kostyuchenko VA, Wang J, de Silva AM, Harris E, Crowe JE, Lok SM. DENGUE VIRUS. Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers. Science. 2015 Jul 7/3/2015; 349(6243): 88-91. PMID: 26138979, PMCID: PMC4672004, PII: 349/6243/88, DOI: 10.1126/science.aaa8651, ISSN: 1095-9203.

Sevy AM, Jacobs TM, Crowe JE, Meiler J. Design of Protein Multi-specificity Using an Independent Sequence Search Reduces the Barrier to Low Energy Sequences. PLoS Comput. Biol. 2015 Jul; 11(7): e1004300. PMID: 26147100, PMCID: PMC4493036, PII: PCOMPBIOL-D-15-00033, DOI: 10.1371/journal.pcbi.1004300, ISSN: 1553-7358.

Sevy AM, Jacobs TM, Crowe JE, Meiler J. Design of Protein Multi-specificity Using an Independent Sequence Search Reduces the Barrier to Low Energy Sequences. PLoS Comput. Biol. 2015 Jul; 11(7): e1004300. PMID: 26147100, PMCID: PMC4493036, PII: PCOMPBIOL-D-15-00033, DOI: 10.1371/journal.pcbi.1004300, ISSN: 1553-7358.

Hooper KA, Crowe JE, Bloom JD. Influenza viruses with receptor-binding N1 neuraminidases occur sporadically in several lineages and show no attenuation in cell culture or mice. J. Virol [print-electronic]. 2015 Apr; 89(7): 3737-45. PMID: 25609803, PMCID: PMC4403400, PII: JVI.00012-15, DOI: 10.1128/JVI.00012-15, ISSN: 1098-5514.

Hooper KA, Crowe JE, Bloom JD. Influenza viruses with receptor-binding N1 neuraminidases occur sporadically in several lineages and show no attenuation in cell culture or mice. J. Virol [print-electronic]. 2015 Apr; 89(7): 3737-45. PMID: 25609803, PMCID: PMC4403400, PII: JVI.00012-15, DOI: 10.1128/JVI.00012-15, ISSN: 1098-5514.

Simões EA, DeVincenzo JP, Boeckh M, Bont L, Crowe JE, Griffiths P, Hayden FG, Hodinka RL, Smyth RL, Spencer K, Thirstrup S, Walsh EE, Whitley RJ. Challenges and opportunities in developing respiratory syncytial virus therapeutics. J. Infect. Dis. 2015 Mar 3/15/2015; 211 Suppl 1: S1-S20. PMID: 25713060, PMCID: PMC4345819, PII: jiu828, DOI: 10.1093/infdis/jiu828, ISSN: 1537-6613.

Simões EA, DeVincenzo JP, Boeckh M, Bont L, Crowe JE, Griffiths P, Hayden FG, Hodinka RL, Smyth RL, Spencer K, Thirstrup S, Walsh EE, Whitley RJ. Challenges and opportunities in developing respiratory syncytial virus therapeutics. J. Infect. Dis. 2015 Mar 3/15/2015; 211 Suppl 1: S1-S20. PMID: 25713060, PMCID: PMC4345819, PII: jiu828, DOI: 10.1093/infdis/jiu828, ISSN: 1537-6613.

Hashiguchi T, Fusco ML, Bornholdt ZA, Lee JE, Flyak AI, Matsuoka R, Kohda D, Yanagi Y, Hammel M, Crowe JE, Saphire EO. Structural basis for Marburg virus neutralization by a cross-reactive human antibody. Cell. 2015 Feb 2/26/2015; 160(5): 904-12. PMID: 25723165, PMCID: PMC4344967, PII: S0092-8674(15)00119-1, DOI: 10.1016/j.cell.2015.01.041, ISSN: 1097-4172.

Flyak AI, Ilinykh PA, Murin CD, Garron T, Shen X, Fusco ML, Hashiguchi T, Bornholdt ZA, Slaughter JC, Sapparapu G, Klages C, Ksiazek TG, Ward AB, Saphire EO, Bukreyev A, Crowe JE. Mechanism of human antibody-mediated neutralization of Marburg virus. Cell. 2015 Feb 2/26/2015; 160(5): 893-903. PMID: 25723164, PMCID: PMC4344968, PII: S0092-8674(15)00074-4, DOI: 10.1016/j.cell.2015.01.031, ISSN: 1097-4172.

Hashiguchi T, Fusco ML, Bornholdt ZA, Lee JE, Flyak AI, Matsuoka R, Kohda D, Yanagi Y, Hammel M, Crowe JE, Saphire EO. Structural basis for Marburg virus neutralization by a cross-reactive human antibody. Cell. 2015 Feb 2/26/2015; 160(5): 904-12. PMID: 25723165, PMCID: PMC4344967, PII: S0092-8674(15)00119-1, DOI: 10.1016/j.cell.2015.01.041, ISSN: 1097-4172.

Flyak AI, Ilinykh PA, Murin CD, Garron T, Shen X, Fusco ML, Hashiguchi T, Bornholdt ZA, Slaughter JC, Sapparapu G, Klages C, Ksiazek TG, Ward AB, Saphire EO, Bukreyev A, Crowe JE. Mechanism of human antibody-mediated neutralization of Marburg virus. Cell. 2015 Feb 2/26/2015; 160(5): 893-903. PMID: 25723164, PMCID: PMC4344968, PII: S0092-8674(15)00074-4, DOI: 10.1016/j.cell.2015.01.031, ISSN: 1097-4172.

Smith SA, Crowe JE. Use of Human Hybridoma Technology To Isolate Human Monoclonal Antibodies. Microbiol Spectr. 2015 Feb; 3(1): AID-0027. PMID: 26104564, DOI: 10.1128/microbiolspec.AID-0027-2014, ISSN: 2165-0497.

Smith SA, Nivarthi UK, de Alwis R, Kose N, Sapparapu G, Bombardi R, Kahle KM, Pfaff JM, Lieberman S, Doranz BJ, de Silva AM, Crowe JE. Dengue Virus prM-Specific Human Monoclonal Antibodies with Virus Replication-Enhancing Properties Recognize a Single Immunodominant Antigenic Site. J. Virol. 2015; 90(2): 780-9. PMID: 26512092, PII: JVI.01805-15, DOI: 10.1128/JVI.01805-15, ISSN: 1098-5514.

Gallichotte EN, Widman DG, Yount BL, Wahala WM, Durbin A, Whitehead S, Sariol CA, Crowe JE, de Silva AM, Baric RS. A new quaternary structure epitope on dengue virus serotype 2 is the target of durable type-specific neutralizing antibodies. MBio. 2015; 6(5): e01461-15. PMID: 26463165, PMCID: PMC4620467, PII: mBio.01461-15, DOI: 10.1128/mBio.01461-15, ISSN: 2150-7511.

Callaway JB, Smith SA, Widman DG, McKinnon KP, Scholle F, Sempowski GD, Dittmer DP, Crowe JE, de Silva AM, Ting JP. Source and Purity of Dengue-Viral Preparations Impact Requirement for Enhancing Antibody to Induce Elevated IL-1ß Secretion: A Primary Human Monocyte Model. PLoS ONE. 2015; 10(8): e0136708. PMID: 26301593, PMCID: PMC4547738, PII: PONE-D-14-32063, DOI: 10.1371/journal.pone.0136708, ISSN: 1932-6203.

Chukwuma VU, Hicar MD, Chen X, Nicholas KJ, Joyner A, Kalams SA, Landucci G, Forthal DN, Spearman PW, Crowe JE. Association of VH4-59 Antibody Variable Gene Usage with Recognition of an Immunodominant Epitope on the HIV-1 Gag Protein. PLoS ONE. 2015; 10(7): e0133509. PMID: 26226263, PMCID: PMC4520566, PII: PONE-D-15-16451, DOI: 10.1371/journal.pone.0133509, ISSN: 1932-6203.

Fibriansah G, Tan JL, Smith SA, de Alwis R, Ng TS, Kostyuchenko VA, Jadi RS, Kukkaro P, de Silva AM, Crowe JE, Lok SM. A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins. Nat Commun. 2015; 6: 6341. PMID: 25698059, PMCID: PMC4346626, PII: ncomms7341, DOI: 10.1038/ncomms7341, ISSN: 2041-1723.

Hotard AL, Lee S, Currier MG, Crowe JE, Sakamoto K, Newcomb DC, Peebles RS, Plemper RK, Moore ML. Identification of residues in the human respiratory syncytial virus fusion protein that modulate fusion activity and pathogenesis. J. Virol [print-electronic]. 2015 Jan; 89(1): 512-22. PMID: 25339762, PMCID: PMC4301159, PII: JVI.02472-14, DOI: 10.1128/JVI.02472-14, ISSN: 1098-5514.

Gallichotte EN, Widman DG, Yount BL, Wahala WM, Durbin A, Whitehead S, Sariol CA, Crowe JE, de Silva AM, Baric RS. A new quaternary structure epitope on dengue virus serotype 2 is the target of durable type-specific neutralizing antibodies. MBio. 2015; 6(5): e01461-15. PMID: 26463165, PMCID: PMC4620467, PII: mBio.01461-15, DOI: 10.1128/mBio.01461-15, ISSN: 2150-7511.

Callaway JB, Smith SA, Widman DG, McKinnon KP, Scholle F, Sempowski GD, Dittmer DP, Crowe JE, de Silva AM, Ting JP. Source and Purity of Dengue-Viral Preparations Impact Requirement for Enhancing Antibody to Induce Elevated IL-1ß Secretion: A Primary Human Monocyte Model. PLoS ONE. 2015; 10(8): e0136708. PMID: 26301593, PMCID: PMC4547738, PII: PONE-D-14-32063, DOI: 10.1371/journal.pone.0136708, ISSN: 1932-6203.

Chukwuma VU, Hicar MD, Chen X, Nicholas KJ, Joyner A, Kalams SA, Landucci G, Forthal DN, Spearman PW, Crowe JE. Association of VH4-59 Antibody Variable Gene Usage with Recognition of an Immunodominant Epitope on the HIV-1 Gag Protein. PLoS ONE. 2015; 10(7): e0133509. PMID: 26226263, PMCID: PMC4520566, PII: PONE-D-15-16451, DOI: 10.1371/journal.pone.0133509, ISSN: 1932-6203.

Fibriansah G, Tan JL, Smith SA, de Alwis R, Ng TS, Kostyuchenko VA, Jadi RS, Kukkaro P, de Silva AM, Crowe JE, Lok SM. A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins. Nat Commun. 2015; 6: 6341. PMID: 25698059, PMCID: PMC4346626, PII: ncomms7341, DOI: 10.1038/ncomms7341, ISSN: 2041-1723.

Hotard AL, Lee S, Currier MG, Crowe JE, Sakamoto K, Newcomb DC, Peebles RS, Plemper RK, Moore ML. Identification of residues in the human respiratory syncytial virus fusion protein that modulate fusion activity and pathogenesis. J. Virol [print-electronic]. 2015 Jan; 89(1): 512-22. PMID: 25339762, PMCID: PMC4301159, PII: JVI.02472-14, DOI: 10.1128/JVI.02472-14, ISSN: 1098-5514.

Smith SA, de Alwis AR, Kose N, Jadi RS, de Silva AM, Crowe JE. Isolation of dengue virus-specific memory B cells with live virus antigen from human subjects following natural infection reveals the presence of diverse novel functional groups of antibody clones. J. Virol [print-electronic]. 2014 Nov; 88(21): 12233-41. PMID: 25100837, PMCID: PMC4248927, PII: JVI.00247-14, DOI: 10.1128/JVI.00247-14, ISSN: 1098-5514.

Smith SA, de Alwis AR, Kose N, Jadi RS, de Silva AM, Crowe JE. Isolation of dengue virus-specific memory B cells with live virus antigen from human subjects following natural infection reveals the presence of diverse novel functional groups of antibody clones. J. Virol [print-electronic]. 2014 Nov; 88(21): 12233-41. PMID: 25100837, PMCID: PMC4248927, PII: JVI.00247-14, DOI: 10.1128/JVI.00247-14, ISSN: 1098-5514.

de Alwis R, Williams KL, Schmid MA, Lai CY, Patel B, Smith SA, Crowe JE, Wang WK, Harris E, de Silva AM. Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera. PLoS Pathog. 2014 Oct; 10(10): e1004386. PMID: 25275316, PMCID: PMC4183589, PII: PPATHOGENS-D-14-00771, DOI: 10.1371/journal.ppat.1004386, ISSN: 1553-7374.

de Alwis R, Williams KL, Schmid MA, Lai CY, Patel B, Smith SA, Crowe JE, Wang WK, Harris E, de Silva AM. Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera. PLoS Pathog. 2014 Oct; 10(10): e1004386. PMID: 25275316, PMCID: PMC4183589, PII: PPATHOGENS-D-14-00771, DOI: 10.1371/journal.ppat.1004386, ISSN: 1553-7374.

Krause JC, Crowe JE. Committing the Oldest Sins in the Newest Kind of Ways-Antibodies Targeting the Influenza Virus Type A Hemagglutinin Globular Head. Microbiol Spectr. 2014 Oct; 2(5): PMID: 26104373, DOI: 10.1128/microbiolspec.AID-0021-2014, ISSN: 2165-0497.

Dulek DE, Newcomb DC, Toki S, Goliniewska K, Cephus J, Reiss S, Bates JT, Crowe JE, Boyd KL, Moore ML, Zhou W, Peebles RS. STAT4 deficiency fails to induce lung Th2 or Th17 immunity following primary or secondary respiratory syncytial virus (RSV) challenge but enhances the lung RSV-specific CD8+ T cell immune response to secondary challenge. J. Virol [print-electronic]. 2014 Sep 9/1/2014; 88(17): 9655-72. PMID: 24920804, PMCID: PMC4136353, PII: JVI.03299-13, DOI: 10.1128/JVI.03299-13, ISSN: 1098-5514.

Dulek DE, Newcomb DC, Toki S, Goliniewska K, Cephus J, Reiss S, Bates JT, Crowe JE, Boyd KL, Moore ML, Zhou W, Peebles RS. STAT4 deficiency fails to induce lung Th2 or Th17 immunity following primary or secondary respiratory syncytial virus (RSV) challenge but enhances the lung RSV-specific CD8+ T cell immune response to secondary challenge. J. Virol [print-electronic]. 2014 Sep 9/1/2014; 88(17): 9655-72. PMID: 24920804, PMCID: PMC4136353, PII: JVI.03299-13, DOI: 10.1128/JVI.03299-13, ISSN: 1098-5514.

Sapparapu G, Sims AL, Aiyegbo MS, Shaikh FY, Harth EM, Crowe JE. Intracellular neutralization of a virus using a cell-penetrating molecular transporter. Nanomedicine (Lond) [print-electronic]. 2014 Aug; 9(11): 1613-24. PMID: 24195674, DOI: 10.2217/nnm.13.139, ISSN: 1748-6963.

Almagro JC, Gilliland GL, Breden F, Scott JK, Sok D, Pauthner M, Reichert JM, Helguera G, Andrabi R, Mabry R, Bléry M, Voss JE, Laurén J, Abuqayyas L, Barghorn S, Ben-Jacob E, Crowe JE, Huston JS, Johnston SA, Krauland E, Lund-Johansen F, Marasco WA, Parren PW, Xu KY. Antibody engineering and therapeutics, The Annual Meeting of the Antibody Society: December 8-12, 2013, Huntington Beach, CA. MAbs [print-electronic]. 2014 May; 6(3): 577-618. PMID: 24589717, PMCID: PMC4011904, PII: 28421, DOI: 10.4161/mabs.28421, ISSN: 1942-0870.

Bates JT, Keefer CJ, Slaughter JC, Kulp DW, Schief WR, Crowe JE. Escape from neutralization by the respiratory syncytial virus-specific neutralizing monoclonal antibody palivizumab is driven by changes in on-rate of binding to the fusion protein. Virology [print-electronic]. 2014 Apr; 454-455: 139-44. PMID: 24725940, PMCID: PMC4004766, PII: S0042-6822(14)00054-3, DOI: 10.1016/j.virol.2014.02.010, ISSN: 1096-0341.

Correia BE, Bates JT, Loomis RJ, Baneyx G, Carrico C, Jardine JG, Rupert P, Correnti C, Kalyuzhniy O, Vittal V, Connell MJ, Stevens E, Schroeter A, Chen M, Macpherson S, Serra AM, Adachi Y, Holmes MA, Li Y, Klevit RE, Graham BS, Wyatt RT, Baker D, Strong RK, Crowe JE, Johnson PR, Schief WR. Proof of principle for epitope-focused vaccine design. Nature [print-electronic]. 2014 Mar 3/13/2014; 507(7491): 201-6. PMID: 24499818, PMCID: PMC4260937, PII: nature12966, DOI: 10.1038/nature12966, ISSN: 1476-4687.

Fibriansah G, Tan JL, Smith SA, de Alwis AR, Ng TS, Kostyuchenko VA, Ibarra KD, Wang J, Harris E, de Silva A, Crowe JE, Lok SM. A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface. EMBO Mol Med [print-electronic]. 2014 Mar; 6(3): 358-71. PMID: 24421336, PMCID: PMC3958310, PII: emmm.201303404, DOI: 10.1002/emmm.201303404, ISSN: 1757-4684.

Messer WB, de Alwis R, Yount BL, Royal SR, Huynh JP, Smith SA, Crowe JE, Doranz BJ, Kahle KM, Pfaff JM, White LJ, Sariol CA, de Silva AM, Baric RS. Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity. Proc. Natl. Acad. Sci. U.S.A [print-electronic]. 2014 Feb 2/4/2014; 111(5): 1939-44. PMID: 24385585, PMCID: PMC3918811, PII: 1317350111, DOI: 10.1073/pnas.1317350111, ISSN: 1091-6490.

Alonas E, Lifland AW, Gudheti M, Vanover D, Jung J, Zurla C, Kirschman J, Fiore VF, Douglas A, Barker TH, Yi H, Wright ER, Crowe JE, Santangelo PJ. Combining single RNA sensitive probes with subdiffraction-limited and live-cell imaging enables the characterization of virus dynamics in cells. ACS Nano [print-electronic]. 2014 Jan 1/28/2014; 8(1): 302-15. PMID: 24351207, PMCID: PMC3906890, DOI: 10.1021/nn405998v, ISSN: 1936-086X.

Aiyegbo MS, Eli IM, Spiller BW, Williams DR, Kim R, Lee DE, Liu T, Li S, Stewart PL, Crowe JE. Differential accessibility of a rotavirus VP6 epitope in trimers comprising type I, II, or III channels as revealed by binding of a human rotavirus VP6-specific antibody. J. Virol [print-electronic]. 2014 Jan; 88(1): 469-76. PMID: 24155406, PMCID: PMC3911710, PII: JVI.01665-13, DOI: 10.1128/JVI.01665-13, ISSN: 1098-5514.

Briney BS, Willis JR, Finn JA, McKinney BA, Crowe JE. Tissue-specific expressed antibody variable gene repertoires. PLoS ONE. 2014; 9(6): e100839. PMID: 24956460, PMCID: PMC4067404, PII: PONE-D-13-41903, DOI: 10.1371/journal.pone.0100839, ISSN: 1932-6203.

Briney BS, Willis JR, Finn JA, McKinney BA, Crowe JE. Tissue-specific expressed antibody variable gene repertoires. PLoS ONE. 2014; 9(6): e100839. PMID: 24956460, PMCID: PMC4067404, PII: PONE-D-13-41903, DOI: 10.1371/journal.pone.0100839, ISSN: 1932-6203.

Hong M, Lee PS, Hoffman RM, Zhu X, Krause JC, Laursen NS, Yoon SI, Song L, Tussey L, Crowe JE, Ward AB, Wilson IA. Antibody recognition of the pandemic H1N1 Influenza virus hemagglutinin receptor binding site. J. Virol [print-electronic]. 2013 Nov; 87(22): 12471-80. PMID: 24027321, PMCID: PMC3807900, PII: JVI.01388-13, DOI: 10.1128/JVI.01388-13, ISSN: 1098-5514.

Finn JA, Crowe JE. Impact of new sequencing technologies on studies of the human B cell repertoire. Curr. Opin. Immunol [print-electronic]. 2013 Oct; 25(5): 613-8. PMID: 24161653, PMCID: PMC3882336, PII: S0952-7915(13)00145-3, DOI: 10.1016/j.coi.2013.09.010, ISSN: 1879-0372.

Munden MM, Williams JL, Zhang W, Crowe JE, Munden RF, Cisek LJ. Intermittent testicular torsion in the pediatric patient: sonographic indicators of a difficult diagnosis. AJR Am J Roentgenol. 2013 Oct; 201(4): 912-8. PMID: 24059384, DOI: 10.2214/AJR.12.9448, ISSN: 1546-3141.

Thornburg NJ, Nannemann DP, Blum DL, Belser JA, Tumpey TM, Deshpande S, Fritz GA, Sapparapu G, Krause JC, Lee JH, Ward AB, Lee DE, Li S, Winarski KL, Spiller BW, Meiler J, Crowe JE. Human antibodies that neutralize respiratory droplet transmissible H5N1 influenza viruses. J. Clin. Invest [print-electronic]. 2013 Oct; 123(10): 4405-9. PMID: 23999429, PMCID: PMC3784541, PII: 69377, DOI: 10.1172/JCI69377, ISSN: 1558-8238.

Crowe JE. Universal flu vaccines: primum non nocere. Sci Transl Med. 2013 Aug 8/28/2013; 5(200): 200fs34. PMID: 23986396, PII: 5/200/200fs34, DOI: 10.1126/scitranslmed.3007118, ISSN: 1946-6242.

Stone JW, Thornburg NJ, Blum DL, Kuhn SJ, Wright DW, Crowe JE. Gold nanorod vaccine for respiratory syncytial virus. Nanotechnology [print-electronic]. 2013 Jul 7/26/2013; 24(29): 295102. PMID: 23799651, PMCID: PMC3754908, DOI: 10.1088/0957-4484/24/29/295102, ISSN: 1361-6528.

Smith SA, de Alwis R, Kose N, Durbin AP, Whitehead SS, de Silva AM, Crowe JE. Human monoclonal antibodies derived from memory B cells following live attenuated dengue virus vaccination or natural infection exhibit similar characteristics. J. Infect. Dis [print-electronic]. 2013 Jun 6/15/2013; 207(12): 1898-908. PMID: 23526830, PMCID: PMC3654755, PII: jit119, DOI: 10.1093/infdis/jit119, ISSN: 1537-6613.

Crowe JE. Immunology. Crowdsourcing immunity. Science. 2013 May 5/10/2013; 340(6133): 692-3. PMID: 23661747, PII: 340/6133/692, DOI: 10.1126/science.1238628, ISSN: 1095-9203.

Gilchuk P, Spencer CT, Conant SB, Hill T, Gray JJ, Niu X, Zheng M, Erickson JJ, Boyd KL, McAfee KJ, Oseroff C, Hadrup SR, Bennink JR, Hildebrand W, Edwards KM, Crowe JE, Williams JV, Buus S, Sette A, Schumacher TN, Link AJ, Joyce S. Discovering naturally processed antigenic determinants that confer protective T cell immunity. J. Clin. Invest [print-electronic]. 2013 May; 123(5): 1976-87. PMID: 23543059, PMCID: PMC3635741, PII: 67388, DOI: 10.1172/JCI67388, ISSN: 1558-8238.

Willis JR, Briney BS, DeLuca SL, Crowe JE, Meiler J. Human germline antibody gene segments encode polyspecific antibodies. PLoS Comput. Biol [print-electronic]. 2013 Apr; 9(4): e1003045. PMID: 23637590, PMCID: PMC3636087, PII: PCOMPBIOL-D-12-01934, DOI: 10.1371/journal.pcbi.1003045, ISSN: 1553-7358.

Bates JT, Keefer CJ, Utley TJ, Correia BE, Schief WR, Crowe JE. Reversion of somatic mutations of the respiratory syncytial virus-specific human monoclonal antibody Fab19 reveal a direct relationship between association rate and neutralizing potency. J. Immunol [print-electronic]. 2013 Apr 4/1/2013; 190(7): 3732-9. PMID: 23455501, PMCID: PMC3608519, PII: jimmunol.1202964, DOI: 10.4049/jimmunol.1202964, ISSN: 1550-6606.

Xu R, Krause JC, McBride R, Paulson JC, Crowe JE, Wilson IA. A recurring motif for antibody recognition of the receptor-binding site of influenza hemagglutinin. Nat. Struct. Mol. Biol [print-electronic]. 2013 Mar; 20(3): 363-70. PMID: 23396351, PMCID: PMC3594569, PII: nsmb.2500, DOI: 10.1038/nsmb.2500, ISSN: 1545-9985.

Hartman ML, Xu R, Crowe BJ, Robison LL, Erfurth EM, Kleinberg DL, Zimmermann AG, Woodmansee WW, Cutler GB, Chipman JJ, Melmed S, . Prospective safety surveillance of GH-deficient adults: comparison of GH-treated vs untreated patients. J. Clin. Endocrinol. Metab [print-electronic]. 2013 Mar; 98(3): 980-8. PMID: 23345098, PMCID: PMC3677286, PII: jc.2012-2684, DOI: 10.1210/jc.2012-2684, ISSN: 1945-7197.

Smith SA, de Alwis AR, Kose N, Harris E, Ibarra KD, Kahle KM, Pfaff JM, Xiang X, Doranz BJ, de Silva AM, Austin SK, Sukupolvi-Petty S, Diamond MS, Crowe JE. The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein. MBio. 2013; 4(6): e00873-13. PMID: 24255124, PMCID: PMC3870244, PII: mBio.00873-13, DOI: 10.1128/mBio.00873-13, ISSN: 2150-7511.

Aiyegbo MS, Sapparapu G, Spiller BW, Eli IM, Williams DR, Kim R, Lee DE, Liu T, Li S, Woods VL, Nannemann DP, Meiler J, Stewart PL, Crowe JE. Human rotavirus VP6-specific antibodies mediate intracellular neutralization by binding to a quaternary structure in the transcriptional pore. PLoS ONE [electronic-print]. 2013; 8(5): e61101. PMID: 23671563, PMCID: PMC3650007, PII: PONE-D-13-06430, DOI: 10.1371/journal.pone.0061101, ISSN: 1932-6203.

Shaikh FY, Crowe JE. Molecular mechanisms driving respiratory syncytial virus assembly. Future Microbiol. 2013 Jan; 8(1): 123-31. PMID: 23252497, PMCID: PMC3577052, DOI: 10.2217/fmb.12.132, ISSN: 1746-0921.

Briney BS, Crowe JE. Secondary mechanisms of diversification in the human antibody repertoire. Front Immunol. 2013; 4: 42. PMID: 23483107, PMCID: PMC3593266, DOI: 10.3389/fimmu.2013.00042, ISSN: 1664-3224.

Engelhardt BG, Sengsayadeth SM, Jagasia M, Savani BN, Kassim AA, Lu P, Shyr Y, Yoder SM, Rock MT, Crowe JE. Tissue-specific regulatory T cells: biomarker for acute graft-vs-host disease and survival. Exp. Hematol [print-electronic]. 2012 Dec; 40(12): 974-982.e1. PMID: 22885125, PMCID: PMC3611587, PII: S0301-472X(12)00343-8, DOI: 10.1016/j.exphem.2012.08.002, ISSN: 1873-2399.

Briney BS, Willis JR, Crowe JE. Location and length distribution of somatic hypermutation-associated DNA insertions and deletions reveals regions of antibody structural plasticity. Genes Immun [print-electronic]. 2012 Oct; 13(7): 523-9. PMID: 22717702, PMCID: PMC3449029, PII: gene201228, DOI: 10.1038/gene.2012.28, ISSN: 1476-5470.

Briney BS, Willis JR, McKinney BA, Crowe JE. High-throughput antibody sequencing reveals genetic evidence of global regulation of the naïve and memory repertoires that extends across individuals. Genes Immun [print-electronic]. 2012 Sep; 13(6): 469-73. PMID: 22622198, PII: gene201220, DOI: 10.1038/gene.2012.20, ISSN: 1476-5470.

Briney BS, Willis JR, Hicar MD, Thomas JW, Crowe JE. Frequency and genetic characterization of V(DD)J recombinants in the human peripheral blood antibody repertoire. Immunology. 2012 Sep; 137(1): 56-64. PMID: 22612413, PMCID: PMC3449247, DOI: 10.1111/j.1365-2567.2012.03605.x, ISSN: 1365-2567.

Krause JC, Tsibane T, Tumpey TM, Huffman CJ, Albrecht R, Blum DL, Ramos I, Fernandez-Sesma A, Edwards KM, García-Sastre A, Basler CF, Crowe JE. Human monoclonal antibodies to pandemic 1957 H2N2 and pandemic 1968 H3N2 influenza viruses. J. Virol [print-electronic]. 2012 Jun; 86(11): 6334-40. PMID: 22457520, PMCID: PMC3372199, PII: JVI.07158-11, DOI: 10.1128/JVI.07158-11, ISSN: 1098-5514.

Engelhardt BG, Jagasia SM, Crowe JE, Griffith ML, Savani BN, Kassim AA, Lu P, Weitkamp JH, Moore DJ, Yoder SM, Rock MT, Jagasia M. Predicting posttransplantation diabetes mellitus by regulatory T-cell phenotype: implications for metabolic intervention to modulate alloreactivity. Blood [print-electronic]. 2012 Mar 3/8/2012; 119(10): 2417-21. PMID: 22262764, PMCID: PMC3311262, PII: blood-2011-10-384750, DOI: 10.1182/blood-2011-10-384750, ISSN: 1528-0020.

Smith SA, Zhou Y, Olivarez NP, Broadwater AH, de Silva AM, Crowe JE. Persistence of circulating memory B cell clones with potential for dengue virus disease enhancement for decades following infection. J. Virol [print-electronic]. 2012 Mar; 86(5): 2665-75. PMID: 22171265, PMCID: PMC3302281, PII: JVI.06335-11, DOI: 10.1128/JVI.06335-11, ISSN: 1098-5514.

Crowe JE. Influenza virus resistance to human neutralizing antibodies. MBio [electronic-print]. 2012; 3(4): e00213-12. PMID: 22851660, PMCID: PMC3419524, PII: mBio.00213-12, DOI: 10.1128/mBio.00213-12, ISSN: 2150-7511.

Shaikh FY, Utley TJ, Craven RE, Rogers MC, Lapierre LA, Goldenring JR, Crowe JE. Respiratory syncytial virus assembles into structured filamentous virion particles independently of host cytoskeleton and related proteins. PLoS ONE [print-electronic]. 2012; 7(7): e40826. PMID: 22808269, PMCID: PMC3396619, PII: PONE-D-12-11914, DOI: 10.1371/journal.pone.0040826, ISSN: 1932-6203.

Briney BS, Willis JR, Crowe JE. Human peripheral blood antibodies with long HCDR3s are established primarily at original recombination using a limited subset of germline genes. PLoS ONE [print-electronic]. 2012; 7(5): e36750. PMID: 22590602, PMCID: PMC3348910, PII: PONE-D-12-02931, DOI: 10.1371/journal.pone.0036750, ISSN: 1932-6203.

Shaikh FY, Cox RG, Lifland AW, Hotard AL, Williams JV, Moore ML, Santangelo PJ, Crowe JE. A critical phenylalanine residue in the respiratory syncytial virus fusion protein cytoplasmic tail mediates assembly of internal viral proteins into viral filaments and particles. MBio [electronic-print]. 2012; 3(1): PMID: 22318318, PMCID: PMC3280462, PII: mBio.00270-11, DOI: 10.1128/mBio.00270-11, ISSN: 2150-7511.

Thornburg NJ, Hayward SL, Crowe JE. Respiratory syncytial virus regulates human microRNAs by using mechanisms involving beta interferon and NF-¿B. MBio. 2012; 3(6): PMID: 23249809, PMCID: PMC3529541, PII: mBio.00220-12, DOI: 10.1128/mBio.00220-12, ISSN: 2150-7511.

Rock MT, McKinney BA, Yoder SM, Prudom CE, Wright DW, Crowe JE. Identification of potential human respiratory syncytial virus and metapneumovirus T cell epitopes using computational prediction and MHC binding assays. J. Immunol. Methods [print-electronic]. 2011 Nov 11/30/2011; 374(1-2): 13-7. PMID: 21854782, PMCID: PMC3220792, PII: S0022-1759(11)00209-2, DOI: 10.1016/j.jim.2011.08.004, ISSN: 1872-7905.

Krause JC, Tsibane T, Tumpey TM, Huffman CJ, Briney BS, Smith SA, Basler CF, Crowe JE. Epitope-specific human influenza antibody repertoires diversify by B cell intraclonal sequence divergence and interclonal convergence. J. Immunol [print-electronic]. 2011 Oct 10/1/2011; 187(7): 3704-11. PMID: 21880983, PMCID: PMC3178754, PII: jimmunol.1101823, DOI: 10.4049/jimmunol.1101823, ISSN: 1550-6606.

Krause JC, Tsibane T, Tumpey TM, Huffman CJ, Basler CF, Crowe JE. A broadly neutralizing human monoclonal antibody that recognizes a conserved, novel epitope on the globular head of the influenza H1N1 virus hemagglutinin. J. Virol [print-electronic]. 2011 Oct; 85(20): 10905-8. PMID: 21849447, PMCID: PMC3187471, PII: JVI.00700-11, DOI: 10.1128/JVI.00700-11, ISSN: 1098-5514.

Joyner AS, Willis JR, Crowe JE, Aiken C. Maturation-induced cloaking of neutralization epitopes on HIV-1 particles. PLoS Pathog [print-electronic]. 2011 Sep; 7(9): e1002234. PMID: 21931551, PMCID: PMC3169560, PII: PPATHOGENS-D-11-00125, DOI: 10.1371/journal.ppat.1002234, ISSN: 1553-7374.

Lindquist ME, Mainou BA, Dermody TS, Crowe JE. Activation of protein kinase R is required for induction of stress granules by respiratory syncytial virus but dispensable for viral replication. Virology [print-electronic]. 2011 Apr 4/25/2011; 413(1): 103-10. PMID: 21377708, PMCID: PMC3072468, PII: S0042-6822(11)00070-5, DOI: 10.1016/j.virol.2011.02.009, ISSN: 1096-0341.

Engelhardt BG, Jagasia M, Savani BN, Bratcher NL, Greer JP, Jiang A, Kassim AA, Lu P, Schuening F, Yoder SM, Rock MT, Crowe JE. Regulatory T cell expression of CLA or a(4)ß(7) and skin or gut acute GVHD outcomes. Bone Marrow Transplant [print-electronic]. 2011 Mar; 46(3): 436-42. PMID: 20577222, PMCID: PMC3217583, PII: bmt2010127, DOI: 10.1038/bmt.2010.127, ISSN: 1476-5365.

Krause JC, Ekiert DC, Tumpey TM, Smith PB, Wilson IA, Crowe JE. An insertion mutation that distorts antibody binding site architecture enhances function of a human antibody. MBio [electronic-print]. 2011; 2(1): e00345-10. PMID: 21304166, PMCID: PMC3037006, PII: mBio.00345-10, DOI: 10.1128/mBio.00345-10, ISSN: 2150-7511.

Pishchany G, McCoy AL, Torres VJ, Krause JC, Crowe JE, Fabry ME, Skaar EP. Specificity for human hemoglobin enhances Staphylococcus aureus infection. Cell Host Microbe. 2010 Dec 12/16/2010; 8(6): 544-50. PMID: 21147468, PMCID: PMC3032424, PII: S1931-3128(10)00355-0, DOI: 10.1016/j.chom.2010.11.002, ISSN: 1934-6069.

Thornburg NJ, Shepherd B, Crowe JE. Transforming growth factor beta is a major regulator of human neonatal immune responses following respiratory syncytial virus infection. J. Virol [print-electronic]. 2010 Dec; 84(24): 12895-902. PMID: 20926560, PMCID: PMC3004333, PII: JVI.01273-10, DOI: 10.1128/JVI.01273-10, ISSN: 1098-5514.

Lindquist ME, Lifland AW, Utley TJ, Santangelo PJ, Crowe JE. Respiratory syncytial virus induces host RNA stress granules to facilitate viral replication. J. Virol [print-electronic]. 2010 Dec; 84(23): 12274-84. PMID: 20844027, PMCID: PMC2976418, PII: JVI.00260-10, DOI: 10.1128/JVI.00260-10, ISSN: 1098-5514.

Hicar MD, Chen X, Briney B, Hammonds J, Wang JJ, Kalams S, Spearman PW, Crowe JE. Pseudovirion particles bearing native HIV envelope trimers facilitate a novel method for generating human neutralizing monoclonal antibodies against HIV. J. Acquir. Immune Defic. Syndr. 2010 Jul; 54(3): 223-35. PMID: 20531016, PMCID: PMC2930513, DOI: 10.1097/QAI.0b013e3181dc98a3, ISSN: 1944-7884.

Williams JV, Edwards KM, Weinberg GA, Griffin MR, Hall CB, Zhu Y, Szilagyi PG, Wang CK, Yang CF, Silva D, Ye D, Spaete RR, Crowe JE. Population-based incidence of human metapneumovirus infection among hospitalized children. J. Infect. Dis. 2010 Jun 6/15/2010; 201(12): 1890-8. PMID: 20446850, PMCID: PMC2873123, DOI: 10.1086/652782, ISSN: 1537-6613.

Hicar MD, Kalams SA, Spearman PW, Crowe JE. Emerging studies of human HIV-specific antibody repertoires. Vaccine. 2010 May 5/26/2010; 28 Suppl 2: B18-23. PMID: 20510738, PMCID: PMC2879399, PII: S0264-410X(10)00144-1, DOI: 10.1016/j.vaccine.2010.02.002, ISSN: 1873-2518.

Xu R, Ekiert DC, Krause JC, Hai R, Crowe JE, Wilson IA. Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science [print-electronic]. 2010 Apr 4/16/2010; 328(5976): 357-60. PMID: 20339031, PMCID: PMC2897825, PII: science.1186430, DOI: 10.1126/science.1186430, ISSN: 1095-9203.

Krause JC, Tumpey TM, Huffman CJ, McGraw PA, Pearce MB, Tsibane T, Hai R, Basler CF, Crowe JE. Naturally occurring human monoclonal antibodies neutralize both 1918 and 2009 pandemic influenza A (H1N1) viruses. J. Virol [print-electronic]. 2010 Mar; 84(6): 3127-30. PMID: 20042511, PMCID: PMC2826039, PII: JVI.02184-09, DOI: 10.1128/JVI.02184-09, ISSN: 1098-5514.

Engelhardt BG, Crowe JE. Homing in on acute graft vs. host disease: tissue-specific T regulatory and Th17 cells. Curr. Top. Microbiol. Immunol. 2010; 341: 121-46. PMID: 20563712, PMCID: PMC3793903, DOI: 10.1007/82_2010_24, ISSN: 0070-217X.

Crowe JE. Recent advances in the study of human antibody responses to influenza virus using optimized human hybridoma approaches. Vaccine. 2009 Dec 12/30/2009; 27 Suppl 6: G47-51. PMID: 20006140, PMCID: PMC2835990, PII: S0264-410X(09)01675-2, DOI: 10.1016/j.vaccine.2009.10.124, ISSN: 1873-2518.

Talbot HK, Shepherd BE, Crowe JE, Griffin MR, Edwards KM, Podsiad AB, Tollefson SJ, Wright PF, Williams JV. The pediatric burden of human coronaviruses evaluated for twenty years. Pediatr. Infect. Dis. J. 2009 Aug; 28(8): 682-7. PMID: 19633513, PMCID: PMC2765860, PII: 00006454-200908000-00005, DOI: 10.1097/INF.0b013e31819d0d27, ISSN: 0891-3668.

Moore ML, Chi MH, Luongo C, Lukacs NW, Polosukhin VV, Huckabee MM, Newcomb DC, Buchholz UJ, Crowe JE, Goleniewska K, Williams JV, Collins PL, Peebles RS. A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction. J. Virol [print-electronic]. 2009 May; 83(9): 4185-94. PMID: 19211758, PMCID: PMC2668460, PII: JVI.01853-08, DOI: 10.1128/JVI.01853-08, ISSN: 1098-5514.

Talbot HK, Crowe JE, Edwards KM, Griffin MR, Zhu Y, Weinberg GA, Szilagyi PG, Hall CB, Podsiad AB, Iwane M, Williams JV, . Coronavirus infection and hospitalizations for acute respiratory illness in young children. J. Med. Virol. 2009 May; 81(5): 853-6. PMID: 19319948, PMCID: PMC2767383, DOI: 10.1002/jmv.21443, ISSN: 1096-9071.

Yang CF, Wang CK, Tollefson SJ, Piyaratna R, Lintao LD, Chu M, Liem A, Mark M, Spaete RR, Crowe JE, Williams JV. Genetic diversity and evolution of human metapneumovirus fusion protein over twenty years. Virol. J. 2009; 6: 138. PMID: 19740442, PMCID: PMC2753315, PII: 1743-422X-6-138, DOI: 10.1186/1743-422X-6-138, ISSN: 1743-422X.

Derdowski A, Peters TR, Glover N, Qian R, Utley TJ, Burnett A, Williams JV, Spearman P, Crowe JE. Human metapneumovirus nucleoprotein and phosphoprotein interact and provide the minimal requirements for inclusion body formation. J. Gen. Virol. 2008 Nov; 89(Pt 11): 2698-708. PMID: 18931065, PMCID: PMC2876975, PII: 89/11/2698, DOI: 10.1099/vir.0.2008/004051-0, ISSN: 0022-1317.

Mok H, Tollefson SJ, Podsiad AB, Shepherd BE, Polosukhin VV, Johnston RE, Williams JV, Crowe JE. An alphavirus replicon-based human metapneumovirus vaccine is immunogenic and protective in mice and cotton rats. J. Virol [print-electronic]. 2008 Nov; 82(22): 11410-8. PMID: 18786987, PMCID: PMC2573258, PII: JVI.01688-08, DOI: 10.1128/JVI.01688-08, ISSN: 1098-5514.

Yu X, Tsibane T, McGraw PA, House FS, Keefer CJ, Hicar MD, Tumpey TM, Pappas C, Perrone LA, Martinez O, Stevens J, Wilson IA, Aguilar PV, Altschuler EL, Basler CF, Crowe JE. Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature [print-electronic]. 2008 Sep 9/25/2008; 455(7212): 532-6. PMID: 18716625, PMCID: PMC2848880, PII: nature07231, DOI: 10.1038/nature07231, ISSN: 1476-4687.

Mok H, Lee S, Wright DW, Crowe JE. Enhancement of the CD8+ T cell response to a subdominant epitope of respiratory syncytial virus by deletion of an immunodominant epitope. Vaccine [print-electronic]. 2008 Sep 9/2/2008; 26(37): 4775-82. PMID: 18662734, PMCID: PMC2561208, PII: S0264-410X(08)00934-1, DOI: 10.1016/j.vaccine.2008.07.012, ISSN: 0264-410X.

Yu X, McGraw PA, House FS, Crowe JE. An optimized electrofusion-based protocol for generating virus-specific human monoclonal antibodies. J. Immunol. Methods [print-electronic]. 2008 Jul 7/31/2008; 336(2): 142-51. PMID: 18514220, PMCID: PMC2519117, PII: S0022-1759(08)00139-7, DOI: 10.1016/j.jim.2008.04.008, ISSN: 0022-1759.

Utley TJ, Ducharme NA, Varthakavi V, Shepherd BE, Santangelo PJ, Lindquist ME, Goldenring JR, Crowe JE. Respiratory syncytial virus uses a Vps4-independent budding mechanism controlled by Rab11-FIP2. Proc. Natl. Acad. Sci. U.S.A [print-electronic]. 2008 Jul 7/22/2008; 105(29): 10209-14. PMID: 18621683, PMCID: PMC2481327, PII: 0712144105, DOI: 10.1073/pnas.0712144105, ISSN: 1091-6490.

Kallewaard NL, McKinney BA, Gu Y, Chen A, Prasad BV, Crowe JE. Functional maturation of the human antibody response to rotavirus. J. Immunol. 2008 Mar 3/15/2008; 180(6): 3980-9. PMID: 18322207, PII: 180/6/3980, ISSN: 0022-1767.

Tian C, Luskin GK, Dischert KM, Higginbotham JN, Shepherd BE, Crowe JE. Immunodominance of the VH1-46 antibody gene segment in the primary repertoire of human rotavirus-specific B cells is reduced in the memory compartment through somatic mutation of nondominant clones. J. Immunol. 2008 Mar 3/1/2008; 180(5): 3279-88. PMID: 18292552, PII: 180/5/3279, ISSN: 0022-1767.

Mok H, Lee S, Utley TJ, Shepherd BE, Polosukhin VV, Collier ML, Davis NL, Johnston RE, Crowe JE. Venezuelan equine encephalitis virus replicon particles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton rats. J. Virol [print-electronic]. 2007 Dec; 81(24): 13710-22. PMID: 17928349, PMCID: PMC2168850, PII: JVI.01351-07, DOI: 10.1128/JVI.01351-07, ISSN: 1098-5514.

Williams JV, Chen Z, Cseke G, Wright DW, Keefer CJ, Tollefson SJ, Hessell A, Podsiad A, Shepherd BE, Sanna PP, Burton DR, Crowe JE, Williamson RA. A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivo. J. Virol [print-electronic]. 2007 Aug; 81(15): 8315-24. PMID: 17522220, PMCID: PMC1951312, PII: JVI.00106-07, DOI: 10.1128/JVI.00106-07, ISSN: 0022-538X.

Lee S, Miller SA, Wright DW, Rock MT, Crowe JE. Tissue-specific regulation of CD8+ T-lymphocyte immunodominance in respiratory syncytial virus infection. J. Virol [print-electronic]. 2007 Mar; 81(5): 2349-58. PMID: 17182672, PMCID: PMC1865932, PII: JVI.01910-06, DOI: 10.1128/JVI.01910-06, ISSN: 0022-538X.

Tian C, Luskin GK, Dischert KM, Higginbotham JN, Shepherd BE, Crowe JE. Evidence for preferential Ig gene usage and differential TdT and exonuclease activities in human naïve and memory B cells. Mol. Immunol [print-electronic]. 2007 Mar; 44(9): 2173-83. PMID: 17196657, PMCID: PMC1859862, PII: S0161-5890(06)00701-2, DOI: 10.1016/j.molimm.2006.11.020, ISSN: 0161-5890.

Cseke G, Wright DW, Tollefson SJ, Johnson JE, Crowe JE, Williams JV. Human metapneumovirus fusion protein vaccines that are immunogenic and protective in cotton rats. J. Virol [print-electronic]. 2007 Jan; 81(2): 698-707. PMID: 17050599, PMCID: PMC1797435, PII: JVI.00844-06, DOI: 10.1128/JVI.00844-06, ISSN: 0022-538X.

Miller SA, Tollefson S, Crowe JE, Williams JV, Wright DW. Examination of a fusogenic hexameric core from human metapneumovirus and identification of a potent synthetic peptide inhibitor from the heptad repeat 1 region. J. Virol [print-electronic]. 2007 Jan; 81(1): 141-9. PMID: 17035305, PMCID: PMC1797239, PII: JVI.01243-06, DOI: 10.1128/JVI.01243-06, ISSN: 0022-538X.

Tian C, Kron GK, Dischert KM, Higginbotham JN, Crowe JE. Low expression of the interleukin (IL)-4 receptor alpha chain and reduced signalling via the IL-4 receptor complex in human neonatal B cells. Immunology [print-electronic]. 2006 Sep; 119(1): 54-62. PMID: 16764687, PMCID: PMC1782340, PII: IMM2405, DOI: 10.1111/j.1365-2567.2006.02405.x, ISSN: 0019-2805.

McKinney BA, Reif DM, Rock MT, Edwards KM, Kingsmore SF, Moore JH, Crowe JE. Cytokine expression patterns associated with systemic adverse events following smallpox immunization. J. Infect. Dis [print-electronic]. 2006 Aug 8/15/2006; 194(4): 444-53. PMID: 16845627, PMCID: PMC1620015, PII: JID36092, DOI: 10.1086/505503, ISSN: 0022-1899.

Rock MT, Yoder SM, Talbot TR, Edwards KM, Crowe JE. Cellular immune responses to diluted and undiluted aventis pasteur smallpox vaccine. J. Infect. Dis [print-electronic]. 2006 Aug 8/15/2006; 194(4): 435-43. PMID: 16845626, PII: JID36240, DOI: 10.1086/505506, ISSN: 0022-1899.

Williams JV, Wang CK, Yang CF, Tollefson SJ, House FS, Heck JM, Chu M, Brown JB, Lintao LD, Quinto JD, Chu D, Spaete RR, Edwards KM, Wright PF, Crowe JE. The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experience. J. Infect. Dis [print-electronic]. 2006 Feb 2/1/2006; 193(3): 387-95. PMID: 16388486, PMCID: PMC1586246, PII: JID34908, DOI: 10.1086/499274, ISSN: 0022-1899.

McKinney BA, Crowe JE, Voss HU, Crooke PS, Barney N, Moore JH. Hybrid grammar-based approach to nonlinear dynamical system identification from biological time series. Phys Rev E Stat Nonlin Soft Matter Phys [print-electronic]. 2006 Feb; 73(2 Pt 1): 21912. PMID: 16605367, DOI: 10.1103/PhysRevE.73.021912, ISSN: 1539-3755.

Bowen AL, Tian C, LaFleur BJ, Crowe JE. Transcriptional control of activation-induced cytidine deaminase and error-prone DNA polymerases is functionally mature in the B cells of infants at birth. Hum. Immunol [print-electronic]. 2006 Jan; 67(1-2): 43-6. PMID: 16698424, PII: S0198-8859(06)00008-5, DOI: 10.1016/j.humimm.2006.02.021, ISSN: 0198-8859.

Weitkamp JH, Lafleur BJ, Crowe JE. Rotavirus-specific CD5+ B cells in young children exhibit a distinct antibody repertoire compared with CD5- B cells. Hum. Immunol [print-electronic]. 2006 Jan; 67(1-2): 33-42. PMID: 16698423, PII: S0198-8859(06)00011-5, DOI: 10.1016/j.humimm.2006.02.024, ISSN: 0198-8859.

Brock SC, Heck JM, McGraw PA, Crowe JE. The transmembrane domain of the respiratory syncytial virus F protein is an orientation-independent apical plasma membrane sorting sequence. J. Virol. 2005 Oct; 79(19): 12528-35. PMID: 16160180, PMCID: PMC1211512, PII: 79/19/12528, DOI: 10.1128/JVI.79.19.12528-12535.2005, ISSN: 0022-538X.

Williams JV, Crowe JE, Enriquez R, Minton P, Peebles RS, Hamilton RG, Higgins S, Griffin M, Hartert TV. Human metapneumovirus infection plays an etiologic role in acute asthma exacerbations requiring hospitalization in adults. J. Infect. Dis [print-electronic]. 2005 Oct 10/1/2005; 192(7): 1149-53. PMID: 16136455, PMCID: PMC1476781, PII: JID34247, DOI: 10.1086/444392, ISSN: 0022-1899.

Williams JV, Martino R, Rabella N, Otegui M, Parody R, Heck JM, Crowe JE. A prospective study comparing human metapneumovirus with other respiratory viruses in adults with hematologic malignancies and respiratory tract infections. J. Infect. Dis [print-electronic]. 2005 Sep 9/15/2005; 192(6): 1061-5. PMID: 16107960, PMCID: PMC1483060, PII: JID34317, DOI: 10.1086/432732, ISSN: 0022-1899.

Williams JV, Tollefson SJ, Johnson JE, Crowe JE. The cotton rat (Sigmodon hispidus) is a permissive small animal model of human metapneumovirus infection, pathogenesis, and protective immunity. J. Virol. 2005 Sep; 79(17): 10944-51. PMID: 16103146, PMCID: PMC1193579, PII: 79/17/10944, DOI: 10.1128/JVI.79.17.10944-10951.2005, ISSN: 0022-538X.

Weitkamp JH, Lafleur BJ, Greenberg HB, Crowe JE. Natural evolution of a human virus-specific antibody gene repertoire by somatic hypermutation requires both hotspot-directed and randomly-directed processes. Hum. Immunol. 2005 Jun; 66(6): 666-76. PMID: 15993712, PII: S0198-8859(05)00060-1, DOI: 10.1016/j.humimm.2005.02.008, ISSN: 0198-8859.

Chen X, Rock MT, Hammonds J, Tartaglia J, Shintani A, Currier J, Slike B, Crowe JE, Marovich M, Spearman P. Pseudovirion particle production by live poxvirus human immunodeficiency virus vaccine vector enhances humoral and cellular immune responses. J. Virol. 2005 May; 79(9): 5537-47. PMID: 15827168, PMCID: PMC1082749, PII: 79/9/5537, DOI: 10.1128/JVI.79.9.5537-5547.2005, ISSN: 0022-538X.

Tai JH, Williams JV, Edwards KM, Wright PF, Crowe JE, Dermody TS. Prevalence of reovirus-specific antibodies in young children in Nashville, Tennessee. J. Infect. Dis [print-electronic]. 2005 Apr 4/15/2005; 191(8): 1221-4. PMID: 15776366, PII: JID33615, DOI: 10.1086/428911, ISSN: 0022-1899.

Bentzen EL, House F, Utley TJ, Crowe JE, Wright DW. Progression of respiratory syncytial virus infection monitored by fluorescent quantum dot probes. Nano Lett. 2005 Apr; 5(4): 591-5. PMID: 15826092, DOI: 10.1021/nl048073u, ISSN: 1530-6984.

Weitkamp JH, Kallewaard NL, Bowen AL, Lafleur BJ, Greenberg HB, Crowe JE. VH1-46 is the dominant immunoglobulin heavy chain gene segment in rotavirus-specific memory B cells expressing the intestinal homing receptor alpha4beta7. J. Immunol. 2005 Mar 3/15/2005; 174(6): 3454-60. PMID: 15749880, PII: 174/6/3454, ISSN: 0022-1767.

Rock MT, Yoder SM, Wright PF, Talbot TR, Edwards KM, Crowe JE. Differential regulation of granzyme and perforin in effector and memory T cells following smallpox immunization. J. Immunol. 2005 Mar 3/15/2005; 174(6): 3757-64. PMID: 15749916, PII: 174/6/3757, ISSN: 0022-1767.

Shaklee JF, Talbot TR, Muldowney JA, Vaughan DE, Butler J, House F, Crowe JE, Smith LH, Edwards KM. Smallpox vaccination does not elevate systemic levels of prothrombotic proteins associated with ischemic cardiac events. J. Infect. Dis [print-electronic]. 2005 Mar 3/1/2005; 191(5): 724-30. PMID: 15688286, PII: JID33581, DOI: 10.1086/427831, ISSN: 0022-1899.

Kallewaard NL, Bowen AL, Crowe JE. Cooperativity of actin and microtubule elements during replication of respiratory syncytial virus. Virology. 2005 Jan 1/5/2005; 331(1): 73-81. PMID: 15582654, PII: S0042-6822(04)00678-6, DOI: 10.1016/j.virol.2004.10.010, ISSN: 0042-6822.

Crowe JE. Human metapneumovirus as a major cause of human respiratory tract disease. Pediatr. Infect. Dis. J. 2004 Nov; 23(11 Suppl): S215-21. PMID: 15577576, PII: 00006454-200411001-00006, ISSN: 0891-3668.

Talbot TR, Stapleton JT, Brady RC, Winokur PL, Bernstein DI, Germanson T, Yoder SM, Rock MT, Crowe JE, Edwards KM. Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine: a randomized controlled trial. JAMA. 2004 Sep 9/8/2004; 292(10): 1205-12. PMID: 15353533, PII: 292/10/1205, DOI: 10.1001/jama.292.10.1205, ISSN: 1538-3598.

Rock MT, Yoder SM, Talbot TR, Edwards KM, Crowe JE. Adverse events after smallpox immunizations are associated with alterations in systemic cytokine levels. J. Infect. Dis [print-electronic]. 2004 Apr 4/15/2004; 189(8): 1401-10. PMID: 15073677, PII: JID31505, DOI: 10.1086/382510, ISSN: 0022-1899.

Suara RO, Crowe JE. Effect of zinc salts on respiratory syncytial virus replication. Antimicrob. Agents Chemother. 2004 Mar; 48(3): 783-90. PMID: 14982765, PMCID: PMC353050, ISSN: 0066-4804.

Williams JV, Harris PA, Tollefson SJ, Halburnt-Rush LL, Pingsterhaus JM, Edwards KM, Wright PF, Crowe JE. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N. Engl. J. Med. 2004 Jan 1/29/2004; 350(5): 443-50. PMID: 14749452, PMCID: PMC1831873, PII: 350/5/443, DOI: 10.1056/NEJMoa025472, ISSN: 1533-4406.

Brock SC, Goldenring JR, Crowe JE. Apical recycling systems regulate directional budding of respiratory syncytial virus from polarized epithelial cells. Proc. Natl. Acad. Sci. U.S.A [print-electronic]. 2003 Dec 12/9/2003; 100(25): 15143-8. PMID: 14630951, PMCID: PMC299925, PII: 2434327100, DOI: 10.1073/pnas.2434327100, ISSN: 0027-8424.

Halasa NB, Whitlock JA, McCurley TL, Smith JA, Zhu Q, Ochs H, Dermody TS, Crowe JE. Fatal hemophagocytic lymphohistiocytosis associated with Epstein-Barr virus infection in a patient with a novel mutation in the signaling lymphocytic activation molecule-associated protein. Clin. Infect. Dis [print-electronic]. 2003 Nov 11/15/2003; 37(10): e136-41. PMID: 14583885, PII: CID31173, DOI: 10.1086/379126, ISSN: 1537-6591.

Weitkamp JH, Kallewaard N, Kusuhara K, Bures E, Williams JV, LaFleur B, Greenberg HB, Crowe JE. Infant and adult human B cell responses to rotavirus share common immunodominant variable gene repertoires. J. Immunol. 2003 Nov 11/1/2003; 171(9): 4680-8. PMID: 14568943, ISSN: 0022-1767.

Venter M, Rock M, Puren AJ, Tiemessen CT, Crowe JE. Respiratory syncytial virus nucleoprotein-specific cytotoxic T-cell epitopes in a South African population of diverse HLA types are conserved in circulating field strains. J. Virol. 2003 Jul; 77(13): 7319-29. PMID: 12805430, PMCID: PMC164818, ISSN: 0022-538X.

Crowe JE, Sannella EC, Pfeiffer S, Zorn GL, Azimzadeh A, Newman R, Miller GG, Pierson RN. CD154 regulates primate humoral immunity to influenza. Am. J. Transplant. 2003 Jun; 3(6): 680-8. PMID: 12780559, PII: 106, ISSN: 1600-6135.

Crowe JE, Williams JV. Immunology of viral respiratory tract infection in infancy. Paediatr Respir Rev. 2003 Jun; 4(2): 112-9. PMID: 12758048, PII: S1526054203000332, ISSN: 1526-0542.

Weitkamp JH, Kallewaard N, Kusuhara K, Feigelstock D, Feng N, Greenberg HB, Crowe JE. Generation of recombinant human monoclonal antibodies to rotavirus from single antigen-specific B cells selected with fluorescent virus-like particles. J. Immunol. Methods. 2003 Apr 4/1/2003; 275(1-2): 223-37. PMID: 12667686, PII: S0022175903000139, ISSN: 0022-1759.

Rock MT, Crowe JE. Identification of a novel human leucocyte antigen-A*01-restricted cytotoxic T-lymphocyte epitope in the respiratory syncytial virus fusion protein. Immunology. 2003 Apr; 108(4): 474-80. PMID: 12667209, PMCID: PMC1782928, PII: 1619, ISSN: 0019-2805.

Brock SC, McGraw PA, Wright PF, Crowe JE. The human polymeric immunoglobulin receptor facilitates invasion of epithelial cells by Streptococcus pneumoniae in a strain-specific and cell type-specific manner. Infect. Immun. 2002 Sep; 70(9): 5091-5. PMID: 12183558, PMCID: PMC128237, ISSN: 0019-9567.

Peters TR, Jennings MT, Crowe JE. Pneumocystis carinii pneumonia in a girl with a midbrain glioma. Pediatr Hematol Oncol. 2002 Mar; 19(2): 141-3. PMID: 11881789, ISSN: 0888-0018.

Crowe JE. Influence of maternal antibodies on neonatal immunization against respiratory viruses. Clin. Infect. Dis [print-electronic]. 2001 Nov 11/15/2001; 33(10): 1720-7. PMID: 11595986, PII: CID010273, DOI: 10.1086/322971, ISSN: 1058-4838.

Crowe JE. Respiratory syncytial virus vaccine development. Vaccine. 2001 Oct 10/15/2001; 20 Suppl 1: S32-7. PMID: 11587807, PII: S0264410X01002870, ISSN: 0264-410X.

Crowe JE, Firestone CY, Murphy BR. Passively acquired antibodies suppress humoral but not cell-mediated immunity in mice immunized with live attenuated respiratory syncytial virus vaccines. J. Immunol. 2001 Oct 10/1/2001; 167(7): 3910-8. PMID: 11564809, ISSN: 0022-1767.

Weitkamp JH, Crowe JE. Blood donor leukocyte reduction filters as a source of human B lymphocytes. BioTechniques. 2001 Sep; 31(3): 464-6. PMID: 11570486, ISSN: 0736-6205.

Pierson RN, Crowe JE, Pfeiffer S, Atkinson J, Azimzadeh A, Miller GG. CD40-ligand in primate cardiac allograft and viral immunity. Immunol. Res. 2001; 23(2-3): 253-62. PMID: 11444390, PII: IR:23:2-3:253, DOI: 10.1385/IR:23:2-3:253, ISSN: 0257-277X.

Crowe JE, Suara RO, Brock S, Kallewaard N, House F, Weitkamp JH. Genetic and structural determinants of virus neutralizing antibodies. Immunol. Res. 2001; 23(2-3): 135-45. PMID: 11444379, PII: IR:23:2-3:135, DOI: 10.1385/IR:23:2-3:135, ISSN: 0257-277X.

Peters TR, Brumbaugh DE, Lawton AR, Crowe JE. Recurrent pneumococcal arthritis as the presenting manifestation of X-linked agammaglobulinemia. Clin. Infect. Dis. 2000 Nov; 31(5): 1287-8. PMID: 11073766, PII: CID000256, DOI: 10.1086/317430, ISSN: 1058-4838.

Weitkamp JH, Tang YW, Haas DW, Midha NK, Crowe JE. Recurrent Achromobacter xylosoxidans bacteremia associated with persistent lymph node infection in a patient with hyper-immunoglobulin M syndrome. Clin. Infect. Dis [print-electronic]. 2000 Nov; 31(5): 1183-7. PMID: 11073750, PII: CID994327, DOI: 10.1086/317461, ISSN: 1058-4838.

Wright PF, Karron RA, Belshe RB, Thompson J, Crowe JE, Boyce TG, Halburnt LL, Reed GW, Whitehead SS, Anderson EL, Wittek AE, Casey R, Eichelberger M, Thumar B, Randolph VB, Udem SA, Chanock RM, Murphy BR. Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy. J. Infect. Dis [print-electronic]. 2000 Nov; 182(5): 1331-42. PMID: 11010838, PII: JID000286, DOI: 10.1086/315859, ISSN: 0022-1899.

Pastey MK, Gower TL, Spearman PW, Crowe JE, Graham BS. A RhoA-derived peptide inhibits syncytium formation induced by respiratory syncytial virus and parainfluenza virus type 3. Nat. Med. 2000 Jan; 6(1): 35-40. PMID: 10613821, DOI: 10.1038/71503, ISSN: 1078-8956.

Weitkamp J-H, Crowe JE Jr. Current approaches to vaccine development against disease caused by respiratory syncytial virus (RSV). Monatsschr Kinderheilkd. 2000; 148: 980-9.

Fisher RG, Crowe JE, Johnson TR, Tang YW, Graham BS. Passive IgA monoclonal antibody is no more effective than IgG at protecting mice from mucosal challenge with respiratory syncytial virus. J. Infect. Dis. 1999 Oct; 180(4): 1324-7. PMID: 10479165, PII: JID990266, DOI: 10.1086/315037, ISSN: 0022-1899.

Pastey MK, Crowe JE, Graham BS. RhoA interacts with the fusion glycoprotein of respiratory syncytial virus and facilitates virus-induced syncytium formation. J. Virol. 1999 Sep; 73(9): 7262-70. PMID: 10438814, PMCID: PMC104251, ISSN: 0022-538X.

Sakurai H, Williamson RA, Crowe JE, Beeler JA, Poignard P, Bastidas RB, Chanock RM, Burton DR. Human antibody responses to mature and immature forms of viral envelope in respiratory syncytial virus infection: significance for subunit vaccines. J. Virol. 1999 Apr; 73(4): 2956-62. PMID: 10074145, PMCID: PMC104055, ISSN: 0022-538X.

Whitehead SS, Firestone CY, Karron RA, Crowe JE, Elkins WR, Collins PL, Murphy BR. Addition of a missense mutation present in the L gene of respiratory syncytial virus (RSV) cpts530/1030 to RSV vaccine candidate cpts248/404 increases its attenuation and temperature sensitivity. J. Virol. 1999 Feb; 73(2): 871-7. PMID: 9882287, PMCID: PMC103906, ISSN: 0022-538X.

Crowe JE, Randolph V, Murphy BR. The live attenuated subgroup B respiratory syncytial virus vaccine candidate RSV 2B33F is attenuated and immunogenic in chimpanzees, but exhibits partial loss of the ts phenotype following replication in vivo. Virus Res. 1999 Jan; 59(1): 13-22. PMID: 10854162, PII: S016817029800118X, ISSN: 0168-1702.

Crowe JE. Host responses to respiratory virus infection and immunization. Curr. Top. Microbiol. Immunol. 1999; 236: 191-214. PMID: 9893361, ISSN: 0070-217X.

Crowe JE Jr, Randolph V, Murphy BR. The live attenuated subgroup B respiratory syncytial virus vaccine candidate RSV 2B33F is attenuated and immunogenic in chimpanzees, but exhibits partial loss of the ts phenotype following replication in vivo. Virus Research. 1999; 59: 13-22.

Crowe JE, Firestone CY, Crim R, Beeler JA, Coelingh KL, Barbas CF, Burton DR, Chanock RM, Murphy BR. Monoclonal antibody-resistant mutants selected with a respiratory syncytial virus-neutralizing human antibody fab fragment (Fab 19) define a unique epitope on the fusion (F) glycoprotein. Virology. 1998 Dec 12/20/1998; 252(2): 373-5. PMID: 9878616, PII: S0042-6822(98)99462-4, DOI: 10.1006/viro.1998.9462, ISSN: 0042-6822.

Crowe JE. Immune responses of infants to infection with respiratory viruses and live attenuated respiratory virus candidate vaccines. Vaccine. 1998 Aug; 16(14-15): 1423-32. PMID: 9711783, PII: S0264-410X(98)00103-0, ISSN: 0264-410X.

Crowe JE, Gilmour PS, Murphy BR, Chanock RM, Duan L, Pomerantz RJ, Pilkington GR. Isolation of a second recombinant human respiratory syncytial virus monoclonal antibody fragment (Fab RSVF2-5) that exhibits therapeutic efficacy in vivo. J. Infect. Dis. 1998 Apr; 177(4): 1073-6. PMID: 9534985, ISSN: 0022-1899.

Karron RA, Wright PF, Crowe JE, Clements-Mann ML, Thompson J, Makhene M, Casey R, Murphy BR. Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children. J. Infect. Dis. 1997 Dec; 176(6): 1428-36. PMID: 9395351, ISSN: 0022-1899.

Juhasz K, Whitehead SS, Bui PT, Biggs JM, Crowe JE, Boulanger CA, Collins PL, Murphy BR. The temperature-sensitive (ts) phenotype of a cold-passaged (cp) live attenuated respiratory syncytial virus vaccine candidate, designated cpts530, results from a single amino acid substitution in the L protein. J. Virol. 1997 Aug; 71(8): 5814-9. PMID: 9223470, PMCID: PMC191836, ISSN: 0022-538X.

Crowe JE Jr, Murphy BR. Vaccines against respiratory syncytial virus and parainfluenza type 3. New Generation Vaccines, 2nd ed, Levine MM, Woodrow GC, Kaper JB, Cobon GS. 1997; 711-25.

Firestone CY, Whitehead SS, Collins PL, Murphy BR, Crowe JE. Nucleotide sequence analysis of the respiratory syncytial virus subgroup A cold-passaged (cp) temperature sensitive (ts) cpts-248/404 live attenuated virus vaccine candidate. Virology. 1996 Nov 11/15/1996; 225(2): 419-22. PMID: 8918930, PII: S0042682296906182, ISSN: 0042-6822.

Crowe JE, Bui PT, Firestone CY, Connors M, Elkins WR, Chanock RM, Murphy BR. Live subgroup B respiratory syncytial virus vaccines that are attenuated, genetically stable, and immunogenic in rodents and nonhuman primates. J. Infect. Dis. 1996 Apr; 173(4): 829-39. PMID: 8603960, ISSN: 0022-1899.

Crowe JE, Firestone CY, Whitehead SS, Collins PL, Murphy BR. Acquisition of the ts phenotype by a chemically mutagenized cold-passaged human respiratory syncytial virus vaccine candidate results from the acquisition of a single mutation in the polymerase (L) gene. Virus Genes. 1996; 13(3): 269-73. PMID: 9035372, ISSN: 0920-8569.

Crowe JE Jr. The role of antibodies in respiratory viral immunity. Seminars in Virology. 1996; 7: 273-83.

Crowe JE, Bui PT, Siber GR, Elkins WR, Chanock RM, Murphy BR. Cold-passaged, temperature-sensitive mutants of human respiratory syncytial virus (RSV) are highly attenuated, immunogenic, and protective in seronegative chimpanzees, even when RSV antibodies are infused shortly before immunization. Vaccine. 1995 Jun; 13(9): 847-55. PMID: 7483808, PII: 0264410X9400074W, ISSN: 0264-410X.

Connors M, Crowe JE, Firestone CY, Murphy BR, Collins PL. A cold-passaged, attenuated strain of human respiratory syncytial virus contains mutations in the F and L genes. Virology. 1995 Apr 4/20/1995; 208(2): 478-84. PMID: 7747420, PII: S0042-6822(85)71178-6, DOI: 10.1006/viro.1995.1178, ISSN: 0042-6822.

Hsu KH, Crowe JE, Lubeck MD, Davis AR, Hung PP, Chanock RM, Murphy BR. Isolation and characterization of a highly attenuated respiratory syncytial virus (RSV) vaccine candidate by mutagenesis of the incompletely attenuated RSV A2 ts-1 NG-1 mutant virus. Vaccine. 1995 Apr; 13(5): 509-15. PMID: 7543716, PII: 0264410X94000025, ISSN: 0264-410X.

Crowe JE. Current approaches to the development of vaccines against disease caused by respiratory syncytial virus (RSV) and parainfluenza virus (PIV). A meeting report of the WHO Programme for Vaccine Development. Vaccine. 1995 Mar; 13(4): 415-21. PMID: 7793140, PII: 0264-410X(95)98266-D, ISSN: 0264-410X.

Kulkarni AB, Collins PL, Bacik I, Yewdell JW, Bennink JR, Crowe JE, Murphy BR. Cytotoxic T cells specific for a single peptide on the M2 protein of respiratory syncytial virus are the sole mediators of resistance induced by immunization with M2 encoded by a recombinant vaccinia virus. J. Virol. 1995 Feb; 69(2): 1261-4. PMID: 7815502, PMCID: PMC188700, ISSN: 0022-538X.

Crowe JE, Cheung PY, Wallace EF, Chanock RM, Larrick JW, Murphy BR, Fry K. Isolation and characterization of a chimpanzee monoclonal antibody to the G glycoprotein of human respiratory syncytial virus. Clin. Diagn. Lab. Immunol. 1994 Nov; 1(6): 701-6. PMID: 8556524, PMCID: PMC368396, ISSN: 1071-412X.

Crowe JE, Bui PT, Davis AR, Chanock RM, Murphy BR. A further attenuated derivative of a cold-passaged temperature-sensitive mutant of human respiratory syncytial virus retains immunogenicity and protective efficacy against wild-type challenge in seronegative chimpanzees. Vaccine. 1994 Jul; 12(9): 783-90. PMID: 7975856, ISSN: 0264-410X.

Crowe JE, Bui PT, London WT, Davis AR, Hung PP, Chanock RM, Murphy BR. Satisfactorily attenuated and protective mutants derived from a partially attenuated cold-passaged respiratory syncytial virus mutant by introduction of additional attenuating mutations during chemical mutagenesis. Vaccine. 1994 Jun; 12(8): 691-9. PMID: 8091846, ISSN: 0264-410X.

Murphy BR, Hall SL, Kulkarni AB, Crowe JE, Collins PL, Connors M, Karron RA, Chanock RM. An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines. Virus Res. 1994 Apr; 32(1): 13-36. PMID: 8030364, PII: 0168-1702(94)90059-0, ISSN: 0168-1702.

Crowe JE, Murphy BR, Chanock RM, Williamson RA, Barbas CF, Burton DR. Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice. Proc. Natl. Acad. Sci. U.S.A. 1994 Feb 2/15/1994; 91(4): 1386-90. PMID: 8108420, PMCID: PMC43163, ISSN: 0027-8424.

Crowe JE Jr, Murphy BR, Chanock RM, Williamson A, Barbas CF III, Burton DR. Human RSV monoclonal antibody Fab cloned from a combinatorial library and produced in E. coli is effective therapeutically when introduced directly into the lungs of RSV-infected mice. Brown F, Chanock RM, Ginsberg HS, Norrby E, eds. Vaccines 94: Modern Approaches to New Vaccines Including Prevention of AIDS. Cold Spring Harbor: Cold Spring Harbor Laboratory Press. 1994; 315-20.

Murphy BR, Crowe JE Jr, Lubeck MD, Hsu K-HL, Hall SL, Karron RA, Clements ML, Wright PF, Belshe RB, Chanock RM. Live attenuated vaccines for respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV 3). Report of the 104th Ross Conference on Pediatric Research, published by Ross Products. 1994; 173-8.

Crowe JE, Collins PL, London WT, Chanock RM, Murphy BR. A comparison in chimpanzees of the immunogenicity and efficacy of live attenuated respiratory syncytial virus (RSV) temperature-sensitive mutant vaccines and vaccinia virus recombinants that express the surface glycoproteins of RSV. Vaccine. 1993 Nov; 11(14): 1395-404. PMID: 8310760, ISSN: 0264-410X.

Chanock RM, Crowe JE, Murphy BR, Burton DR. Human monoclonal antibody Fab fragments cloned from combinatorial libraries: potential usefulness in prevention and/or treatment of major human viral diseases. Infect Agents Dis. 1993 Jun; 2(3): 118-31. PMID: 8173784, ISSN: 1056-2044.

Crowe JE Jr, Barbas CF III, Bui P, Cababa D, Jones TM, Zebedee SL, Murphy BR, Chanock RM, Burton DR. Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivity. Brown F, Chanock RM, Ginsberg HS, Lerner RA, eds. Vaccines 93: Modern Approaches to New Vaccines Including Prevention of AIDS. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory. 1993; (()): 7-11.

Barbas CF, Crowe JE, Cababa D, Jones TM, Zebedee SL, Murphy BR, Chanock RM, Burton DR. Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivity. Proc. Natl. Acad. Sci. U.S.A. 1992 Nov 11/1/1992; 89(21): 10164-8. PMID: 1279672, PMCID: PMC50298, ISSN: 0027-8424.

Murphy BR, Hall SL, Crowe JE Jr, Collins PL, Subbarao EK, Connors M, London WT, Chanock RM. The use of chimpanzees in respiratory virus research. Erwin J, Landon JC, eds. Chimpanzee Conservation and Public Health: Environments for the Future. 1992; 21 28.